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Abstract
Current understanding of the role of excluding certain foods in the treatment of 
asthma is still limited. A series of observational studies has been carried out 
monitoring the levels of food specific IgG antibodies to ovalbumin and p~ 
lactoglobulin, utilising an in-house ELISA in young asthmatic children aged between 
2-15 years and adults. The levels of these antibodies were also considered in relation 
to non-atopic individuals with no personal or family history of atopic conditions. 
Information from a self-administered comprehensive questionnaire provided 
additional information on all groups regarding family history of atopy, adverse 
reactions to foods and customary dietary habits.
A wide range of anti-ovalbumin and anti-p-lactoglobulin IgG levels were observed in 
all asthmatic and non-atopic subjects. In both asthmatic young children and adults 
with or without other atopic conditions, the specific anti-ovalbumin IgG levels were 
significantly higher (between P<0.001 and P<0.05), than the non-atopic groups. In 
contrast, specific anti-p-lactoglobulin IgG levels were significantly higher (P<0.01) in 
asthmatic young children with other atopic conditions compared with the non-atopic 
subjects. However, specific anti-P-lactoglobulin IgG levels were significantly higher 
(P<0.01) in adults with asthma only compared with matched non-atopic subjects.
A single blind prospective study was undertaken to examine the effects of dietary 
eggs and cows’ milk avoidance for 8 weeks in asthmatic children on the signs and 
symptoms of their asthma. Significantly reduced circulating levels of anti-ovalbumin 
IgG (P<0.01) and anti-P-lactoglobulin IgG (P<0.05), were observed in these children 
following the dietary exclusion, indicating compliance on the diet. Other benefits of 
the dietary intervention included less frequently reported episodes of asthmatic attack 
and significantly increased (P<0.05) PEFR reading. Undesirable outcomes of the diet 
intervention included slight weight loss in 7 of 13 children, although this was not 
statistically significantly different.
Evidence from this thesis supports the concept of the role of diet in the induction of 
the asthmatic condition, together with the role of diet intervention in the treatment of 
the asthmatic condition.
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Chapter 1 
Introduction
1.0 General introduction
There has been a steady increase, over the past 10-15 years, in public awareness and 
interest in the importance of diet and health associated with the rising incidence of 
“food allergy” (Ferguson, 1992; Lessof, 1994). Unfortunately, the public often 
associates the term “allergy” with any type of adverse reaction, be it immunologically 
based, or not. The term “allergy” is defined as “a specific, acquired change in host 
reactivity mediated by an immunologic mechanism and causing an untoward 
physiologic response"' (cited from Kleigman, 1996). This definition therefore 
precludes the use of the term allergy for disorders in which immunologic mechanisms 
have not been demonstrated. It is now clear that food allergy or more accurately, 
“adverse reaction to food” is a clinical manifestation of an immunological process in 
which specific antibodies or sensitised T-lymphocytes interact with food constituents 
(Bleummk, 1983; Ferguson, 1992). An adverse reaction may occur after ingestion of 
a particular food (or foods), after inhalation or by epicutaneous (skin) contact or 
injectants.
An adverse reaction to food was described as far back as 2,000 years ago when 
Lucretius (a Latin poet, 94-55 BC) remarked, “Differences are so great that one 
man’s meat is another man’s poison" (cited from Roitt, 1997). Sir Thomas More 
(1478-1535) describes an incidence where King Richard III took advantage of his 
adverse reaction to strawberries: the King served strawberries at a banquet attended 
by one of his guests who was his enemy, and when he (the King) developed 
distinctive rashes he accused his guest of attempted poisoning and had him killed 
(cited from Roitt, 1997).
In 1901, adverse reaction to foods in children became a cause of great concern among 
paediatricians when an infant, fed on cows’ milk, had an anaphylactic reaction. In 
1905, Schlossman and Finkelstein successfully identified the presence of antibodies to 
cows’ milk in the serum of infants fed on it (cited from Hamburger, 1989). In the 
following year, a Viennese paediatrician, Baron Clemens von Pirquet (cited from 
Hamburger, 1989), discovered the immunological basis of systemic reactions to the 
administration of antiserum in the management of bacterial diseases. He referred to 
this as an allergic reaction to a foreign substance i.e. the antigen.
More recently, the underlying cause of “adverse reactions to food” is better 
understood. However, controversy still exists over the value of dietary intervention in 
the treatment of one of the symptoms of adverse reactions - allergy.
1.1 Adverse reactions to foods
The subject of adverse reactions to foods has a long history of being regarded as 
marginal because of cultural beliefs related to health and illness. Some of the more 
controversial areas regarding adverse reactions to foods include hyperkinetic 
behaviour; allergic tension-fatigue; chronic fatigue syndrome; aggressive behaviour; 
Candida hypersensitivity syndrome; food allergy-induced migraine; and rheumatoid 
arthritis and asthma (Schwartz, 1992).
Adverse reactions to foods however, do occur and some of these reactions are due to 
allergic responses triggered by components in food in susceptible people (Klurfeld, 
1993; Lessof, 1994). However confusion and misunderstanding often arise with the 
terminology used in defining adverse reactions to food. May (1976), reported that the 
term allergy was formerly restricted to the immunological type of reaction, however, 
in the late 1980’s it was applied indiscriminately to a variety of adverse reactions to 
food. Schwartz (1992) suggested that adverse reactions (sensitivity) to foods should 
be categorised either as food hypersensitivity (allergy) or as food intolerance. Only 
when an immunological mechanism causes the reaction should the condition be
regarded as allergic. When no immune mechanism is involved, the adverse reaction 
should be regarded as a form of food intolerance.
1.1.1 Adverse reaction (sensitivity)
Adverse reaction is the general term used to define a clinically abnormal response to 
an exposure to a food or food additive.
1.1.2 Food allergy (hypersensitivity) usually involves type I and type IV
Food allergy is defined as an immunological reaction resulting firom the ingestion of a 
food. This reaction may occur even after ingestion (i.e. digestion or absorption) of a 
small quantity of the food. Food allergy is synonymous with hypersensitivity. It is 
reproducible and has been well linked with reactions that involve an IgE- 
immunological mechanism (Anderson, 1997). Examples of food allergy include 
immediate sometimes violent reactions to nuts, eggs, milk, fish and shellfish (Kay, 
1992). Also see Section 1.8.
1.1.3 Food anaphylaxis
This is defined as a classic allergic (hypersensitivity) reaction in which 
immunological activity of the IgE antibody and the release of chemical mediators are 
involved. Anaphylaxis may be life threatening. Anaphylaxis reactions begin with 
sneezing and itching, followed by generalised urticaria, profound bronchospasm, and 
circulatory collapse (cited from Cant, 1988). The time span is variable, but reactions 
occurring within minutes of ingesting the food allergen are potentially fatal.
1.1.4 Food intolerance
This is a general term describing an abnormal physiological response to an ingested 
food or food additive. Food intolerance does not involve an immunological reaction
and thus can include metabolic, pharmacological, or toxic responses to food or food 
additives (Hamburger, 1989).
1.1.5 Food toxicity (poisoning)
This is a term that implies an adverse reaction caused by the direct action of a food or 
food additive without the involvement of an immune reaction. Toxins may either be 
present vrithin the food or released by micro-organisms or parasites contaminating the 
food (Hamburger, 1989).
1.1.6 Pharmacological
This is defined as an adverse reaction to a food or food additive as a result of 
naturally derived or added chemicals that produce a drug-like pharmacological effect. 
An example of this is high amounts of caffeine in strong coffee or tea and large 
quantities of amines fi-om fermented foods such as cheese, red wine, sauerkraut and 
fish products.
1.2 The basis of immunology
The beginnings of the application of immunology in the treatment of disease occurred 
in the East. The discipline of immunology grew fi*om observations that individuals 
who had recovered fi*om certain infectious diseases were thereafter protected from the 
disease. The Latin term immunis. meaning exempt, is the source of the English word 
immunity, meaning the state of protection from infectious diseases (Kuby, 1997).
The first recorded attempts to induce immunity were performed by the Chinese and 
Turks in the 15th century. They either inhaled or inserted into small cuts in the skin (a 
technique called variolation) a powder made from the scabs of healing smallpox 
pustules. In 1718, Lady Mary Wortley Montagu, the wife of the British ambassador to 
Constantinople, observed the positive effects of variolation on the local population
and had the technique applied to her own children. The technique was improved by 
the English physician Edward Jenner in 1798. He was the first person to recogn.se 
and suecessMly use the eowpox virus to vaccinate people against smallpox m the late
1700s (Unanue & Benacerf, 1984; Kuby, 1997).
1.3 The immune response
When a foreign substance breaks through a physical barrier (e.g. skin or mucous 
membrane), the organism is able to recognise and respond to the invasion in a 
protective manner. The immune response falls into two categories: 1) mnate or non­
specific immunity, refers to the basic resistance to disease that the individual is bom 
with and 2) acquired or specific immunity, requires the activity of a functional 
immune system involving cells called lymphocytes and their products. Below is a
brief summary of these two responses.
1.3.1 Innate immunity
Innate immune responses are produced primarily by leukocytes; phagocytic cells such 
as the monocytes; macrophages; and polymorphonuclear neutrophils. These cells bmd 
the micro-organisms and kill them. This type of immunity is a non-specific 
recognition system and does not improve with repeated exposure to foreign molecules
(Kirkwood & Lewis, 1994).
In general the immune responses are divided into two systems: D cell-mediated 
immunity and ii) humoral immunity, i) Cell-mediated immunity is dependent upon 
the direct interaction of T-type lymphocytes and phagocytic cells with the antigen, ii) 
Humoral immunity refers to the protection provided by a group of proteins produced 
by B-type lymphocytes. These proteins are found in serum, saliva, and mucous, and
are known as antibodies.
1.3.2 Acquired immunity
An acquired immune response is highly specific for a particular antigen. The response 
improves with each successive encounter with the same pathogen. This means that it 
remembers the infectious agent and can prevent it fi-om causing the disease later. 
Examples of acquired immune response are found in diseases such as measles and 
diphtheria whereby lifelong immunity is generated follovring an infection or 
vaccination (Benjamini et d ., 1997).
1.4 The antigen
The term “antigen” refers to any substance or molecule that is capable of inducing a 
specific immune response (cellular or humoral). If the response leads to a state of 
immunity, the antigen is said to be immunogenic. Antigens in general, do not have a 
characteristic or specific chemical composition distinguishing them fi-om analogous 
substances that are not antigenic. Therefore the definition of an antigen is entirely an 
operational one depending on whether the substance or molecule elicits an immune 
response. However several factors are known to enable the antigen to induce antibody 
formation. These factors depend to a great extent on the degree of “foreigness” of the 
substance and its molecular weight (Unanue & Benacerf, 1984; Kimball, 1986; Aas, 
1989; Benjamini et al., 1997; Roitt, 1997).
Antigens can be categorised into four groups: those we eat, the allergens; those we 
breathe in, the inhalants; those that come into contact vrith our skin, the contactants; 
and those that are injected, such as stings or antibiotics, the injectants. Airborne 
antigens such as pollens and dust, can act in two ways: as inhalants, when they are 
breathed in, as contactants, when they land on the skin or eyes (Brostoff & Gamlin, 
1992).
The term “antigen” is used for any molecule which is recognised by T-lymphocytes 
or any type of antibody. “Allergens” are foreign molecules (non-infectious antigens)
which can be recognised by IgE antibodies and can trigger allergic reactions. 
Allergens are thus a restricted subset of antigens. Allergen is a single component of a 
protein extract. Proteins which are recognised by the majority of allergic individuals 
are termed major allergens whereas proteins not recognised by the allergic sera are 
regarded as non-allergenic (Frew, 1997).
1.4.1 Antigenicity
An immune response induced by an antigen, produces antibodies that react 
specifically with the antigen. The antigen-binding site of an antibody has a unique 
structure that allows a complementary “fit” to the structure of the specific antigen. 
The portion of the antigen that binds specifically with the binding site of an antibody 
is termed an antigenic determinant or epitope (cited firom Benjamini et al., 1997). A 
substance must have the following characteristics to be an antigen: (1) foreigness and 
(2) high molecular weight (Benjamini et al., 1997) (see Section 1.4).
1.4.1.1 Foreigness
A major requirement for antigenicity concerns the phylogenetic relationship between 
the host and the antigen. Phylogenetic is defined as the complete developmental 
history of a race or group of organisms. Those substances foreign to the host are the 
ones most capable of inducing an immune response. In contrast, substances similar to 
or identical to the host will not stimulate immune responses. Thus bovine serum 
albumin (BSA), which is a normal component of cow serum, is strongly 
immunogenic in mice but not in cows.
1.4.1.2 Molecular weight
The second requirement for antigenicity is that the substance should have a relatively 
high molecular weight greater than approximately 5,000 daltons e.g., albumin, tetanus 
toxin (Lessof et d., 1989; Benjamini et al., 1997).
1.5 Food allergens
All natural antigens (be they allergens, inhalants, contactants or injectants) have so far 
been shown to be proteins. The majority of them are glycoproteins. They contain one 
or more sugar molecules in addition to the amino acids (Aas, 1989). A protein is 
mainly composed of a number of amino acids bound together in peptide linkages with 
or without carbohydrate residues in the primary structure. Dietary proteins (which 
may or may not have allergenic properties) contain a number of amino acids and 
other substances. Each potentially allergenic protein has a number of antigenic 
determinants. When absorbed (consumed, inhaled, injected or in skin contact), the 
antigenic molecules trigger antibody production. The antigenicity differs from protein 
to protein and appears to be influenced by a combination of genetic and 
environmental factors (Aas, 1989).
Although any food that contains protein may be considered as potentially allergenic, 
some foods have been identified or frequently incriminated as causing allergic 
reactions more readily than others in humans. This may be partly because these foods 
are frequently consumed and partly because of a high content of allergenic material. 
Cows’ milk, hens’ eggs and shellfish seem to be the most potent allergens, followed 
by some fi*uits such as tomatoes, strawberries, oranges and bananas. Meat, peanuts, 
chocolates and cereals are also implicated (Lessof, 1992; Andre et al., 1994; Altman 
& Chiaramonte, 1996; Anderson, 1997).
Cows’ milk contains approximately 3% protein. The most prominent allergens found 
in cows’ milk are p-lactoglobulin followed by casein, a-lactalbumin and bovine 
serum albumin, p-lactoglobulin has a molecular weight of 36,000 daltons and 
accounts for 7-12% of total milk proteins (Isolauri, 1995; Nakai & Modler, 1996). 
Like cows’ milk, hens’ eggs contain a variety of well-characterised proteins. Proteins 
in hens’ eggs are often cited as a common cause of adverse reaction to foods. 
Ovalbumin has a molecular weight of 45,000 daltons and is the most abundant protein 
in hens’ eggs. It represents about 65% of the total protein content and is the antigen
with the highest antigenic activity. Besides ovalbumin, lysozyme, ovotransferrin, and 
ovomucoid are also antigenic components of hens’ eggs (Wahn, 1988; Nakai & 
Modler, 1996).
1.5.1 Food allergies
The allergens in eggs remain active even after boiling; P-lactoglobulin in cows’ milk 
is the most stable milk protein in heat. The active antigenic fraction of pasteurised 
milk is only slightly susceptible to proteolytic enzymes. These findings infer that the 
antigenic material of foodstuffs will have a good chance of reaching the circulation 
unaltered after digestion and may lead to hypersensitivity reactions in susceptible 
people. However, information on the pathophysiological events occurring in the gut 
after the ingestion of allergenic food in a sensitive individual are few (de Week, 
1996).
Fish allergens act both as dietary and as inhalant allergens (Aas, 1989; Douglas et al., 
1995). The inhalation of steam from cooking fish or dust from dried fish material can 
provoke asthma in many patients. Other types of food that play an important role as 
an inhalant allergen source are wheat and other types of cereal flours. These inhalant 
allergens mostly become inactivated almost immediately when processed. A large 
number of bakers develop occupational “allergy” to wheat by developing allergic 
rhinitis and/or asthma, but most of them can eat any sort of bakery products without 
any allergic reaction because the allergen is altered during processing (Aas, 1984).
The types of foods most commonly implicated at the onset of atopic reactions in 
children and adults are eggs, milk, peanuts, shellfish, and fish (Oehling, 1981; 
Oehling, et al., 1992; Sampson, 1992). Eggs and milk have been used extensively in 
double blind food challenge studies and exclusion diet studies (Shakib et al., 1984; El 
Rafei et al., 1989; Oehling et al., 1992; Lovegrove et d ., 1994; Roger et al., 1994).
1.6 The antibodies
Protein molecules that combine specifically with antigens are termed antibodies. 
Collectively, proteins with antibody activity are referred to as immunoglobulins and 
account for about 20% of the serum proteins in individuals. The immunoglobulins 
themselves are a highly diverse family of proteins that have been categorised into 
groups, based on variations of amino acid sequences, antigenic properties, molecular 
weight, and their mediation of various immunological fimctions.
Antibody molecules are essentially required to carry out two principle roles in 
immune defence (Staines et d ., 1993):
1. to recognise and bind to foreign material i.e. the antigen.
2. to trigger the elimination of the antigen. This involves the binding of certain 
molecules (effector molecules) to the antibody-coated antigen in order to trigger 
complex elimination mechanisms e.g. the complement system of proteins, and 
phagocytosis by cells such as neutrophils and macrophages.
There are five classes of immunoglobulins identified in human serum. They are 
termed immunoglobulin (Ig), IgG, IgM, IgA, IgD and IgE. All immunoglobulin 
molecules have a common structure consisting of three units (Figure 1.1). Two of the 
units are identical and involved in binding to an antigen - Fab (jfragment antigen 
binding) arms of the molecule. These units contain regions of sequence that vary 
greatly from one antibody to another and confer on a given antibody its unique 
binding specificity (Roitt, 1997). The existence of two Fab arms enhances the affinity 
of antibody for the antigen. The third unit - Fc (Fragment crystalline) is involved in 
binding effector molecules. The antibody molecule has a four chain structure. It 
consists of two identical heavy chains spanning Fab and Fc and two identical light 
chains associated only with Fab. These are held together by interchain disulphide as 
shown in Figure 1.1. Each fi*agment has a molecular weight of approximately 50,000 
daltons (Roitt, 1997).
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Figure 1.1. The basic chain structure of immunoglobulins.
N
heavy chain
light chain
C
C
The immunoglobulin unit consists of two identical light polypeptide chains and two 
identical heavy polypeptide chains linked together by disulphide bonds.
N = amino terminal ends of the peptide chains.
C = carboxyl ends of the peptide chains.
Roitt, (1997)
1.6.1 Immunoglobulin G
IgG is the most abundant immunoglobulin in serum (average 12 mg/ml in an adult) 
and accounts for 70-75% of the total Ig pool (See Tables 1.1 & 1.2). The IgG 
molecule has a molecular weight of 150,000 daltons. It diffuses more readily than 
other immunoglobulins into the extravascular body spaces where it carries the 
majority of the neutralising bacterial toxins and binds to the micro-organisms to 
enhance their phagocytosis. IgG is the only immunoglobulin that crosses the human 
placenta from maternal circulation to the fetus; it provides protection prior to birth 
and for the first few weeks of an infant’s life, against foreign antigens.
Active synthesis of IgG antibodies in a fetus starts towards the end of the gestation 
period (i.e. in third trimester). The passage of IgG through the placenta continues 
until delivery. A normal new-born child has an IgG concentration in the serum of 
approximately 150% compared to the mother. It is not until three or four months after 
birth in the infant’s serum, that the maternal IgG drops as a result of catabolism (the
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half-life of IgG is 23 days) and the infant’s serum will be comparatively low. Then 
the infant begins to synthesise his/her own IgG antibodies. The adult concentrations 
of IgG, through active synthesis, will only be reached at about five to six years of age. 
(Bennich, 1985).
Four subclasses of IgG have been identified and the relative distribution of these 
subclasses among serum IgG molecule is 70%, 20%, 7%, and 3% for IgGl, IgG2, 
IgG3, and IgG4, respectively (Bennich, 1985). The antibody response to some 
antigens is characterised by a proportional representation of IgG antibodies of all four 
subclasses, but there is a tendency for certain antibodies to be associated primarily 
with one of the subclasses.
1.6.2 Immunoglobulin A
Secretory IgA molecules have a molecular weight of 160,000 daltons. IgA appears 
selectively in the seromucous secretions such as saliva, tears, nasal fluids, sweat, and 
colostrum and in secretions of the lung, genitourinary and gastrointestinal tracts, 
where it protects external body surfaces fi*om antigenic attack. IgA represents 13% of 
the human serum Ig pool (average 1.8 mg/ml) (see Tables 1.1 & 1.2). It is secreted in 
epithelial cells and then transported actively across the cytoplasm and secreted into 
the external body fluids. The fi*agment of the receptor, remaining bound to the IgA, is 
termed the secretory IgA.
1.6.3 Immunoglobulin M
IgM is often referred to as the “macroglobulin” antibody because of its high 
molecular weight of about 900,000 daltons. It represents about 6% of the total serum 
immunoglobulin (average 1.0 mg/ml) and is largely confined to the intravascular pool 
(see Tables 1.1 & 1.2). As with IgA, a single J-chain is incorporated into the cyclic 
pentamer. IgM is an extremely good activator complement and effective agglutinator
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and cytolytic agent. IgM serves as the first line defence against infectious organisms 
(Roitt, 1997).
1.6.4 Immunoglobulin D
IgD was discovered in the 1960s by Bence Jones as a result of studies of an unusual 
human myeloma protein (Unanue & Benacerf, 1984). It has a molecular weight of
180,000 daltons and represents about 0.2% of serum immunoglobulin (average 0.03 
mg/ml) (see Table 1.1). It is susceptible to proteolytic degradation and has a short 
shelf life. IgD is found on the surface of some cells such as fetal lymphocytes.
1.6.5 Immunoglobulin £
Only a trace amount of IgE is present in the serum (2x10^ mg/ml) (see Table 1.1 & 
1.2). It has a molecular weight of 200,000 daltons and is able to bind with high 
affinity to the Fc region on mast cells and basophils. This reaction leads to 
involvement in body defence against parasitic infection such as ringworm and flukes. 
In the tropics, where parasites are common, high levels of IgE may be found, even in 
“healthy” people who do not have adverse reactions to food. In temperate countries, 
the level of IgE is usually very low in “healthy” individuals (non-allergic). IgE is 
associated with atopic conditions such as hay fever, asthma and eczema and food 
allergy (Benjamini et al., 1997).
Tables 1.1 and 1.2, provide a summary of the features associated with the 
immunoglobulin classes in adults and children.
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Table 1.1. Important features of the immunoglobulin classes
Features IgG IgE IgA IgM IgD
Molecular weight (daltons) 150,000 200,000 160,000 900,000 180,000
» concentration in adult serum (mg/ml) 12 2x10® 1.8 1.0 0.03
Percent of total Ig 80 0.002 13 6 0.2
Half-life (days)* 23 2 5.5 10 2.8
Placental passage ++ - - - -
Benjamini et al. (1997), Roitt (1997)
» Approximate
* A measure of the mean survival time of antibody molecules following their formation,
usually expressed as the time required to eliminate 50 per cent of a known quantity of
immunoglobulin from the body (Borland's Pocket Medical Dictionary, 1995).
Table 1.2. Immunoglobulin (IgG, IgA, IgM and IgE) levels in children
Age IgGg/L IgE+SD (kU/L) IgAg/L IgM g/L
Cord 5.2-18.0 <0.2 0.02-0.2
Weeks 0-2 5.0-17.0 0.5+5 0.01-0.08 0.05-0.2
2-6 3.9-13.0 0.02-0.15 0.08-0.4
6-12 2.1-7.7 0.05-0.4 0.15-0.7
Months 3-6 2.4-8.8 0.10-0.5 0.2-1.0
6-9 3.0-9.0 3+11 0.15-0.7 0.4-1.6
9-12 3.0-10.9 0.20-0.7 0.6-2.1
Years 1-2 3.1-13.8 8+29 0.3-1.2 0.5-2.2
2-3 3.7-15.8 0.3-1.3 0.5-2.2
3-6 4.9-16.1 15+52 0.4-2.0 0.5-2.0
6-9 5.4-16.1 0.5-2.4 0.5-1.8
9-12 5.4-16.1 18+63 0.7-2.5 0.5-1.8
12-15 5.4-16.1 22+75 0.8-2.8 0.5-1.9
Adults 26+81
Ward et (1996)
1.7 Allergic reactions by immune response
Under certain circumstances, immunity, instead of providing protection, produces 
damaging results that are occasionally fatal. Such harmful reactions are known as 
hypersensitivity reactions. In man, many of the common allergic diseases belong to
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the group designated as atopy. This is a type of allergic sensitisation that is partly 
hereditary and which leads to clinical symptoms of asthma, eczema, allergic rhinitis, 
urticaria and angiooedema. The symptoms are sometimes associated with 
gastrointestinal complaints such as diarrhoea and vomiting. The operation of the 
immune system associated with atopy is rather complex. An outline and insight into 
why and how allergic reactions arise is made easier by classification into four types 
(Coombs and Gell, 1975):
1.7.1 Type I: atopic or anaphylactic (immediate) hypersensitivity
It has been well established that type 1 hypersensitivity reactions are mediated by IgE 
antibodies (see Section 1.6.5) which bind to receptors on mast cells. When cross- 
linked by antigens on second exposure, the IgE antibodies trigger the mast cells to 
release several pharmacological active agents that are responsible for the 
characteristic symptoms of anaphylaxis. Reactions are rapid, within minutes, after 
exposure to the antigen. The term anaphylaxis was coined by Portier and Richet in 
1902, from the Greek “ana” that means “away from”, and “phylaxis” that means 
“protection” (cited from Benjamini et al., 1997).
The cross-linking of IgE receptors on mast cells induces each mast cell to release its 
content of mediators i.e. histamine. Histamine is an amine produced by 
decarboxylation of histidine, found in all body tissues. It induces: capillary dilation, 
which increases capillary permeability and lowers blood pressure; contraction of 
smooth muscle tissue; an increase in gastric acid secretion; and acceleration of the 
heart rate and it is also a mediator of immediate hypersensitivity (Borland’s Pocket 
Medical Dictionary, 1995). If histamine is released locally as a result of interdermal 
injection of an antigen, such as in a mosquito bite, it elicits a typical “weal and flare” 
reaction. If histamine is released systemically, this may result in a more severe 
reaction, such as difficulty in breathing in asthmatics due to constriction of 
bronchiolar muscles; uterine cramps; or involuntary urination and defecation; hives; 
oedema due to massive fluid loss into tissue spaces and a drastic fall in blood pressure
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due to shock. Fatal outcomes of anaphylaxis in humans are due to (1) asphyxiation 
from laryngeal oedema, (2) suffocation from bronchiolar constriction or (3) loss of 
adequate blood pressure from overwhelming peripheral oedema. Approximately 50% 
of the general population generates an IgE response to air-borne antigens (inhalants), 
however only 10% of the population develop clinical symptoms after repeated 
exposure to common environmental antigens, most commonly manifested as allergic 
rhinitis, bronchial asthma, atopic dermatitis or adverse reactions to food (Dockhom, 
1989; Benjamini et al., 1997; Roitt, 1997; Borland’s Medical Dictionary, 1995). This 
syndrome is referred to as “atopy” which means uncommon and the term “atopic” is 
used to describe an affected person.
In recent years, several studies have highlighted the possible involvement of IgG 
antibodies in this type of hypersensitivity. Berrens & Homedes (1991) reported a 
significant correlation between specific antibody (IgG and IgE) concentrations and 
also demonstrated a good correlation between personal history and symptoms of 
adverse reactions to food. Shakib et d., (1977) reported significantly elevated 
concentrations of IgE and IgG; (particularly IgG4) in serum of patients with atopic 
dermatitis compared to non-atopic individuals. However the role of specific IgG 
antibodies in food allergy is still poorly understood and there has been considerable 
controversy concerning the possible role of specific IgG antibodies in the 
pathogenesis of allergic diseases (James & Burks, 1994).
In a symposium attended by immunologists, allergists, bioengineers and chemists, in 
Switzerland, the audience was given the opportunity to express its opinion before and 
after the lectures which included “Controversial aspects in diagnosis and treatment of 
food allergy and intolerance” (Wuthrich, 1996). Two questions related to this study 
were put to the audience: Question 1: “Do you believe that the presence of specific 
IgE towards a food item is of high diagnostic value in food allergy?” and Question 2: 
“Do you believe that determination of specific IgG towards a panel of foods plays a 
role in the diagnostic procedure of food allergy?” (see Table 1.3). At the end of the 
discussion an increase from 12% to 21% of the audience was convinced that specific
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IgG can be a diagnostic tool in food allergy. In addition, 3 and 2 votes of the ‘don’t 
know’ group went into the ‘convinced’ and ‘non-convinced’ groups respectively in 
relation to specific IgE towards a food item as a high diagnostic value for food 
allergy.
Table 1.3. Percent of votes from the session on ‘Controversial aspects in the 
diagnosis of food allergy
Questions on diagnostic procedures before presentation after presentation
yes no don’t
know
yes no don’t
know
Diagnostic value determination of food-specific IgE
Do you believe that the presence of specific IgE towards a food item is
of high diagnostic value in food allergy?
61 33 6 64 35 1
Do you believe that determination of specific IgG towards a panel of 
foods plays a role in the diagnostic procedure in food allergy?
12 75 11 21 67 12
(Wuthrich, 1996)
1.7.2 Type H: cytotoxic hypersensitivity
The symptoms of cytotoxic hypersensitivity occur when the specific antibodies 
(usually IgM or IgG) bind to antigens on the surface of cells and activate the 
complement that ends up destroying the cells. The simplest form of cytotoxin reaction 
is observed after transfusion of ABO incompatible blood or rhesus incompatibility 
reaction. So far, there is very little evidence that cytotoxic reactions operate in the 
food-mediated allergic response or adverse reactions to foods.
1.7.3 Type HI: immune-complex mediated hypersensitivity
The body may be exposed to an excess of antigens over a period of time. When the 
antigen and antibodies unite to form an insoluble complex at fixed sites within the 
body, an acute inflammatory reaction occurs. In the tissues they increase capillary 
permeability, influx phagocytes, release lysosomal enzymes and consequently lead to 
tissue destruction. The Arthus reaction and serum sickness represent type III 
hypersensitivity.
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1.7.4 Type IV: cell mediated (delayed type) hypersensitivity
These reactions involve the interaction between antigen and antigen-sensitive T- 
lymphocytes leading to the release of soluble mediators or lymphokines. The most 
familiar type IV reaction is the Mantoux reaction obtained by injection of tuberculin 
while the best-recognised clinical condition is contact dermatitis. Epicutaneous 
contact with low-molecular-weight food constituents may lead to this type of 
reaction.
Foods and food constituents that are capable of inducing contact dermatitis include 
garlic, lemons, oranges, cinnamon and vanilla. Reactions usually occur after 
epicutaneous contact whereby these haptens become antigenic on combination via 
covalent bonds with protein in the skin. Specific surface receptors bind the hapten- 
carrier complex and these provoke the cell to secrete lymphokines. At the site of 
reactions, some lymphokines dilate small blood vessels while others cause the blood 
vessel to leak so that fluid and blood cells move into the surrounding tissue and cause 
swelling. This results in an inflammatory reaction characterised by redness, swelling, 
scaling and exudation of fluid. The whole reaction takes approximately 18-48 hours 
and is therefore termed as delayed type hypersensitivity (Bleumink, 1983; Benjamini 
et d ., 1997). Sometimes this is implicated in delayed cows’ milk sensitivity.
1.8 Adverse reactions to food involving the immune system
There are a Avide range of symptoms indicating adverse reactions to food which 
involve an immune response that affects many parts of the body. These symptoms can 
occur within minutes and are termed “immediate hypersensitivity”.
In the oral allergy syndrome, the lips, cheeks, tongue or throat may swell or itch 
within minutes of contact with foods such as eggs or nuts. Similar reactions can affect 
the skin, causing angiooedema, urticaria, eczema, pruritis and erythema (skin 
inflammation). Some foods provoke gastrointestinal symptoms. Allergic reactions
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may stimulate overactive movements of the gastrointestinal tract and increased 
secretion of mucous which often result in nausea, vomiting, bloating, abdominal 
cramps and diarrhoea. Respiratory symptoms of adverse reactions to food include 
rhinitis, sneezing, asthma, recurrent coughing, wheezing and laryngeal oedema. 
Anaphylaxis can also occur in some individuals and can be fatal.
Adverse reactions to foods (by immune response) are more common in children than 
in adults (Lessof, 1994; Joral et al., 1995). The risk of developing allergic reactions to 
food (type I or atopy) has been reported to be greater in early infancy than in later life 
(Bleumink, 1983; Chandra et d., 1989). The large or frequent ingestion of food 
proteins and the increased permeability of the gastrointestinal tract, may explain why 
infants may be more prone to developing antibodies to antigenic materials in food 
than adults (Sampson, 1992) (see also Section 1.5).
Foods commonly associated with adverse reactions include eggs, peanuts, nuts, cows’ 
milk, soya, wheat, peas, fish, and shellfish (see Section 1.5). An adverse reaction 
involving food is essentially the “hyper-reaction” of a food protein, with the excessive 
production of antibodies by the immune response. The production of serum 
antibodies to specific food proteins is a normal physiological response. Several 
studies have shown that the presence of IgG and IgE antibodies is high to common 
dietary protein antigens (e.g. wheat gliadin, bovine milk or hen ovalbumin) in several 
clinical disorders such as atopic eczema, Coeliac Disease, chronic urticaria and 
asthma compared with matched controls (Finn et al., 1985; Lewis-Jones et al., 1987; 
Barnes et aJ., 1988; Morris et d., 1993; Bircher et al., 1994;). In a clinical study 
carried out in Spain by Oehling et al. (1992), 1.6% (400 out of 25,000) of patients 
seen during a 5 year period were identified and diagnosed as having atopic 
constitutions. Of these 400 patients, 18.5% had respiratory symptoms induced by 
foods and 15.5% were diagnosed as asthmatic. It was also observed that 85.2% of the 
patients with respiratory symptoms had elevated total IgE serum levels for their ages. 
The authors concluded that it was likely that a link existed between elevated levels of 
antibodies to food proteins and the extent of manifestation of disease. In an earlier
19
study of 284 children with bronchial asthma in Spain, Dieguez et al. (1978) reported 
that 8.45% of cases had an asthma attack induced by foods. The foods commonly 
implicated were chicken’s eggs followed by cows’ milk and fish but no biochemical 
data was reported. We can infer firom the evidence reported that an adverse reaction 
to foods involving the immune system may play a role in provoking asthmatic signs 
and symptoms.
1.9 Dietary avoidance of food allergens
Avoidance of food allergens in individuals with an atopic constitution may be the 
solution in preventing or delaying the development of allergic disorders. Studies 
employing exclusion diets during pregnancy have found a significant reduction in 
specific IgG antibodies to ovalbumin, gliadin and p-lactoglobulin (Falth-Magnusson 
et d., 1988 (b); Lilja et al., 1988) and alpha-casein and P-lactoglobulin (Cavagni et 
d., 1988; Lovegrove et al., 1994). Chandra et d . (1989) conducted a follow-up study 
of dietary exclusion in infants with atopic constituents fi*om birth to the age of 18 
months. Mothers of these infants were requested to avoid milk and milk products, 
eggs, fish, peanuts and soybean for a maximum period of 6 months for the duration of 
lactation. I hey reported that eczema was less common in infants who were breastfed 
and whose mother was on an exclusion diet compared to the control group. However, 
they did not attempt to measure the IgG or IgE concentrations in serum of the mothers 
or infants, although a random sample of breast milk was tested for IgE concentrations 
against lactoglobulin and ovalbumin to measure the compliance of mothers.
Recent studies have shown that maternal antigen avoidance during the lactation 
period and delaying highly antigenic foods in an infants’ diet, substantially lowers the 
firequency of allergic disorders in the first eighteen months of life (Arshad et al., 
1992; Faith Magnusson & Kjellman, 1992; Lovegrove et al., 1994). Therefore, there 
appears to be a protective role in maternal elimination of antigenic foods during late 
pregnancy and lactation. Lovegrove (1991), reported that adhering to a strict diet 
devoid of milk during late pregnancy and lactation and also delaying the introduction
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of milk into the infant’s diet had a significant preventative effect on allergy 
development at 18 months of age in infants of atopic women. The author reported that 
although dietary restriction was a laborious procedure, compliance was good. This 
was done by keeping in close contact with the subjects which boosted their morale. 
Further exclusion of these antigenic foods during infancy and possibly beyond may 
clinically benefit children with atopic constitutions.
1.10 Prevalence of allergic diseases including atopy
Allergic diseases are important causes of morbidity throughout the world. The 
prevalence of allergic diseases in childhood and adolescence (i.e. bronchial asthma, 
allergic rhinoconjunctivitis and atopic dermatitis) is increasing in both industrialised 
and the developing countries (Anderson, 1989; Croner & Kjellman, 1990).
The majority of estimates of allergic disease prevalence indicates a range between 20 
and 35% (Bousquet & Michel, 1988; Per Venge, 1994; Goh et al., 1996). In several 
studies of allergic diseases in children (Aberg et ^ ., 1989; Anderson et al., 1992; 
Weeke, 1992; Weitzman et d., 1992), it was variously reported that the one year 
prevalence rate of bronchial asthma ranged from 1-3% when investigated in general 
practice and 5-7% in population studies. In a British National Cohort Study of 16,883 
surviving children bom in March, 1958 and followed for 23 years, it was identified 
that the annual prevalence of asthma (or wheezy bronchitis) was highest at the age of 
7 years (8.1%) with a male: female ratio of 1.2:1, but thereafter remained fairly 
constant at around 3 to 4%. Prevalence of asthma was higher in males up to 16 years 
of age (male:female ratio of 1.4:1) but by the age of 23 years, the prevalence ratio had 
reversed with a substantially higher prevalence in females (male:female ratio of 
0.68:1.00) (Anderson et al., 1992). Hide (1996) reported that at least 10% of school 
children suffer from asthma. Aberg et al. (1989) reported that the prevalence of 
asthma in Swedish school children was 2.4%, allergic rhinoconjunctivitis 7.4%, 
eczema 7.8% and total allergic diseases 16.9%. Asthma and allergic
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rhinoconjunctivitis Avere reported to occur more frequently in boys than in girls. 
HoAvever, eczema was found more frequently in girls than in boys.
In a newborn, the risk of developing an allergy is 40-60% if both parents are allergic, 
20-40% if one parent is allergic, and 5-15%, if no one in the immediate family is 
affected (Bleumink, 1983; Weeke, 1992; Lessof, 1994).
1.11 Clinical and laboratory procedures for the diagnosis of allergy
The use of diagnostic tests for allergy is beset Avith difficulties (Johansson, 1984). 
However, the current established laboratory methods used in diagnosis of allergy 
include (1) specific IgE antibody using radioallergosorbent testing (RAST) or 
immunoCAP (CAP), (2) skin prick testing (SPT), (3) double blind placebo challenge, 
food challenge (DBPCFC), (4) food protein antigens and (5) total IgE.
1.11.1. Radioallergosorbent test (RAST) and ImmunoCAP (CAP)
RAST and CAP are quantitative assays for the determination of specific IgE 
antibodies m human serum or plasma. The advantage of these tests over SPT are that 
there is no risk of systemic reaction. It can be used in patients Avith severe skin disease 
such as atopic dermatitis. The disadvantages over SPT are, it is costly and results of 
the test are not available immediately (Kemeny, 1989).
1.11.1.1.RAST
In this procedure, the individual’s serum is incubated Avith a solid support such as 
paper discs to which the food antigen is attached. Then, the disc is washed to remove 
non-specific IgE, and incubated Avith a radio-labelled antibody specific for IgE 
(Benjamini et d., 1997; OAvnby, 1997).
4^ Little is knoAvn on the prevalence of asthma and allergic diseases in the south-east
Asia. However, Leung & Ho (1994) reported that the prevalence of asthma in 
Chinese secondary school children in Hong Kong, Kota Kinabalu in Malaysia and 
San Bu in China were 11.6%, 8.2% and 1.9%, respectively.
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1.11.1.2 CAP
The allergen of interest, covalently coupled to immunoCAP, reacts with the specific 
IgE in the subject’s serum. After washing away non-specific IgE, enzyme labelled 
antibodies for IgE are added. After incubation, unbound enzyme-anti-IgE is washed 
away and the bound complex is then incubated with a fiuorimetric substrate. After 
stopping the reaction, the fluorescence of the eluate is measured. The higher the 
response value the more the specific IgE is present in the serum (Pharmacia & 
Upjohn manual, 1995).
Clinically, RAST or CAP is used where skin testing with extracts might pose a 
hazard, particularly of anaphylaxis in patients suspected of being very sensitive to a 
particular allergen. It may also be employed in individuals with skin disease such as 
eczema so extensive as to preclude skin testing. The RAST is, however, less sensitive 
than direct skin testing and more expensive (Metcalfe, 1984).
1.11.2 Prick, scratch and intradermal tests
Skill icsis help diagnose allergic rhinitis or asthma. Skin allergies such as dermatitis 
and urticaria, are diagnosed using patch tests. Positive patch tests are the result of 
infiltration into the skin of lymphocyte cells in response to the application of the 
causative substance, e.g. nickel, whereas positive skin-prick tests result from the 
release of histamine and other chemicals of mast-cells.
Skin tests are recommended to be performed by a specialist because of potential risk 
of anaphylaxis (Cross, 1997). Skin tests with an allergenic extract can provoke 
immediate (type 1) response, with a weal which develops within minutes and subsides 
within 1-2 hours. Late reactions (including type III) may reach a maximum after 5-7 
hours. In addition, delayed hypersensitivity (type IV) can arise after an interval of 24- 
48 hours.
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Before skin testing, a patient must therefore be assessed by an experienced physician. 
Through a patient’s history and physical examination, the physician should be able to 
identify any unusual risks of skin testing. Skin testing is generally safe, but it always 
has a risk of inducing a systemic allergic reaction (anaphylaxis) especially in unstable 
asthmatic patients because of a greater risk of systemic reactions (Ownby, 1997). 
Emergency equipment to treat anaphylaxis must be readily available when patients 
undergo skin tests.
1.11.2.1 Skin-prick testing (SPT)
This involves making a tiny prick with a needle through a drop of allergen placed on 
the skin. Testing is usually carried out in the inner surface of the forearm. A number 
of allergens will be tested at the same time. The skin is marked with a pen to identify 
the site of each test and a separate needle is used at each site, so that there is no 
contamination by other allergens being tested which may cause a test to be falsely 
positive. Once the tiny amount of allergen (approximately 100,000 molecules) has 
entered the skin at the prick test site it will trigger a reaction in any sensitive mast 
cells which it meets. Chemicals from these cells cause fluid to leak out of the tiny 
blood vessels in the skin forming a raised blister-like ‘weal’. A positive reaction Avill 
first be noticed as intense itching which begins within 1-2 minutes. This is followed 
by the weal, which expands, reaching its maximum size in 10-15 minutes. The weal is 
surrounded by a wider area of redness and itching. The test appeared to be painless 
and quite safe as only a small amount of allergen is introduced into the skin, thus 
producing little risk even to the most sensitive individual. This method seems to be 
the method of choice in the UK (Davies & Oilier, 1989).
1.11.2.2 Intradermal testing
Intradermal testing is widely used in the USA. In this method, a tiny amount of 
allergen is injected into the skin using a fine needle and syringe. Although very 
diluted allergen extracts are used, side effects can occur in very sensitive patients. In
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addition it is painful, and requires skill in its execution. The type of reaction on the 
skin produced by intradermal testing is similar to that produced by the skin-prick test 
(Davies & Oilier, 1989).
1.11.3 Food challenge
Food challenge may be performed in an open single-blind or double-blind manner. In 
a double-blind food challenge, both the patient and at least one medical observer are 
unaware of whether the placebo or specific food is being given. This method is to 
provide objective information, as it eliminates both patient and physician bias. This 
oral food challenge is performed following removal of suspected foods from the diet 
for 2-4 weeks and during the subsequent symptom-free periods. Foods may be loaded 
into capsules, or masked in other foods. The initial dose of food to be administered 
can be estimated from the amount ingested prior to previous reactions. In the absence 
of such information, an initial dose of 10 to 100 mg or less is reasonable. The 
procedure has to be performed in a doctor’s consultation room or in hospital where 
observation is available and personnel and equipment are on hand to treat severe 
reactions, should they occur. Close observation of the patient is carried out for a 
reasonable period, taking into consideration the time interval previously noted 
between ingestion and subsequent reactions. If a reaction is not precipitated by the 
initial test dose, the following dose may be increased two to tenfold. This procedure is 
repeated until a reaction occurs or the volume of food administered approximates the 
amount of food present in usual serving. A positive reaction confirms food allergy, 
while the absence of a positive reaction is not absolute evidence of non-allergy in the 
patient. This is because it has been observed that patients do not always react to the 
first challenge, but may react to the subsequent challenge (Metcalfe, 1984).
1.11.4 Determination of food protein antigens
Food antigens have been identified in serum and breast milk (Jakobsson et al., 1985; 
Lovegrove et al., 1993; Morris et al., 1993) and post-prandially (Dannaeus et al..
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1979; Kilshaw & Cant, 1984; Husby et al., 1985, 1986). The objective of the 
determination of food antigens in serum and breast milk has been to increase 
knowledge of the amounts of these antigens in foods that are taken up from the gut 
and to investigate the importance of this uptake in the development of atopic 
conditions. Ovalbumin has been the most widely studied antigen using the Enzyme- 
linked immunosorbent assay (ELISA) (Husby 1985, 1986; Peng et al., 1990; 
Hampton et ^ ., 1990; Lovegrove, 1991; Morris, 1991). p-lactoglobulin has been 
determined in both serum (Husby et M., 1985, 1986) and breast milk (Kilshaw & 
Cant, 1984; Jakobsson et al., 1985). Methods include a radioimmunoassay or ELISA 
(Morris, 1991; Lovegrove, 1991).
1.11.5 Total serum IgE
The most frequently used method in determining the concentrations of total IgE in 
human serum is a two site immunometric assay. The first antihuman IgE antibody is 
attached to a solid phase (immunoCAP) and reacts with the concentration of IgE in 
the serum sample. After the non-bound proteins are washed away, a second labelled 
anti-IgE is added and incubated. Following another washing, the quantity of labelled 
IgE is measured and converted into units of IgE, by comparison to a standard curve 
(Ownby, 1997).
1.12 Enzyme-linked immunosorbent assay (ELISA)
The binding of an antibody to an antigen forms the basis of all immunochemical 
methods (Harlow & Lane, 1988). Immunoassays are one of the most powerfiil of all 
immunochemical techniques. These assays employ a wide range of methods to detect 
and quantify antigens and antibodies and to study the structure of an antigen. There 
are many variations on the methods in which the immunoassays are performed. 
However, methods such as ELISA and radioimmunoassays (RIA) are very sensitive 
for detecting antigens and antibodies, and are extremely economical in the use of 
reagents (Harlow & Lane, 1988; Benjamini et al., 1997; Roitt, 1997).
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Antibodies constitute an acquired immunity that provides protection against 
infectious organisms and their toxic products. Hence, the interaction between antigen 
and antibody is of utmost importance. Because of the exquisite specificity of the 
immune response, the interaction between antigen and antibody in vitro is widely 
used for diagnostic purposes, for detection and identification of either antigen or 
antibody.
Competitive RIA employs isotopically labelled molecules and specific antibodies. 
This method enables measurement of extremely small amounts of antibody. RIA is 
carried out by mixing together the radioactively labelled antigen and a known, limited 
concentration of specific antibody. The bound antigen-antibody complex is then 
separated fi*om the fi^ ee antigen and antibody. Although RIA is a very sensitive 
method in the detection of antigen, it employs however high cost equipment and the 
investigators are exposed to radiological hazards through radioactive materials.
ELISA however is currently one of the most widely used immunological techniques, 
particularly in clinical medicine, for the detection of antigens or antibodies in serum 
samples. It does not require any radioactive materials. ELISA employs the properties 
of various plastics such as polyvinyl or polystyrene to adsorb monomolecular layers 
of proteins onto their surface. Although the absorbed molecules may lose some of 
their antigenic determinants, sufficient amounts remain unaltered and can still react 
with their corresponding antibodies. The presence of these antibodies, bound to 
antigen adsorbed onto the plastic, may be detected by the use of anti­
immunoglobulins labelled with an enzyme and can be detected by the appearance of 
colour upon the addition of proper substrate (see Figure. 2.2) (Hanson, 1985; Harlow 
& Lane, 1988; Benjamini et al., 1997; Morris, 1991; Lovegrove, 1991; Roitt, 1997).
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1.13 Asthma
Asthma is one of the commonest problems world-wide. It is estimated that there are 
over 3 million and 10 million people in the United Kingdom and the United States of 
America respectively, with asthma (Levy & Hilton, 1993; Goldstein, 1994). Recent 
epidemiological studies suggest that the prevalence of asthma is steadily increasing, 
while death rates attributed to asthma remain stable or have slightly increased over 
the past years (Frew & Holgate, 1996). The main evidence for an increase in asthma 
over the last 25 years comes from approximately 50 studies from around the world 
measuring the prevalence of asthma on more than one occasion in the same 
population. Several studies investigated the presence of asthma in the respondents, 
and others have asked about symptoms, such as wheezing, that are associated with 
asthma. These studies all reported an increase of asthma over time (Bumey, 1997). 
The cause of this increase in prevalence of asthma is unclear. However, several 
factors have been proposed as its causal factors. These include increased 
environmental pollution from motor vehicles, possible indoor pollution associated 
with increased nitrogen dioxide via gas appliances for cooking, or heating, and 
dietary changes that include the increased used of bottle feeding with cows’ milk, in 
infancy (Tunnicliffe et al., 1994; Frew & Holgate, 1996; Brauer & Kennedy, 1996).
1.13.1 Clinical implications of asthma
Asthma appears to have a major impact on medical, domestic, school and industrial 
life. It has been estimated that currently there are about 100,000 hospital admissions 
each year for acute asthma (all ages), and in 1989 there were 2213 deaths in the UK 
recorded due to asthma. The average asthma patient consults his or her general 
practitioner approximately five times per year. The one year period prevalence rate of 
asthma in general practice is twice as high in boys compared with girls (Levy & 
Hilton, 1993).
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Asthma is a disorder in which the airways, carrying air in and out of the lungs, 
contract too easily and too much. This may occur spontaneously or, commonly, in 
response to a wide range of stimuli, including exposure to allergens, viral infections, 
exercise, cold air, fog and irritant fumes, as well as internal factors, including 
laughing at night time and stress (Lee, 1992; Holgate, 1997). This may result in 
coughing, wheezing, chest tightness and shortness of breath that may worsen at night. 
Asthma is characterised by inflammation, reversible airways, obstruction and 
increased airway hyperresponsiveness involving special cells (called mast cells and 
eosinophils). In asthma, these cells secrete a range of chemical substances (called 
mediators) that cause the airways to narrow. The main features of asthma include the 
presence in the airway of inflammatory cells, plasma exudation, oedema, smooth 
muscle hypertrophy, mucus plugging and shedding of epithelium (Bleecker & 
Valentine, 1988; Woodhead, 1993).
The most common form of asthma occurs in association with allergy to common 
environmental agents frequently encountered at home such as house dust mites, pets 
and fungi. Repeated exposure to these agents in those who inherit certain genes for 
allergy and asthma leads to excessive formation of antibody IgE. In asthma, IgE in 
part is responsible for triggering the release of mediators from the mast cells and 
eosinophils. In addition, T-lymphocytes in the airways are stimulated by the 
allergens, secreting a range of small proteins called cytokines. Cytokine is responsible 
for replenishing fresh mast cells and eosinophils and creates a comfortable 
environment, in which they can survive, causing an increase in total IgE. Thus 
inflammation creates the spasmodic symptoms of asthma. Anti-asthma drugs, such as 
cromoglycate and the inhaled corticosteroids, help control the inflammation and in 
turn control the symptoms of asthma (Holgate, 1997).
Asthma is not inherited as a single gene disorder. Currently, a positive family history 
of atopic (IgE mediated) disease is the common predictor of risk. Children bom to a 
couple with a strong family history of atopy have a 30-60% chance of developing an 
allergic disorder. The chance is increased if both parents are affected. Boys are more
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at risk than girls. Some, but not all studies suggest that maternal history is more 
important than paternal. This stronger influence could be genetic or could be due to 
environmental effects sensitising the baby in utero (Hubbard, 1997). Asthma can arise 
at any age, but there are peaks of onset in childhood and in middle life. Childhood 
asthma is usually associated with atopic allergy, whereas asthma which has onset at 
adulthood often (but not always) arises in non-atopic individuals. Both allergic and 
non-allergic asthma appear to have significant inherited components.
The inheritance of asthma per sq does not obey simple Mendelian Laws, and there is 
increasing evidence that the timing, nature and level of allergen exposure in early life 
may be crucial to the later development of asthma. Babies bom to atopic mothers 
exhibit delayed maturation of their immune system in the first few weeks of life 
(Hubbard, 1997). Exposure to allergens, such as house dust mites, animals, pollens or 
certain foods, at this time may cause the immune system to switch to allergic 
reactions instead of developing tolerance to the harmless substances in normal 
individuals (Lovegrove, 1991; Holgate, 1996; Hubbard, 1997).
The relationship between infant feeding practices and atopic disease has been 
extensively researched but results remain inconclusive. However, there is some 
evidence that the development of asthma in a child may be delayed if the mother 
avoids certain foods while breast-feeding and also postpones the introduction of 
allergenic foods on weaning.
Asthma in most cases starts either in childhood or in middle age. ‘Early onset’ asthma 
is more common in males, and ‘late onset’ asthma more common in females. Early 
onset asthma generally occurs in atopic individuals. These asthmatics often suffer 
fi*om other allergic disorders such as allergic rhinitis and eczema and have a family 
history of these disorders. Late onset asthma however, generally occurs in non-atopic 
individuals and it would appear that external antigens play no part in this condition 
(Edwards & Bouchier, 1991).
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In adults and children the asthmatic response can be triggered by a wide variety of 
agents. These include antigens, viral infections, exercise, exposure to fiimes and other 
irritants, certain drugs, food, drink and food additives (Kay, 1992). The specific 
antigen in a particular individual may be suspected fi'om the clinical history. 
However, sometimes the clinical history does not point to the specific antigen or 
antigens. In asthmatic children aged less than two years, cows’ milk allergy is 
reported to be the most common allergy followed by allergy to eggs (Weeke, 1992).
Anderson (1989) and Weeke (1992), reported that some of the factors that determine 
asthma prognosis are age, “immunotherapy”, “sex”, “mother’s age at childbirth”, 
“infections”, other allergic diseases, and signs and symptoms of adverse reactions to 
food. They recommended that new approaches to treating asthma are needed and it 
was suggested that the treatment should start earlier in an attempt to inhibit 
inflammation and development of asthma. Atherton (1991) and Bahna (1991), 
commented that less interest and investigative effort have been directed towards a 
possible role for foods in the provocation of atopic asthma. This may possibly be due 
to the general feeling that an inhaled antigen is more likely to be the main causal 
factor, and immediate sensitivity reactions to foods are less fi*equent in children with 
asthma as compared to eczematous children.
1.13.2 Clinical stages of asthma
Asthma is categorised into 3 clinical stages. The following gives a brief outline of 
these stages (Levy & Hilton, 1993; Woodhead, 1993; Frew & Holgate, 1996).
1.13.2.1 Acute severe asthma (status asthmaticus)
Acute severe asthma is an acute medical emergency characterised by severe 
wheezing, incapacitating breathlessness (to the extent that the patient can hardly 
speak), and tachycardia. These attacks may be triggered by an allergen and differ in 
aetiology fi'om the severe attack, which evolves over several days of worsening
31
symptoms usually associated with infection. An acute asthma attack is normally 
treated with oxygen, nebulised or intravenous bronchodilators, intravenous fluids, 
intravenous corticosteroids, antibiotics, and ventilation, if required.
1.13.2.2 Acute mild or moderate asthma
Acute mild or moderate asthma can be divided into 2 categories: 1) mild asthma with 
episodic symptoms and 2) continuous asthma. Acute mild or moderate asthma is 
characterised by the inability to speak six words or more in one breath. The asthma 
patient is usually treated with a p2-adrenoceptor agonist by inhalation (e.g. Fenoterol, 
Pirbuterol, Rimiterol, Salbutamol, Terbutaline, Salmeterol). These drugs relieve 
bronchospasm within a few minutes, reach a peak at 15-30 minutes, and last for 3 to 4 
hours.
1.13.2.3 Chronic asthma
Chronic asthma may not be obvious in its presentation (Shapiro et ^ ., 1997). The 
presentation is more subtle even if there may be recurrent episodes of wheezing and 
shortness of breath. Patients with chronic cough which persists after each respiratory 
infection, recurrent bronchitis or pneumonia may be considered in the chronic asthma 
category. In chronic asthma, attention has recently turned to the use of regularly
I ^
inhaled corticosteroids such as beclomethasone along with^p2-at^J'enoceptors agonist.
1.13.3 Assessment of asthma in general practice
The severity of an acute asthma attack is measured by observing the patient and 
making objective measurements of the peak expiratory flow rate (PEFR), heart rate 
and respiratory rate. This is to enable distinction between those with a severe attack 
and those with life-threatening features (Frew & Holgate, 1996; Batt, 1997):
32
Features of severe asthma include:
• too wheezy or breathless to complete a sentence in one breath;
• rapid respiratory rate of 25 breaths per minute or above;
• heart rate of 110 beats per minute or above (tachycardia);
• PEFR equal to less than 50% of predicted normal at best;
Features of life-threatening asthma include:
• PEFR less than 33% of predicted normal at best;
• a silent chest, cyanosis or feeble (reduced) respiratory effort;
• bradycardia or hypotension;
• exhaustion, confusion or coma.
1.13.4 Treatment in asthma
New therapeutic approaches to asthma involve either improvements in existing 
classes of drugs, or the development of novel drugs. Over the last 2 decades there 
have been no new types of drug introduced, although several new classes of 
compound are currently under development. Improvements in existing 
bronchodilators include long acting inhaled p2-agonists. Corticosteroids are the most 
effective anti-inflammatory drugs. There is no immediate prospect of a cure for 
asthma (Barnes, 1992).
At present, inhaled asthma drugs are placed into two categories - preventers and 
relievers. Preventer drugs are either corticosteroids or belong to another anti­
inflammatory group (Intal). Reliever drugs are p2-agonist and they are there to relieve 
symptoms when they occur, and therefore do not need to be taken regularly. Reliever 
drugs can either be short or long acting.
^  Herbal remedies have been claimed to be of values for allergies, however, there is no 
evidence to such claim. Chinese medicinal plants have been reported to be effective in 
the treatment of eczema in individuals who do not respond to conventional treatment 
(Kay & Lessof, 1992; Atherton, 1994). They agreed that further careful studies are 
required to confirm its effectiveness and as a safe alternative treatment approach. No 
studies however, have been found in relation to the use of herbal remedies for the 
treatment of asthma. 33
1.13.4.1 Short-acting |32-agonîsts:
p2-agonists are highly effective and remain the most widely used bronchodilators in 
the treatment of asthma. This is because they act as functional antagonists and reverse 
airway bronchial smooth muscle contraction, also reducing vascular permeability and 
increasing mucociliary clearance. They are best given by the inhaled rather than the 
oral route because of more rapid effectiveness and the much lower doses used. 
Symptoms of coughing and wheezing are quickly and noticeably relieved within 15 
minutes, the effect lasting for up to six hours. The most frequently prescribed short- 
acting p2“agonist brand names are Ventolin (generic name, salbutamol) (Allen & 
Hanburys); Bricanyl (terbutaline sulphate) (Astra); Berotec (fenoterol) (Boehringer 
Ingelhein) (BNF, 1997).
1.13.4.2 Long acting P2-agonist:
There are two long acting p2-agonists on the market, Serevent (salmeterol) (Allen & 
Hanburys) and Foradil (Eformoterol) (Novartis). Both are inhaled, both cause 
bronchodilation for over 12 hours and are licensed for twice daily administration 
only. The only important clinical difference between these two is that formoterol acts 
more quickly, achieving near maximum bronchodilation within 15 minutes, whereas 
salmeterol takes up to one hour. The long acting p2-agonist has been shown to reduce 
day time and nocturnal symptoms of asthma over 24 hours. They are also very 
effective in preventing exercise-induced symptoms of asthma.
1.13.4.3 Inhaled corticosteroids
Inhaled corticosteroids are effective in reducing the rates of less acute and less severe 
exacerbation of asthma. The most frequent preventer drugs of asthma are Becotide 
and Becloforte (beclomethosone diproprionate) (Allen & Hanburys); Flixotide 
(fluticasone propionate) (Allen & Hanburys); Pulmicort (budesonide) (Astra). Inhaled 
corticosteroids appear to have significant and markedly beneficial effects upon a large
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variety of parameters, including: (1) reduction in symptoms; (2) improvement in lung 
function; (3) reduction in frequency and severity of acute exacerbation; (4) reduction 
in mortality and morbidity; (5) improvement in quality of life; (6) cost-effectiveness; 
control of airway hyper-responsiveness; (7) normalisation of the chronic 
inflammatory changes in the airways and (8) normal growth of lung function. 
Furthermore, inhaled corticosteroids are effective in the treatment of asthmatic 
patients, regardless of disease severity.
In some children, treatment with inhaled corticosteroids is associated with short-term 
delayed growth of the lower leg. In one longitudinal study, it was observed that a 
reduction of osteocalcin (used as a marker for bone formation) occurred after 400-800 
pg/day of corticosteroid was inhaled. There is no evidence that inhaled 
corticosteroids, when appropriately prescribed in standard doses have any adverse 
effect on long-term growth in children (Price, 1997). Price (1997) suggested that 
children taking high doses of oral corticosteroid should have their height measured 
every three to four months by trained personnel using regularly calibrated equipment.
1.13.4.4.0ral corticosteroids
Oral corticosteroids are used to treat asthma in 2 ways. Firstly, oral corticosteroids 
are used for acute severe asthma, when they are frequently given by intravenous 
infusion, and secondly, for chronic asthma when it is severe and unresponsive to other 
treatment (Thomson, 1992). Oral corticosteroids are effective in the majority of 
chronic asthmatics who have exacerbation of the disorder. It is necessary to 
distinguish worsening of the asthmatic condition from asthmatic episodes. Asthmatic 
episodes respond well to inhaled p2"^goiiists, whereas exacerbation is associated with 
a progressive worsening of symptoms, which are unresponsive to bronchodilators and 
which, when acute and severe, can be life-threatening. Oral corticosteroids are 
reserved for short-term treatment of exacerbation of the condition, which is 
ineffective by inhaled corticosteroids.
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1.14 Association between asthma and eczema
Both asthma and eczema are manifestations of the atopic condition. Eczema appears 
to be associated with asthma in childhood rather than in adults. Eczema usually 
begins at 12 weeks of age, with approximately 10% of children being affected by the 
age of four years (Buck, 1997). Asthma generally manifests itself at around 3 years of 
age and affects approximately 12-15% of children.
Many of the children who have atopic eczema go on to develop adverse reactions to 
inhalant allergens. Allergen avoidance in asthma care has been proven to be effective 
in recent years, with the house dust mites cited as the most important of the airborne 
allergens. Research has shown that reduction of the offending house dust mites and its 
allergen, by encasing the mattress in mites permeable covers and regular vacuuming 
of the carpet, reduces significantly the amount of house dust mite allergens, and has 
also shown significant clinical improvement in children with atopic eczema. Allergen 
avoidance appears to be effective in atopic conditions (Hide et al., 1994; Buck, 1997)
1.15 Association between asthma and allergic rhinitis
Allergic rhinitis is simply inflammation of the nose. Nasal inflammation results in 
blockage, sneezing and watery discharge. Allergic rhinitis fi*equently accompanies 
asthma, particularly when “allergy” is an important factor in asthma. Allergic rhinitis 
may be seasonal (for example, hay fever) or perennial, but is of great importance both 
because of the secondary effect it has on the chest, and symptomatically in its own 
right. When rhinitis is present, mouth breathing tends to occur due to nose blockage. 
This causes drying, heat loss fi"om the lungs, and bronchospasm in the asthmatic. It 
seems that similar mechanisms are related to exercise induced asthma (Hill, 1997; 
Scadding, 1997).
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1.16 Lung function tests
Lung fimction tests are mandatory for the assessment of asthma to determine the
method
degree of functional disturbance. It is an objective, non-invasive, and cost-effectiveyin 
diagnosing and monitoring the patient with asthma (cited from Frew & Holgate, 
1996; Shapiro et d., 1997). A single set of tests, however complex, does not provide 
an accurate picture of the individual asthmatic status, “fr provides only a snap shot o f 
a rapidly moving target” as described by Holgate (1996). Therefore, repeated tests 
are essential and should be simple. Measurement of PEFR using a portable meter 
(peak flow meter or peak flow gauge) satisfies these aims. PEFR is the maximum rate 
of airflow which can be achieved during a sudden forced expiration from a position 
of full inspiration. When using the peak flow meter, the pointer is set at zero. The 
patient takes a maximum breath in, places teeth and lips around the mouthpiece, 
making a tight seal, then exhales in a short, sharp, hard blow. The best of three 
attempts is usually accepted as the PEFR and the pointer returned to zero between 
blows. The results will be related to the height, age and sex of the individual. PEFR is 
impaired particularly in the presence of diffuse airways obstruction (Brewis, 1985).
PEFR measurement is favourable, as the technique is reproducible, quick, simple and 
convenient. It is particularly important in asthma in which airways obstruction varies 
considerably. Occasional measurements of the pulmonary function made in the clinic 
are of limited relevance in asthma and much more information about severity, 
provoking factors and response to treatment can be obtained from frequently repeated 
measurements made by the patient in his or her own home or work environment.
Regular measurement of peak flow rate is important in acute severe asthma. It allows 
an estimate of severity to be made and this may be useful in comparing one episode 
with another. More importantly, it allows progress to be assessed objectively. Diurnal 
variation averaging 15% or more is a typical finding in asthma (Rees, 1997). A 
worsening of symptoms usually precedes worsening of flow rates. A decrease in flow 
rate of 10% (measured from baseline value) will be regarded as significant
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(Hargreave, 1997). If the peak flow rate is improving then the subject can reasonably 
be assumed to be progressing satisfactorily. When bronchial inflammation decreases, 
symptoms and flow rates improve. Similarly, an increase in flow rate of 10% 
(measured firom baseline value) is considered as a significant improvement (Mallik, 
Personal communication).
There is no necessity for more complex tests such as forced expiratory volume in one 
second (FEVJ (Frew & Holgate, 1996). However, serial FEV^iEVC (fimctional vital 
capacity) readings are possible with recently introduced miniaturised electronic 
spirometers, but add little to the information given using PEFR meters (Hargreave, 
1997).
Children as young as 4 years can be taught to perform lung function tests with 
birthday party toys that make whistle sounds to reinforce forced expiration (cited 
fi*om Shapiro et d., 1997).
1.17 Influence of smoking on asthma
Cigarette smoking is a major cause of avoidable ill health. There is compelling 
evidence that smoking is the principle cause, in older people, of chronic obstructive 
lung disease also known as chronic obstructive pulmonary disease. However there is 
no direct evidence that smoking is a major cause of asthma in younger people. New 
knowledge has led to a reconsideration of the traditionally neutral attitude towards 
asthmatics who smoke. Studies of young families have shown that children whose 
parents smoke, are almost twice as likely to develop asthma as those brought up in a 
non-smoking household (Calverley, 1997). Smokers are more likely to cough and 
develop respiratory tract infections than are non-smokers. (Calverley, 1997).
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1.18 Dietary assessment
Methods for assessing food consumption of individuals can be categorised into two 
major groups i.e. the quantitative and qualitative. The choice of the method depends 
primarily on the aim of the study.
Quantitative dietary assessment methods consist of diet recalls or food records 
designed to measure the quantity of individual foods consumed over a period of time. 
By increasing the number of measurement days, quantitative estimates of recent food 
intake, habitual food intake of individuals can be obtained (Rockett & Colditz, 1997). 
There are three types of quantitative dietary assessment: 24-hr dietary recall, 3 or 
more days estimated record and weighed record.
The 24-hr dietary recall provides a snapshot of a person’s eating habits. The 
advantages of the 24-hr dietary recall method include low respondent burden, high 
compliance, low cost, ease and speed of use, use of standardised interview, an 
element of surprise (so that the respondent is less likely to modify his or her eating 
habits), its suitability for illiterate respondents. Disadvantages include its reliance on 
memory, unsatisfactory method for young children and a large number of respondents 
are required to make the survey meaningful. Errors in the estimation of portion sizes 
of foods also occur, but can be reduced by using food models to assist the respondent. 
The “flat slope syndrome” may be a problem in this method where individuals appear 
to overestimate low intakes and underestimate high intakes and individuals tend to 
omit foods which are infrequently consumed (Macdiarmid & Blundell, 1997). 
However the flat slope syndrome can be overcome and the data on a one-day record 
of dietary intake is made reliable if subject numbers in a study are sufficiently large. 
Because diet is known to vary from day to day, a 24-hr dietary recall does not yield 
an accurate picture of his or her diet. The method, however, does provide population 
means for intakes.
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The 3-day food record aims to provide a quantitative assessment of food intake over 
three days. Two weekdays and one weekend day are included to take account of food 
consumption patterns on weekdays versus weekend days. To assess portion sizes, 
household measures or weighing scales are utilised. Respondents may change their 
usual eating pattern to simplify the measuring or weighing process, or, alternatively, 
to impress the investigator. Accuracy and precision are greater for the weighed record 
compared with dietary record or 24-hr recall. Misreading scales and /or errors in 
recording, however, may occur. Subjects must be numerate and literate and highly 
motivated as the method involves more time than 24-hr recall. Studies using dietary 
record have a bias toward recruiting educated subjects (Rockett & Colditz, 1997).
The assessment of habitual food intake is considered as the most problematic tasks in 
human nutrition. The weighed records which are regarded as the ‘gold standards’ 
have their drawbacks (Bingham, 1987). Recently, Bingham et al. (1994) carried out a 
validation study on a 7-day estimated food diary or open-ended food diary, 24-hr 
urine nitrogen values and dietary nitrogen intake and other biological markers 
including vitamin C and P-carotene. The 7 day estimated food diary consists of 15 
most used sets of photographs and shapes selected from the thirty sets used to assess 
portion size in the structured 24-hr dietary recall. They observed that the 7-day 
estimated food diary or open-ended food diary was reliable and gave results for food 
and nutrients that were most similar to those of 16 day weighed records.
Qualitative dietary assessment methods include food frequency questionnaires and 
dietary history. Both methods obtained retrospective information on the patterns of 
food used during a longer, less precisely defined time period than the quantitative 
dietary assessment methods such as 24-hr recall, 3-day food record or 7 day estimated 
food diary. This method is frequently used to assess habitual intake of foods or 
specific classes of foods. A food frequency questionnaire consists of a list of foods 
and an associated set of frequency-of-use response categories. The list of foods may 
be extensive, to enable estimates of total food intake, hence dietary diversity can be 
achieved. Alternatively, the list may focus on specific groups of foods or particular
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food items. The questionnaire may also quantify the usual portion sizes consumed for 
each food item.
The purpose of dietary history is to obtain retrospective information on the usual food 
intake and meal pattern of individuals over varying periods of time. The time periods 
covered often include the previous month, six months, or previous year.
1.19 Area of selected study
Considering various arguments, and taking advantage of the availability of the novel 
method of quantifying the anti-ovalbumin IgG and anti-g-lactoglobulin IgG 
developed by Lovegrove (1991) and Morris (1991) in the School of Biological 
Sciences, University of Surrey, the studies described in this thesis continue the work 
of immune-responses to foods focusing on asthmatic children and adults.
1.20 Aims of current studies
Lovegrove (1991) and Morris (1991) investigated the occurrence of specific food 
antibodies in adults and infants. They were both successful in developing a semi- 
quantitatively ELISA for measuring specific IgG for gliadin, P-lactoglobulin and 
ovalbumin in serum, and standards were produced using the techniques of affinity 
purification and nephelometry in the School of Biological Sciences, University of 
Surrey.
The work of Lovegrove and Morris facilitated continuing studies in relation to 
adverse reactions to food that may be useful in the treatment of asthmatic children 
and adults by dietary intervention. The association between adverse reaction to food 
allergens and respiratory diseases appears to be less well established than that of 
environmental antigens and respiratory disease. Although nasal stuffiness, sneezing 
and nasal discharges have been reported in children with cows’ milk allergy (Gerrard
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et al., 1973), the relationship between asthma and adverse reactions to food is still not 
clear.
Wheezing has been reported in varying proportions of cows’ milk allergic children 
(Vitoria et al., 1982). The tendency to develop hypersensitivity reactions may be due 
partly to the total amount of antigens absorbed and partly to the nature and quantity of 
circulating antibodies or the number of sensitised lymphocytes and their distribution. 
One possible way of reducing the amount of specific food antigens is through dietary 
exclusion. Knowledge about the immune response of asthmatics and healthy children 
to foods is still limited. The importance of food exclusion in the prevention of 
asthmatic episodes in children has not been properly evaluated (Atherton, 1991). This 
could be due to the fact that research in humans especially in children to a certain 
extent is restricted, mainly because of ethical consideration and the difficulty 
involved in blood sampling and removal of certain foods in their diet, specifically 
milk, milk products and foods containing eggs.
Therefore it is timely and appropriate that a study on adverse reactions to food and 
asthma be conducted in children, using similar protocols developed by Lovegrove 
(1991) and Morris (1991) to answer some of the questions raised and to reduce the 
occurrence of asthmatic attacks and minimise the asthmatic symptoms. However, due 
to the fact that the recruitment of “normal” children is difficult, it was therefore 
thought necessary to conduct a study on adults as well.
Dietary manipulation and elimination diets are useful tools for evaluating adverse 
reactions to food which are difficult to diagnose clinically (Lee, 1995). However 
there are many confounding factors in this approach such as conditions at home, 
which are not controlled. Furthermore, the risk of malnutrition has to be considered 
with prolonged implementation of a diet devoid of eggs and milk, particularly in 
children. It is therefore important to have records of the daily food intake of these 
asthmatic children participating in the diet elimination study. The 7-day estimated 
food record in alternate weeks will facilitate the assessment of non-compliance or
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deviation from the elimination diets during the study period. In addition, the food 
record will also provide valuable information on the effectiveness of dietary 
elimination in children with asthma, particularly the adequacy of their food intake and 
its consequences on the nutritional status of the children. The dietary manipulation 
will cover a period of eight weeks because the half-life of IgG is 23 days (see Section 
1.6).
1.21 Hypothesis
In this study it is hypothesised that the anti-ovalbumin IgG and anti-p-lactoglobulin 
IgG concentrations in atopic adults and children will be considerably elevated 
compared to normal subjects, indicating an underlying specific adverse reaction to 
food not previously recognised and this adverse reaction to food may exacerbate the 
signs and symptoms of asthma. In addition, it is hypothesised that the exclusion of 
certain dietary protein from groups of asthmatic individuals will be beneficial in the 
eleviation of signs and symptoms of asthma.
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Chapter 2
Immunological methods for detection of food antibodies
2.0 Materials and methods
2.1 Materials
2.1.1 Chemicals and reagents
a) Biotin streptavidin peroxidase complex (Amersham International (Amersham, 
UK)
b) 3,3,’, 5,5’ Tetramethybenzidine (Boehringer Manheim (Manheim, Germany)
c) Citric acid, di-Sodium hydrogen orthophosphate, gelatine, sodium hydrogen 
carbonate, sodium carbonate, sodium dihydrogen orthophosphate, sodium 
chloride (Fisher Scientific, UK Ltd, Loughborough, Leicestershire, UK)
d) Biotinylated goat anti-human IgG, p-lactoglobulin, bovine serum albumin, a- 
casein, human serum albumin. Tris (hydroxymethyl) aminomethane, 
polyoxyethylene sorbitan monolaurate (Tween 20), Ovalbumin Grade V (Sigma 
Chemical Company Ltd, Poole, Dorset, UK)
e) Calcichew 500 mg (Shire Pharmaceuticals Ltd, Andover, Hants, UK)
f) a-lactalbumin (British Drug House Ltd, Poole, Dorset, UK).
g) All water used was distilled.
h) All buffer recipes are shown in Appendix 1.
2.1.2 Equipment
a) Booklets on Egg fi*ee food products. Cows’ milk fi*ee food products (British 
Dietetic Association, Birmingham, UK)
b) Wright Peak Flow meter (Clement Clarke International Ltd ,UK)
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c) Antigen affinity column (1000A° porous silica beads containing ovalbumin or p- 
lactoglobulin B ligand) (a gift firom Clifinar Associates, University of Surrey, 
Guildford, UK)
d) Pepti-junior Formula S, Pepti-junior recipe booklet (Cow & Gate, Trowbridge, 
Wilts, UK)
e) Disposable columns (Evergreen Scientific, Los Angeles, California)
f) Viscing dialysis tubing (Medical International Ltd, London, UK)
g) Flat bottomed polystyrene and polyvinyl microtitre plates (Maxisorp, Nunc, 
Denmark)
2.2 Methodology
2.2.1 Blood sampling
Approximately 2 ml non-fasting venous blood was taken from subjects who 
volunteered to participate in the study for the measurement of anti-ovalbumin IgG, 
anti-p-lactoglobulin IgG, total IgE and anti-ovalbumin IgE.
2.2.2 Selection of standard sera
The sera from 6 atopic adults (asthmatic, asthmatic with eczema or eczematous), 
selected at random from staff and postgraduate students at the University of Surrey 
were analysed by indirect ELISA for the presence of anti-ovalbumin IgG and anti-p- 
lactoglobulin IgG. The sera samples with the highest optical density for either anti­
ovalbumin IgG or anti-p-lactoglobulin IgG were selected as the standard sera. An 
affinity purification was carried out to quantify the anti-ovalbumin IgG and anti-P- 
lactoglobulin IgG concentration in the standard sera (see Section 2.2.1.3).
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2.2.3 Affinity purification of anti-ovalbumin and anti-p-Iactoglobulin IgG in 
standard sera
Affinity purification is a method commonly used to purify antigen-specific 
antibodies. In this method, pure antigen (ligand) is bound covalently to a solid 
support (matrix). The antibodies to be purified are specifically absorbed by a 
complementary binding substance (ligand) immobilised on a solid phase (matrix). 
The non-specific antibodies are removed by washing and the specific antibodies are 
eluted by altering the composition of the solvent to favour dissociation. The 
advantage of this procedure is its unique ability to isolate specific antibodies from a 
mixed pool (Harlow & Lane, 1988).
The solid phase matrix used for affinity chromatography must have a degree of 
porosity to enable good flow properties which do not hinder the penetration of 
macromolecules. The ligand used should exhibit specific and reversible binding 
affinity for the substance to be purified. Release of the bound protein is done by 
lowering the pH to less than 3. The basic step for affinity purification is shown in 
Figure 2.1.
The procedure for affinity purification of the anti ovalbumin IgG is divided into three 
steps (see Figure 2.1 and Sections 2.2.3.1-2.2.3.3)
I. preparation of the antigen-matrix
II binding of the antibody to the antigen-matrix
III elution of the antibody
2.2.3.1 Preparation of antigen matrix (Step I)
The antigen matrix was kindly prepared by Clifinar Associate, University of Surrey. 
0.5 g activated lOOOA® aminopropyl porous silica beads were added to 1.25% (w/v) 
gluteraldehyde in phosphate buffer saline (PBS) and rolled for 2 hours at room 
temperature. The beads were then washed with 100 ml PBS containing 0.02% (w/v) 
sodium azide. 10 mg of each ligand (ovalbumin and P-lactoglobulin) was dissolved in
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10 ml PBS plus 0.02% (w/v) sodium azide. The protein solution (either ovalbumin or 
p-lactoglobulin B) was added to the beads and rolled fiirther for another 2 hours. The 
beads were allowed to settle and the supernatant aspirated off. 10 ml PBS containing 
0.22 g glycine was added to the beads, rolled for an hour and left to stand overnight at 
room temperature. The beads were washed with PBS. 10 ml PBS containing 0.3% 
(v/v) HCl was added to the beads and rolled for 30 minutes. The beads were again 
washed with PBS to return the pH of the beads to 7. The beads were then placed in a 
5 ml disposable column. PBS containing 0.02% (w/v) sodium azide was then added 
to the beads and stored at 4®C until required.
2.2.3.2 Binding of the antigen matrix (Step H)
The column was emptied ensuring that it did not run dry. The column was washed 
with 20 ml PBS. 4 ml of standard serum was added to the appropriate column either 
ovalbumin or P-lactoglobulin B and mixed on a roller for 30 mins at room 
temperature. The sample was drained out and the column was washed with 20 ml 
PBS followed by O.IM acetate buffer, pH 5.5, to drain away any non-specific bound 
proteins.
2.2.3.3 Elution of the antibody (Step m )
3 ml of 0.0IM HCl glycine, pH 2.2, was then added to the column and rolled for a 
further 30 min. An additional 2 ml of HCl glycine, pH 2.2, was added and the eluate 
collected. The column was finally washed with PBS to return it to neutral pH and 
stored in PBS containing 0.02% (w/v) sodium azide at 4°C. The eluate was dialysed 
immediately overnight at 4°C against 2L PBS to return it to a neutral pH. The PBS 
was changed 3 times during the period of dialysis. The eluate was then lyophilised.
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Figure 2.1. Method of affinity purification of the anti-ovalbumin IgG 
standard affinity column was prepared using the following procedure.
STEP I
Wash with PBS
Wash with PBS
Wash with PBS
Wash with PBS
S T E P n
Wash with PBS 
Wash with 0.1 M acetate buffer pH 5.5
S T E P m
Standard serum, rolled 30 min.
0.3% HCl added, rolled 30 min.
Ovalbumin in acetate buffer, pH 4.4, rolled 4 hr.
0.01 M HCl glycine, pH 2.2, rolled 30 min.
PBS + glycine, rolled 1 hr, stand overnight
Eluate specific IgG collected, dialysed overnight against PBS
lOOOA® aminopropyl silica beads + PBS, 
+ gluteraldehyde, rolled 2 hr.
2.2.4 Quantitation of anti-ovalbumin IgG and anti-g-lactoglobulin IgG in 
standard (control) sera
The lyophilised eluate was rehydrated in 0.5 ml distilled water. The concentration of 
anti-ovalbumin IgG and anti-P-lactoglobulin IgG within the eluate was determined by 
immunoturbidimetric performed by staff at the Immunology Department, The Royal 
Surrey County Hospital, Guildford, Surrey.
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2.2.4.1 Recovery
The recovery of anti-ovalbumin IgG and anti-p-lactoglobulin IgG was determined by 
indirect ELISA. The concentrated purified sample was diluted to the concentration of 
original standard sera. The purified and original standard sera were then double 
diluted at 1:50, 1:100, 1:200, 1:400 and 1:800. The per cent recovery of the specific 
antibodies in the purified sample was then calculated fi*om the optical density against 
the unpurified sample.
2.2.5 Indirect ELISA for the detection of antibodies
Antibodies can be detected and quantitated with indirect ELISA. Firstly the antigen is 
bound passively by incubation with the microtitre plate (Nunc, Denmark). Serum is 
then added to the antigen-coated microtitre well and allowed to react with the bound 
antigen. The unbound antibody is removed by washing and the bound antibody is 
detected using enzyme-labelled anti-IgG. Any fi*ee antibody is washed away, and a 
substrate for the enzyme is added. The colour reacting product that forms is measured 
by a specialised spectrophotometric plate reader (Labsystems Multiskan 
Biochromatic, Labsystem, UK) at 450 nm.
2.2.5.1 Assay protocol for anti-ovalbumin IgG in serum
Firstly, a 200 pi of ovalbumin (50 pg/ml) in 0.05 M PBS, pH 7.4, was added to the 
inner 60 wells of a polystyrene flat bottomed microtitre plate (Nunc, Denmark). After 
incubation for an hour at 37®C in a moist chamber, the plate was washed 4 times with 
casein buffer, pH 7.6. The standard serum (200 pl/well) was then double diluted at 
1:50, 1:100, 1:200, 1:400 and 1:800; and the sample sera were diluted at 1:100 and 
1:200 in casein buffer and added to the appropriate wells in duplicate. The analysis 
was repeated if the sample’s optical density was not on the linear part of the standard 
curve. Two quality control samples (low and high values) were also added in the 
appropriate wells in duplicate. The plate was then incubated in a moist chamber at
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4®C overnight. After washing 4 times with casein buffer, peroxidase labelled sheep 
anti-human IgG conjugate diluted at 1:5,000 concentration (200 pl/well) was then 
added and incubated at 37®C for a further 2 hours. The plate was again washed 4 
times with PBS, pH 7.4, containing 0.1% (w/v) gelatine and 0.05% (v/v) Tween 20. 
A substrate solution 3,3’,5,5’-tetramethylbenzidine hydrochloride (TMB) was then 
added to the plate (150 pl/well) and incubated at 37®C for another 30 minutes. The 
colour reaction was stopped by the addition of 1 M hydrochloric acid (50 pl/well). 
The plate was read on an ELISA plate reader at a wavelength of 450 nm. Lastly, the 
concentration of anti-ovalbumin IgG in the samples was then calculated against the 
standard curve using a flexical computer programme (Pharmacia-Wallace Oy, 1989- 
90).
2.2.S.2 Assay protocol for anti-|3-IactogIobuIin IgG in serum
Firstly the inner 60 wells of a flexible PVC flat bottomed microtitre plate was coated 
with 200 pi P-lactoglobulin B (10 pg/ml) in 0.1 M bicarbonate/carbonate buffer, pH 
9.6, and incubated in a moist chamber at 4®C overnight. The plate was then washed 4 
times with 0.05M PBS, pH 7.4, containing 0.05% (v/v) Tween 20 and 1% (w/v) 
gelatine (PBSGT). All further dilutions and washings of the plate were carried out in 
this buffer and ftirther incubations were carried out at 37®C. The standard sera (200 
pl/well) were then double diluted 1:50, 1:100, 1:200, 1:400 and 1:800. The samples’ 
sera were double diluted at 1:50 and 1:100. The analysis was repeated if sample’s 
optical density was not on the linear part of the standard curve. The standard and 
samples were added, in the appropriate wells in duplicate with 2 quality control 
samples (low and high values), to the plate which was incubated for 2 hours. After 
washing, 200 pl/well of biotinylated goat anti-human IgG was added to all wells at a 
dilution of 1:30,000 and incubated for 2 hours. The plate was washed again and 
streptavidin-biotin horseradish peroxidase conjugate (200 pl/well) was added at a 
dilution of 1:1000 and incubated for 1 hour. This was followed by washing the plate 
as before, then 3,3’,5,5’-tetramethylbenzidine hydrochloride (TMB) substrate (150 
pl/well) was added and incubated for 30 minutes. The reaction was stopped by the
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addition of IM hydrochloric acid (50 pl/well). The coloured end-point was read on an 
ELISA plate reader at a wavelength of 450 nm. The concentration of the anti-P- 
lactoglobulin IgG in the samples was then calculated against the standard curve using 
a flexical computer programme.
Figure 2.2. Indirect ELISA of IgG antibodies.
STEP I.
STEPn
STEPm
STEP IV
STEP V
Coat tbe antigen to tbe plate. 
Incubate
Wasb
Add samples and standards. 
Incubate.
Wasb
Add enzyme labelled species 
specific antibody. Incubate.
Wasb
Add enzyme substrate. 
Incubate
■ O O O
MA
E E E
m
E E E
Stop tbe reaction witb acid and read tbe optical density of eacb 
well at 450 nm.
2.2.6 Assay reproducibility
The intra-assay variation was determined by running an assay with standard sera and 
2 quality controls. The quality controls were selected as high and low values within 
the linear curve of standard. The assay was carried out with standards and six of the 
quality controls. The inter-assay variation was determined by the inclusion of the high 
and low quality controls in duplicates. The inter and intra-assay coefficient of 
variation (CV) was calculated for quality controls.
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2.2.7 Specificity of standard in the ELISA for anti-ovalbumin IgG and anti-p- 
lactoglobulin IgG
Analysis was carried out on the control (standard) sera and two other samples sera to 
identify if there was any crossreactivity with other proteins of similar structures to 
anti-ovalbumin IgG or anti-p-lactoglobulin IgG coated in the ELISA plate.
The assay protocol for crossreactivity analysis was similar to the assay protocols 
discussed in sections 2.2.5.1 and 2.2.5.2; for the anti-ovalbumin IgG crossreactivity 
analysis, buffer only or buffer containing 50 pg/ml of one of the following 
crossreactants: Human serum albumin (HSA), Bovine serum albumin (BSA), P- 
lactoglobulin B, a-casein and a-lactalbumin. For anti-P-lactoglobulin IgG 
crossreactivity analysis, buffer only and buffer that contain the following 
crossreactants - HSA, BSA, ovalbumin, a-casein and a-lactalbumin. The buffer only 
and those with crossreactants were incubated on the plate at 37®C for one hour. A 
range of standard sera and samples sera was then added to the appropriate well. The 
rest of the assay was carried out as described in sections 2.2.1.5.1 and 2.2.1.5.2. 
Optical density values of the plate measured at 450 nm were obtained. The percentage 
of crossreactivity was calculated against the buffer only wells.
2.2.8 Total IgE and specific IgE in serum
Total IgE and specific IgE for ovalbumin and p-lactoglobulin IgE were measured 
quantitatively with the CAP system of Pharmacia (Uppsala, Sweden). This analysis 
was carried out at The Royal Surrey County Hospital (Deacock, Personal 
communication). This method has been shown to be highly sensitive (Leimgruber et 
al., 1991). The procedure involves a solid phase consisting of a flexible, hydrophilic 
antigen matrix polymer, encased in a capsule (CAP). This capsule is dipped into a 
sample of the subject’s serum and allowed to bind any antibody that is specific to the 
antigen. Finally a fluorimetric substrate is added and the fluorescence measured 
which will be proportional to the amount of specific IgE to the antigen in the sample
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(Leimgruber et d., 1991; Pharmacia & Upjohn manual, 1995; Benjamini et al., 
1997).
This method is calibrated against the International Reference Preparation WHO 
75/502 (Ward et ^ ., 1996). Values under 0.35 kU/L are considered to be negative, 
those between 0.35 and 0.70 kU/L to be weakly positive or borderline (grade 1), those 
between 0.7 and 17.5 to be positive and those >17.5 kU/L to be strongly positive. 
Values between 0.70 and 3.5 kU/L are attributed to grade 2, values between 3.5 and
17.5 kU/L are attributed to grade 3 and the subsequent strong positive values, from
17.5 to >100 kU/L, being attributed to grades 4-6. This method shows a variation of 
10% between batch coefficients at normal and elevated concentrations.
2.3 Results
2.3.1 Quantitation of anti-ovalbumin IgG and anti-p-lactoglobulin IgG within 
standard sera
Quantitation of the standard sera samples was successfiilly performed. Table 2.1 
shows the calculated value of the total anti-ovalbumin IgG and anti-p-lactoglobulin 
IgG within the two standard sera using the immunoturbidimetric. The recovery of 
anti-ovalbumin IgG and anti-P-lactoglobulin IgG in the purified eluate was 48% and 
95% respectively.
The food specific IgG antibody in the standard sera was calculated using the 
following formula:
E = (B/A) X C X (100/D) (see Table 2.1).
A = volume of serum passed through column 
B = eluate lyophilised and rehydrated 
C = total antibody concentration from immunoturbidimetric 
D = percentage recovery 
E = total food specific IgG in standard serum
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The concentration of anti-ovalbumin IgG and anti-P-lactoglobulin IgG in the standard 
sera was 0.78 mg/ml and 0.29 mg/ml respectively. The standard serum dilution was 
plotted and concentration of sample sera (in Chapters 3, 4 & 5) was read against the 
linear section of the standard curve (see Figures 2.3 & 2.4).
Table 2.1. Results of affinity purification and quantitation of anti-ovalbumin 
IgG and anti-p-lactoglobulin IgG of standard sera
Standard serum Anti-ovalbumin
IgG
Anti-p-lactoglobulin
IgG
A volume of serum passed through column (ml) 4 4
B eluate lyophilised and rehydrated (ml) 0.5 0.5
C total antibody concentration (mg/ml) 3 2.2
(immunoturbidimetric)
D recovery (%) 48 95
E total specific IgG in standard serum (mg/ml) 0.78 0.29
2.3.2 Validity of the assay
For the assay reproducibility, the inter-assay and intra-assay CV calculated from 6 
observations carried out within one month are shown in Table 2.2. The intra-assay 
CV was between 2% and 8% whereas the inter-assay CV was between 8% and 18%. 
The crossreactivity of eggs and milk specific antibody IgG is shown in Table 2.3.
2.3.3 Crossreactivity of ovalbumin and p-lactoglobulin with other allergens
Table 2.3 shows the results of crossreactivity analysis of control serum and two other 
subjects’ sera with other possible crossreactants. Results indicated that crossreactivity 
with other protein was within the range of 0-9% of the buffer only. Similar results 
were observed in the 2 samples sera.
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Table 2.2. Inter-CV and intra-CV for anti-ovalbumîn IgG and anti-p- 
lactoglobulîn IgG ELISA in sera
Quality Controls Intra-assay ELISA plate n=6 Inter-assay ELISA plate n=6
Mean ± SD (pg/ml) CV(%) Mean + SD (pg/ml) CV(%)
Anti-ovalbumin IgG
Low 124 + 9.7 8 123 +18.0 15
High 703 +13.3 2 677 ± 118.4 18
Anti-p-lactoglobulin IgG
Low 70 + 3.8 5 64 + 6.5 10
High 198 + 8.5 4 168 ± 12.8 8
n = number of assays
Table 2.3. Crossreactivity of other proteins with the standard sera and 2 
other samples sera
Other proteins OD in other protein/OD plain buffer (%)
(50pg/ml) Standard sera Serum 1 Serum 2
Ligand - ovalbumin
Plain buffer (untreated) - - -
Human serum albumin 3 1 3
Bovine serum albumin 1 2 4
a-casein 9 - -
a-lactalbumin 7 1 4
p-lactoglobulin 7 4 3
Ligand - p-lactoglobulin B
Plain buffer (untreated) - - -
Human serum albumin - - 7
Bovine serum albumin - - 5
a-casein - - 1
a-lactalbumin - - 1
Ovalbumin - 6 1
OD = optical density at 450 nm
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Figure 2.3. Standard curve used in the determination of the anti-ovalbumin 
IgG concentrations in sample sera (mean ± SD, n=6)
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Figure 2.4. Standard curve used in the determination of the anti-p- 
lactoglobulin IgG concentrations in sample sera (mean ± SD, n=6)
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2.4 Discussions
The method employed in the purification of specific antibodies appeared to be simple, 
quick and providing an acceptable yield of the specific antibodies. Initially 2 ml of 
standard sera was added to the column. Any non-specific binding protein in the 
column was washed away using PBS only. The eluate was not lyophilised and 
quantitation was unsuccessful giving a reading of <0.07 g/L. The purification was 
repeated using 4 ml of standard sera. 0.1 M acetate buffer was added to wash away 
any non-specific protein bound to the column at the end of step II (see Figure 2.1).
The eluate was lyophilised and then dissolved in 0.5 ml distilled water. The 
concentration of the specific IgG was then determined by nephelometry.
Results of the analytical method employed for the semi-quantitative determination of 
specific antibody in standard sera in this study mirrored results fi-om the analytical 
methods developed by Lovegrove (1991) and Morris (1991). The recovery for the 
specific food antibodies in this study, 48% for anti-ovalbumin IgG and 95% for anti- 
p-lactoglobulin IgG were however slightly higher compared to the study by 
Lovegrove (1991) and Morris (1991), which were 32% and 74% for anti-ovalbumin 
IgG and anti-P-lactoglobulin IgG, respectively. This may be due to the additional 
washing of the column with 0.1 M acetate buffer, pH 5.5, at the end of step II (see 
Figure 2.1), besides using PBS to wash away any non-specific proteins attached to the 
column. This additional washing with 0.1 M acetate buffer, pH 5.5, appeared to 
remove non-specific protein bound to the column thus ensuring a more homogenous 
eluate.
Five concentrations of antibody ranging fi*om 1-16 pg/ml for ovalbumin and 0.35-6.0 
pg/ml for P-lactoglobulin were used for the standard curve in each run. The 
reproducibility of the standard curve was demonstrated by the inclusion of low and 
high value quality controls. The mean intra- and inter-coefficient of variation in this 
study was calculated to be less than 20% for both anti-ovalbumin IgG, anti-P- 
lactoglobulin IgG assays and total IgE assays. The within and between-run reproducibility
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of <8% and <18% respectively in this study were below the results obtained in studies 
of both Lovegrove (1991) and Morris (1991) i.e. <8% and ^ 2 %  for intra- and inter- 
coefficient variation respectively. These intra- and inter-coefficient variations 
obtained in this study were within the acceptable limits of the recommended 
analytical validation in the application of routine bioavailability, bioequivalence and 
pharmacokinetics studies (Shah et al., 1992).
The crossreactivity analysis showed very little or no changes in the specific antibody 
to the antigen bound to the plate in the presence of other crossreactants. The 
concentrations of crossreactants added (50 pg/ml) was higher than the naturally 
circulating food antigens (Paganelli & Levinsky, 1980; Lovegrove, 1991). The 
reported percentage of crossreaction in this study was low despite the high protein 
added. Thus, it is safe to assume that the antibody in the particular sample tested in 
this study is specific for that antigen bound to the plate.
It appeared that the analytical methods used for the determination of specific food 
IgG antibody in this study developed by Lovegrove (1991) and Morris (1991) were 
reliable.
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Chapter 3
Child Observational Study: Differences in specific food antibody 
(IgG) levels in asthmatic children and non-atopic children
3.0 Introduction
The diagnosis and treatment of food allergy has been hindered because of the lack of 
consensus on a simple diagnostic method. Several methods have been employed to 
define the basis of altered immune responses to diagnose food allergy. These can 
include the DBPCFC, SPT, total IgE in serum, food specific IgE antibody analysis 
using the RAST or CAP and clinical history of food allergy. The DBPCFC has been 
considered as the ‘gold-standard’ being the most objective procedure’ of food allergy 
diagnosis (May, 1976; Bock et g ., 1988; Pastorello, 1995). DBPCFC and SPT 
however, have a number of drawbacks.
The DBPCFC test is difficult to perform and has to be carried out in an environment 
where clinical support is at hand in case of anaphylactic reactions or the induction of 
severely acute asthmatic episodes in asthmatic patients, particularly children. Both 
procedures are not therefore practical for use by General Practitioners (OP) or by staff 
in the children’s Out-patient department of hospitals. Measurements of total and 
specific IgE are not cost-effective (de Week, 1966). Current 1997 charges for total 
IgE and for RAST are approximately £10.00 per test under the National Health 
Service (NHS) at the Protein Unit, The Royal Surrey County Hospital (Deacock, 
Personal communication). Pastorello (1995), suggested that positive SPT and specific 
IgE results may be unrelated to clinical symptoms and may simply be due to 
crossreaction between allergens present in commercial materials. A clinical history of 
food allergy however, offers a low level of reliability on its own, as it may reflect 
human attitudes to food.
For progress in food allergy, de Week (1996), suggested that we begin to look beyond 
DBPCFC procedures. He suggested observation of local reactions after allergen
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challenge by coloscopy, analysis of cellular reactions and mediator release in the gut 
mucosa and in intestinal fluid, or analysing stools. Although the above procedures are 
useful, they may not be feasible or appropriate for the general atopic population, 
specifically atopic children who show no signs or symptoms of food allergy.
As discussed in section 1.7.1, type I hypersensitivity reactions are mediated by IgE 
antibodies. In recent years, several studies have identified that aside from IgE 
antibody, IgG antibodies may also be involved in this type of hypersensitivity (Berren 
& Homedes, 1991; Morris et ^ ., 1992; Lovegrove et al., 1993).
Several studies have shown that the presence of IgG antibodies in the serum for 
common dietary protein antigens (namely wheat gliadin, bovine milk or hen 
ovalbumin) is higher in several allergic disorders such as atopic eczema, coeliac 
disease and chronic urticaria than in matched non-atopic individuals (Finn et d., 
1985; Lewis-Jones et al., 1987; Barnes et d., 1988; Morris et d., 1992; Bircher et d.,
1994) (see also Section 1.8). In a study carried out on 18 atopic adults and their 
reactions to 3 food antigens, Morris et d., (1992) reported that the specific anti­
ovalbumin IgG concentrations in the atopic adults (mean ±s.e.m, 369+93 pg/ml) were 
significantly higher than in the non-atopic adults (169+31 pg/ml; P<0.05). Using 
percentage of control serum. Firm et d ., (1985) observed that 30.4% of 56 adults with 
atopic eczema had higher IgG antibody levels to gliadin compared with 6.5% of 262 
controls (P<0.0005). Lovegrove (1991) and Morris (1991), both of the University of 
Surrey, investigated the occurrence of specific food antibodies in atopic adults and 
infants. They were successful in developing a novel method for the quantification of 
specific IgG and IgA for gliadin, P-lactoglobulin and ovalbumin in serum and the 
antigens gliadin, P-lactoglobulin and ovalbumin in serum using affinity purification 
and nephelometry for the standard sera. Indirect ELISA was then used to measure the 
specific antibodies in sample sera and quantified against the known values of specific 
IgG in standard sera.
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In view of the fact that Lovegrove (1991) and Morris (1991) successfully identified 
and quantified specific food IgG antibodies, can food specific IgG antibodies be used 
as an alternative marker in the diagnosis of food allergy? Reference values of total 
IgE and specific IgE for the healthy population and atopic population were established 
and documented by the International Reference Preparation WHO 75/502 (Ward et 
al., 1996). Total IgG values in serum are also documented with reference values. 
However, to date no studies have established the absolute values of specific IgG in 
any category of population with the exception of Lovegrove (1991) and Morris 
(1991). Therefore, it is essential that an observational study be conducted on the 
atopic population to evaluate specific IgG in serum and to compare this with the 
healthy non-atopic population. The study in this chapter has compared specific food 
IgG to ovalbumin and P-lactoglobulin in a selected atopic population, and asthmatic 
children to a control group of non-atopic children in order to answer the question 
“How useful is specific IgG in serum as an alternative screening test of food allergy?”
3.1 Aim of the study
The aim of the study was to determine the food IgG antibody concentrations 
specifically the anti-ovalbumin IgG and anti-p-lactoglobulin IgG in asthmatic 
children and non-atopic children. This was an observational study. The results 
provided the basis for selection of asthmatic children for the dietary intervention 
study (Chapter 4) and the possibility of food specific IgG antibodies as an alternative 
marker for the diagnosing of food allergy was considered.
3.1.1 Ethical approval
Ethical Committee approval was obtained from the South West Surrey Regional 
Health Authority Local Research Ethics Committee (Ref. No. BG/sb dated 15 March
1995) and North West Surrey Local Research Ethics Committee (Ref. 
MHT/AI/AMW/PRO/71/95 dated 10 August 1995).
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3.2 Methods
3.2.1 Sampling size
The sample size was determined using a computer program InStat. The sample size 
calculation was based on previous data of Morris et al., (1992) comparing the anti­
ovalbumin IgG concentrations in atopic adults with matched for age and gender 
healthy non-atopic adults. No similar data is reported for infants or children. The anti­
ovalbumin IgG concentrations of the atopic and healthy non-atopic adults reported in 
Morris et al., (1992) study were 369 ± 394 pg/ml (mean ± SD) and 169 ±131 pg/ml 
of the healthy non-atopic group. The minimum difference of anti-ovalbumin IgG 
between the mean numbers of the 2 groups (atopic and non-atopic) detected as 
significant was estimated at 200 pg/ml anti-ovalbumin IgG. The sample size 
calculated was 101 subjects in each group using a power index of 95% with a P<0.05.
3.2.2 Subject recruitment
The subjects who participated in this study were asthmatic children aged 2 to 16 years 
recruited fi*om the Out-patient Department in The Royal Surrey County Hospital and 
The Frimley Children Centre between April 1995 and July 1996. The total number of 
asthmatic children successfully recruited was 111. Parents who agreed to their 
children participating in the study were requested to sign a consen^^d complete a 
structured questionnaire (see Appendices 2 & 3) either while waiting to see the doctor 
or at home. Questionnaires completed at home were either mailed in a stamp- 
addressed envelope or returned to the investigator on the follow-up visit. Parents of 
each subject were given a 5 g tube of anaesthetic cream (EMLA cream) with 
occlusive dressings. A roll of bandage was also given to parents who felt the child 
might mess up the cream. The Emla cream is a white local anaesthetic cream for 
topical use to produce anaesthesia of the skin, enabling less painful needle insertion. 
Parents were given verbal and written instructions on application of the cream to the 
back of both hands, an hour prior to the appointment time for the follow-up visit.
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Occasionally, demonstrations were given on how to apply the cream if they were 
uncertain of the verbal and written instructions. Analgesia with Emla Cream is 
usually achieved after a minimum of 60 minutes under an impermeable, occlusive 
dressing.
Of the 111 asthmatic children recruited, blood sample was successfully taken fi’om 71 
(64%) asthmatic children. Forty asthmatic children had to be excluded from the 
study. This was either due to the parents’ refusal on the follow-up visit or children’s 
refusal of venepuncture or they failed to give a sufficient amount of blood. Further 
recruitment of asthmatic children had to be abandoned because of the failure to 
recruit a sufficient number of non-atopic children.
Non-atopic children (the Control Group) were also recruited in the same hospitals. 
They were either “In-patient” or “Out-patient” children who required some form of 
blood investigation. The parents of these children were approached between April 
1995 and May 1997 to participate in this study. In the beginning, the “control” 
children were screened through personal interview by the investigator with parents, to 
identify if they had any personal or family history of asthma, diabetes (Ardawi et al., 
1994), cystic fibrosis or glandular fever. Although 45 children qualified as non-atopic 
controls through personal interview, only 10 of the 45 blood samples were accepted, 
as “clean” controls i.e. no family history of atopy. Thirty-five children had to be 
excluded as they were identified as atopic (i.e. they had a personal and/or family 
history of atopic conditions such as asthma, eczema, allergic rhinitis, urticaria or 
other forms of allergy or adverse reactions) from the questionnaire.
In the later stage of recruitment, more stringent criteria for selection of non-atopic 
children was used during interview with parents concerning personal and family 
history of any atopic conditions, allergy or adverse reactions. Venepuncture was 
carried out on several children daily in the paediatric ward for blood investigations, 
the majority of whom were less than 2 years of age. The majority of those above 2 
years of age, had blood investigations for allergy, infections, cystic fibrosis and other
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medical conditions and had a personal or family history of atopy. With such stringent 
criteria, only a further 9 non-atopic children recruited were eligible as controls.
An alternative strategy was then adopted for the recruitment of non-atopic controls. 
One hundred and twenty left-over children’s sera were collected over a period of 6 
months from the Biochemistry Department of Frimley Park Hospital. For the 
purposes of confidentiality, the secretary of the Chief Paediatric Consultant obtained 
the addresses of these children. Addresses were successfully located for the donors of 
only 35 sera and questionnaires were forwarded through the Paediatric Unit. 
Addresses for the donors of the remaining 85 sera were not found as they had been 
referred by their GP’s for blood investigation in the hospital. Therefore they were not 
registered as patients of the hospital concerned. Of the 35 questionnaires mailed out, 
26 (74%) were completed and returned to the researcher via the hospital. 
Unfortunately, all respondents via this method failed to be accepted as non-atopic 
controls. They were either diagnosed with cystic fibrosis, diabetic or had personal 
and/or a family history of atopic conditions. This method again failed to produce a 
sufficient number of non-atopic children.
Two posters were signed by the Paediatric Consultant involved in this asthma study 
requesting the co-operation of Senior House Officers (SHO) to help recruit non- 
atopic children aged between 2 and 16 years. The posters were strategically placed on 
the wall of the clinical examination room of the Children’s Ward in The Royal Surrey 
County Hospital and at Frimley Park Hospital over the two year period. A box of 15 
questionnaires, information sheets for parents, consent forms and blood tubes were 
left in the clinical examination room for this purpose at any one time. The researcher 
had several informal meetings and personal discussions with the Consultants, 
Registrars and SHO regarding the matter. Recruitment of non-atopic children was 
only successful in the presence of the researcher. The head of the anaesthetic team 
was also approached, again with the aim of blood samples being taken during 
cannulation prior to surgery. This approach was again fi*uitless as the chief 
anaesthetist refused additional stress to children during cannulation prior to surgery.
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In May 1997, the recruitment of non-atopic controls was terminated, with 19 
successfully recruited.
3.2.3 Questionnaire to assess allergy and family patterns of allergy
3.2.3.1 Questionnaire design and pre-testing
The questionnaires for the paediatric study (this chapter) and adult study (chapter 5) 
were designed with the help of a pilot study on asthma and food allergy in adults by 
an undergraduate of this University (Ranky, 1995) after discussing with colleagues 
previously involved in questionnaire design (Fallowfield, 1995). The questionnaires 
were then commented on by Dr. J.B. Morgan and pre-tested initially on 10 post­
graduates from various departments of the University of Surrey. The respondents 
were a mixed group. They were either friends of the researcher or friends of the 
respondents with whom the researcher had no prior contact.
The paediatric questionnaire was also pre-tested on 10 parents of asthmatic children at 
The Royal Surrey County Hospital. The respondents were then asked to comment on 
the questionnaire for any ambiguity, simplicity and complexity of questions; and time 
required to fill it in. Dr. A.S. Mallik, a Paediatric Consultant and Dr. J.B. Morgan 
then reviewed the improved version. The questionnaire took between 15 to 40 
minutes to complete (see Appendix 3).
The structured questionnaire was designed to investigate any family history of atopic 
conditions, adverse reactions of subjects to environmental allergens, foods and drinks, 
avoidance of any particular foods or drinks in the treatment of their asthma, parents’ 
perceived views of food avoidance and parents’ smoking habits. Parents were also 
requested to fill in their children’s current intake of specific foods associated with 
major contribution of food allergens, in a food frequency table. Information on 
parents’ educational levels and profession was included in the questionnaire. A 
section on parents’ educational achievements had to be omitted for subjects recruited 
in The Royal Surrey County Hospital as the Consultant Paediatricians in that hospital
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felt it was an invasion of the privacy of parents and thus might cause distress, 
upsetting the doctor-patient relationship. Parents of subjects were assured that the 
information collected would be kept strictly confidential and all children would be 
identified by reference numbers.
Approximately a year later an additional questionnaire was designed and mailed to 
parents of the asthmatic children who participated in this study (see Appendix 4). The 
additional questionnaire included an inquiry about other atopic conditions (such as 
eczema, allergic rhinitis, urticaria etc.); detailed atopic conditions in first degree 
family and in mother’s and father’s families; type of cooking and heating facilities 
and the number of times the family moved house after delivery of the participating 
asthmatic children. Information on the presence or absence of other atopic conditions 
other than asthma was crucial. This enables categorisation of the asthmatic children 
into several groups, such as asthmatic only, asthmatic with eczema, asthmatic with 
allergic rhimtis and so forth. The study intends to identify whether other atopic 
conditions in the asthmatic children had any influence on the specific food antibody 
IgG concentrations.
3.2.3.2 Questionnaire completed by parents
Of the 90 initial questionnaires given to parents in the clinics during recruitment, 87 
(97%) were returned. Three questionnaires of the non-atopic subject were not 
returned. Attempts were made to obtain the addresses of these children, however this 
failed. These children were not registered with the hospital as GPs had referred them 
for blood investigations.
Of the 71 asthmatic children recruited, 11 parents did not give their addresses in the 
first questionnaire. The additional questionnaires (as discussed earlier in section 
3.2.3.1) were mailed to the parents of these 60 asthmatic children. Of the 60 mailed 
follow-up questionnaires, 49 (82%) were completed and returned. Two questionnaires 
were returned to sender as the respondents had moved house. In summary, 49 subjects
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completed by proxy, both initial and follow-up questionnaires; and 22 subjects 
completed by proxy, the initial questionnaires only. Questions on types of cooking 
facilities, home heating systems, number of times moved house after delivering 
participating child and distance of home fi’om busy roads were not analysed as the 
follow-up questionnaire was not completed by non-atopic children. These questions 
were excluded fi’om the results.
3.2.4 Blood sampling
Approximately 1-2 ml of non-fasting venous blood was taken fi’om all subjects and 
controls. The blood sample was allowed to clot at room temperature, centrifuged, 
aliquoted and frozen at -20°C until completion of subject and control recruitment. The 
sera samples were then analysed in one batch using indirect ELISA (as discussed in 
Chapter 2) for the measurement of anti-ovalbumin IgG and anti-p-lactoglobulin IgG 
concentrations.
3.2.5 Anthropometric measurements
3.2.5.1 Weight
Subjects were asked to remove their shoes and heavy clothing. A digital balance or a 
beam balance (Seca, CMS Weighing Equipment Ltd) accurate to about 5 kg was 
used. The scales were placed on a hard flat surface and re-set to zero before each 
weighing. Weights were taken to the last 0.1 kg.
3.2.5.2 Height
Subjects were instructed to stand on a flat floor without shoes with their heels and 
back in contact with the upright wall or stadiometer, the head held comfortably erect 
and arms hanging at the sides in a natural manner. The head indicator was gently
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lowered down the wall/scale until it touched the subject’s head and measurement was 
recorded to the last 0.1 cm.
Of the 71 asthmatic children recruited, weight was measured in 64 (90%) and height 
measured in 58 (82%) children, respectively. Accurate anthropometric measurements 
(either weight or height or both) were not taken in 13 children, as these children were 
uncooperative. Height and weight measurements of these children were therefore 
excluded from the results. Of the 19 non-atopic controls recruited, weight and height 
were measured in 12 (63%) and 9 (47%) non-atopic children, respectively. 
Anthropometric measurements were not taken in these children due to insufficient 
time between recruitment of subjects and either venepuncture or cannulation carried 
out by a busy SHO. Weight and height measurements were equally impossible to 
record after the procedure, as the majority of these children were emotionally upset 
and crying.
3.2.S.3 Anthropometric classification for the evaluation of growth and 
nutritional status using Z-score and Percentile cut-offs
Z-score for weight, height and weight by height are calculated using the following
formula (Frisancho, 1993):
Z score = (Standard’s mean value - value of subiecti 
standard deviation of standard
The reference value of standard’s mean and standard deviation of standards for 
weight, height and weight by height was based on the ‘anthropometric standards’ by 
age for males and females of 1 to 74 years derived from the first and second National 
Health and Nutrition Examination Surveys (the NHANES I and II) of 1971-74 and 
1976-80 (Frisancho, 1993). The percentile weight and height of the subjects were 
determined using the calculated value of the subject’s Z-score (see Table 3.1). 
Subsequently, the growth and nutritional status of subjects were evaluated by the help 
of the five statistical anthropometric categories as shown in Table 3.2.
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Table 3.1. Equivalents of percentile and Z-scores in normal distribution 
(Frisancho, 1993)
Below mean Above mean
Percentile Z-score Percentile Z-score
0.0 to 4.9 -3.090 to -1.650 50.0 to 54.9 0.000 to 0.120
5.0 to 9.9 -1.645 to 1.290 55.0 to 59.9 0.126 to 0.250
10.0 to 14.9 -1.282 to -1.040 60.0 to 64.9 0.253 to 0.380
15.0 to 19.9 -1.036 to -0.850 65.0 to 69.9 0.385 to 0.520
20.0 to 24.9 -0.842 to 0.680 70.0 to 74.9 0.524 to 0.670
25.0 to 29.9 -0.675 to -0.530 75.0 to 79.9 0.675 to 0.840
30.0 to 34.9 -0.524 to -0.390 80.0 to 84.9 0.842 to 1.030
35.0 to 39.9 0.385 to -0.260 85.0 to 89.9 1.036 to 1.280
40.0 to 44.9 -0.253 to -0.130 90.0 to 94.9 1.282 to 1.640
45.0 to 50.0 -0.126 to -0.000 95.0 to 99.9 1.645 to 3.090
Table 3.2. Anthropometric classification for the evaluation of growth and 
nutritional status (Frisancho, 1993)
Percentile Z-score Growth status* Weight status^
Category I 0.0 to 5.0 Z < -1.650 Short Low weight
Category II 5.1 to 15.0 -1.645 < Z < -1.040 Below average Below average
Category HI 15.1 to 85.0 -1.036 < Z < +1.030 Average Average
Category IV 85.1 to 95.0 +1.036 < Z < +1.640 Above average Above average
Category V 95.1 to 100.0 Z > +1.645 Tall Heavy Weight
Z-score = (standard’s mean value - value of subjects / standard deviation of standard). 
^Growth Status defined with reference to sex-specific height
^Weight Status defined with reference to sex-specific weight by age and/or by frame size.
3.2.6 Statistical analysis
The data was analysed on a Personal Computer using the Statistical Package for 
Social Sciences (SPSS). The statistical analyses were performed by using the non- 
parametric, Mann-Whitney U tests because data for the anti-ovalbumin IgG and anti-
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P-lactoglobulin IgG was not normally distributed despite being transformed 
logarithmically.
3.3 Results
3.3.1. The subjects
The clinical categorisation of asthmatic and non-atopic children recruited for whom 
complete data was collected (with the exception of 3 non-atopic children who did not 
complete the questionnaire) is summarised in Figure 3.1. Of the 90 children recruited, 
15 (17%) were asthmatic, 34 (38%) were asthmatic with other atopy such as eczema, 
allergic rhinitis or urticaria, 22 (24%) were asthmatic with other atopy unknown and 
19 (21%) were non-atopic children where neither the child, parents nor close relatives 
were known to be atopic. Table 3.3 shows details of subjects by gender. The majority 
of the asthmatic children participating in this study were male giving a ratio of 1:0.5- 
1:0.7 to female asthmatic children. The mean age of subjects was comparable in all 
the study groups. The mean age of the asthmatic, asthmatic with other atopy unknown 
and non-atopic groups was 6.9±3.6 years (range 3-14), 6.5±3.7 years (range 2-15) and 
6.1±4.0 years (range 2-15) respectively (see Table 3.4). The mean age of the 
asthmatic with other atopy group, appeared to be a year younger than the other 3 
study groups i.e. 5.3±3.6 years (range 2-14).
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Figure 3.1. Distribution of subjects
non-atopic
21%
asthmatic with 
other atopy 
unknown 
24%
asthmatic only 
17%
asthmatic with 
other atopy 
38%
Table 3.3. Gender of asthmatic only, asthmatic with other atopy, asthmatic 
with other atopy unknown and non-atopic children
Study groups Gender n(%)
Male Female Ratio
1 asthmatic only 15 9(60) 6(40) 1:0.7
2 asthmatic with other atopy 34 23(67) 11 (32) 1:0.5
3 asthmatic with other atopy unknown 22 15 (68) 7(32) 1:0.5
4 non-atopic 19 13 (68) 6(32) 1:0.5
Total 90 60 (67) 30 (33) 1:0.5
n = number of subject in the group
Table 3.4. Mean age of asthmatic only, asthmatic with other atopy, asthmatic 
with other atopy unknown and non-atopic children
(Mean+standard deviation, range)
Study groups number Age (years)
Mean ± SD Range
1 asthmatic only 15 6.9 ± 3.6 3 - 1 4
2 asthmatic with other atopy 34 5.3 ± 3.6 2 - 1 4
3 asthmatic with other atopy unknown 22 6.5 ± 3.7 2 - 1 5
1+2+3 all asthmatic children 71 6.0 ± 3.6 2 - 1 5
4 non-atopic 19 6.1 ± 4.0 2 - 1 5
Total 90
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The mean birth weight for all study groups is shown in Table 3.5. No information 
was obtained in relation to whether the child was delivered full term or prematurely. 
However, the mean birth weight appeared to be comparable and above 3 kg. for all 
study groups.
Results for mean weight; Z-score for weight, percentile weight and weight status are 
presented in Table 3.6, and height, Z-score for height, percentile height and growth 
status are presented in Table 3.7. There appeared to be no marked differences 
between the mean weight, mean height and mean weight for height between any of 
the asthmatic groups compared with the non-atopic group. Group 1 (asthmatic only) 
showed a mean current weight greater than the other 3 groups and height taller than 
the 3 groups. In contrast, group 4 (non-atopic group) had the greatest mean percentile 
weight and mean percentile height of all the groups. Both groups 1 and 3, had a 
negative mean Z-score for weight which gave a percentile weight below the 50th 
percentile. Groups 3 and 4 however, had a positive mean Z-score for weight which 
indicated a percentile weight of more than the 50th percentile. It is interesting to note 
that group 2 (asthmatic with other atopy) had the lowest mean weight, mean 
percentile weight and mean height.
All study groups had a mean weight status in category III, which reflected an average 
weight. Nevertheless, there appear to be no marked differences in all the study groups 
in terms of the growth status (height). The mean growth status for all groups was in 
category II, which indicated mean growth as below average (i.e. less than the 50th 
percentile).
Table 3.8 gives an elaboration of Tables 3.6 and 3.7 in relation to the distribution of 
children in the study groups according to the various percentiles for weight, height 
and weight by height measurements. The mean height for age percentile for all groups 
was shown to be in category III. The majority of these children, 8 (62%) children 
from group 1; 19 (63%) children from group 2; 7 (47%) children from groups 3 and 5 
(56%) children from group 4 had height for age between 15.1 and the 85th percentile.
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Similarly, the majority of children in all groups with the exception of children in 
group 3, had weight for age between 15.1 and the 85th percentile. In other words the 
children tended to be of average weight. The children in group 3 (asthmatic with 
other atopy unknown) were fairly evenly distributed in terms of the weight for age 
between 0 and the 95th percentile. Using the parameter weight by height, it appeared 
that 39 (70%) asthmatic children (groups 1+2+3) had weight by height between 15.1 
and the 85th percentile compared with 4 (57%) non-atopic children (group 4) who 
had their weight by height measurement between 85.1 and the 100th percentile. 
Therefore non-atopic children appeared to be tall and lean compared with their 
asthmatic counterparts (see Table 3.8).
Table 3.5. Mean birth weight of asthmatic only, asthmatic with other atopy, 
asthmatic with other atopy unknown and non-atopic children
(Mean+standard deviation, ranges)
Study groups Di Birth weight (kg)
(%) Mean+SD Range
1 asthmatic only n=I5 15 (100) 3.36 + 0.49 2.8 - 4.5
2 asthmatic with other atopy n=34 34 (100) 3.25 + 0.62 1.5 - 4.6
3 asthmatic with other atopy unknown n=22 20 (91) 3.23 + 0.51 1.9 - 4.0
1+2+3 all asthmatic children n=71 69(97) 3.27 + 0.56 1.5 - 4.6
4 non-atopic (nl9) 15 (79) 3.17 + 0.70 1.4 - 3.9
Total 84 (93)
n = number of subjects in the group 
Ui = number of subjects with known birth weight
NB Totals does not always add up to 90 (total sample) as data is missing in some cases. See text 
for details.
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Table 3.8. Percentages of the percentile of weight for age, height for age and 
height for weight for the children who are asthmatic only (group 1), asthmatic 
with other atopy (group 2), asthmatic with other atopy unknown (group 3) and 
non-atopic (group 4) children
Percentiles Asthmatic children (%) Non-atopic 
children (%)
Group 1 
n=15
Group 2 
n=34
Group 3 
n=22
Groups 1+2+3 
0=71
Group 4 
0=19
Height for age n,=13 (87) n,=30 (88) n,=15 (68) 02=58 (82) 02=9 (47)
0.0 - 5.0 2(15) 4(13) 4(27) 10 (17) 1(11)
5.1 -15.0 2(15) 5(17) 2(13) 9(16) 2(22)
15.1 - 85.0 8(62) 19 (63) 7(47) 34 (59) 5(56)
85.1 - 95.0 1(8) 2(7) 0 3(5) 0
95.1 -100 0 0 2(13) 2(3) 1(11)
Weight for age n,=15 (100) n,=32 (94) n,=17(77) 02=64 (90) 02=12 (63)
0.0 - 5.0 0 1(3) 5(29) 6(9) 2(17)
5.1-15.0 2(13) 6(19) 6(35) 14(22) 0
15.1 - 85.0 9(60) 19 (59) 2(12) 30(47) 7(58)
85.1 - 95.0 3(30) 4(13) 4(24) 11 (17) 1(8)
95.1 -100 1(7) 2(6) 0 3(5) 2(17)
Weight by 
height
U2=13 (87) 02=29 (85) 02=14 (64) 02=56 (62) 02=7 (37)
0.0 - 5.0 1(8) 0 0 1(2) 0
5.1 -15.0 1(8) 2(7) 0 3(5) 0
15.1 - 85.0 8(62) 21 (72) 10 (71) 39 (70) 3(43)
85.1 - 95.0 0 3(10) 1(7) 4(7) 3 (43)
95.1 -100 3(23) 3(10) 3(21) 9(16) 1(14)
Group 2 = asthmatic with other atopy 
Group 3 = asthmatic with other atopy unknown 
Group 4 = non-atopic
n, = number of subject’s weight and height measured
U; = number of subjects where both weight and height were measured
NB Totals do not always add up to 90 (total sample) as data is missing in some cases. See text 
for details.
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3.3.2 Parents’ educational attainment
The question relating to the educational level of parents included in the questionnaire 
was removed for subjects recruited from The Royal Surrey County Hospital because 
the Paediatric Consultants from that hospital felt it was too sensitive. However, this 
question was included in the questionnaire for subjects from The Frimley Children 
Centre and The Frimley Park Hospital. The majority of parents of the asthmatic (all 
groups combined) and non-atopic children recruited in Frimley had reached 
GCSE/CSE (O) level of education. Approximately one third had reached higher 
education (see Table 3.9), although numbers in the non-atopic group were small.
Table 3.9. Parents’ educational level of asthmatic and non-atopic children
Educational level Asthmatic (n=42) Non-atopic (n=13)
Father n(%) Mother n(%) Father n(%) Mother n(%)
No information 4(1) 3(23)
< 0 level 2(5) 3(7) 2(15) 3(23)
0 level (GCSE/CSE) 17(40) 24(57) 3(23) 5(39)
A level (HND/BTEC) 6(14) 6(14) 1(8) 2(15)
University/College 13 (31) 9(21) 4(31) 3(23)
n = number responded to question on parents’ educational level 
NB Totals do not always add up to 90 (total sample) as data is missing in some cases. See text 
for details.
3.3.3 Smoking
There was a higher frequency of smokers in families of non-atopic children (60%) 
compared with families of asthmatic children (25%). In addition, most parents of 
asthmatic children who smoked, wrote in the questionnaires that they smoked outside 
the house or in the absence of the subjects (see Table 3.10).
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Table 3.10. Smokers in families of asthmatic, asthmatic with other atopy, 
asthmatic with other atopy unknown and non-atopic children
Study groups Number responded to question n(%) Smoker in subject’s house n(%)
Asthmatic 51 (72) 13 (25)
Non-atopic 15 (79) 9(60)
n = number
NB Totals do not always add up to 90 (total sample) as data is missing in some cases. See text 
for details.
3.3.4 Anti-ovalbumin IgG and anti-g-lactoglobulin IgG concentrations
Tables 3.11 and 3.12 show the mean concentrations of anti-ovalbumin IgG and anti- 
P-lactoglobulin IgG in the 3 asthmatic groups (asthmatic only, asthmatic with other 
atopy, asthmatic with other atopy unknown) and non-atopic children. These 
concentrations are also shown graphically in Figures 3.2 and 3.3. Specific food IgG 
antibodies were detected in all subjects. The mean concentrations of anti-ovalbumin 
IgG were [mean±SD, (range)], 1704±1910 (108-5756) pg/ml; 1519+1395 (14-5273) 
pg/ml; 1153±1404 (75-4665) pg/ml and 300±310 (18-1422) pg/ml in asthmatic only, 
asthmatic with other atopy, asthmatic with other atopy unknown and non-atopic 
groups, respectively. The asthmatic only (group 1) had the highest mean anti­
ovalbumin IgG concentrations among the 4 study groups. The mean concentration of 
anti-ovalbumin IgG was observed to be significantly higher in all the three groups of 
asthmatic children (asthmatic only, P<0.05; asthmatic with other atopy, P<0.001; 
asthmatic with other atopy unknown, P<0.01) compared with the non-atopic group.
The asthmatic with other atopy had the highest mean anti-P-lactoglobulin IgG 
concentration compared with the other 3 groups. The mean concentration of anti-p- 
lactoglobulin IgG was 218±261 (5-678) pg/ml; 224±288 (5-1267) pg/ml; 124+131 
(5-535) pg/ml and 66+72 (5-204) pg/ml in the asthmatic only, asthmatic with other 
atopy, asthmatic with other atopy unknown and non-atopic groups, respectively. 
Although a higher trend was observed for the mean concentrations of anti-p- 
lactoglobulin IgG in all three asthmatic groups compared with the non-atopic group.
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the difference was not statistically significant with the exception of the asthmatic with 
other atopy group P<0.01.
Table 3.11. Anti-ovalbumin IgG concentrations (pg/ml) in asthmatic only, 
asthmatic with other atopy, asthmatic with other atopy unknown and non-atopic 
children
(Mean+standard deviation, ranges)
Study groups n Anti-ovalbumin IgG concentrations(pgZml)
Mean+SD Range
1 asthmatic only 15 1704.1+1910.1* 108 - 5756
2 asthmatic with other atopy 34 1519.9+1395.1*** 14 - 5273
3 asthmatic with other atopy unknown 22 1153.5+1404.4** 75 - 4665
4 non-atopic 19 300.2+310.4 18 -1422
Total 90
n = number
* mean value of group 1 was significantly different from that of group 4
*** mean value of group 2 was significantly different from that of group 4
** mean value of group 3 was significantly different from that of group 4
Figure 3.2. Anti-ovalbumin IgG concentrations (pg/ml) in asthmatic, 
asthmatic with other atopy, asthmatic with other atopy unknown and non-atopic 
children
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Table 3.12. Anti-p-lactoglobulin IgG concentrations (}ag/ml) in asthmatic, 
asthmatic with other atopy, asthmatic with other atopy unknown and non-atopic 
children
(Mean+standard deviation, ranges)
Study groups Anti-p-lactoglobulin IgG 
concentrations (pg/ml)
Mean+SD Range
1 asthmatic only 15 218.1+261.0 5-678
2 asthmatic with other atopy 34 223.8+287.6** 5 -1267
3 asthmatic with other atopy unknown 22 124.1+130.9 5-535
4 non-atopic 19 65.6+71.5 5-204
Total 90
n = number
** mean value of group 2 was significantly different from that of group 4
Figure 3.3. Anti-p-lactoglobulin IgG concentrations (pg/ml) in asthmatic, 
asthmatic with other atopy, asthmatic but other atopy unknown and non-atopic 
children
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79
3.3.5 Analysis of questionnaires
The questionnaire was designed to examine any association between specific food 
antibody concentrations with family or personal history of atopy, food allergy, 
smoking status in family, the age when weaning foods were introduced and the 
current frequency of consumption of allergenic food.
3.3.5.1 History of atopy
Figure 3.4 shows the presence of atopic conditions in a family (mother, father, 
siblings, mother’s family and father’s family) of the asthmatic and asthmatic with 
other atopy. This information was only available from those who returned the second 
questionnaire. A family history of atopy was reported in 93% and 97% of asthmatic 
children only and asthmatic children with other atopy, respectively. One asthmatic 
child and one asthmatic child with other atopic conditions, reported no history of 
atopy in either their first degree or extended family.
Figure 3.5 shows a breakdown of atopic conditions such as asthma, eczema, allergic 
rhinitis and urticaria in families of the 3 asthmatic groups. Fifty per cent or more of 
all 3 asthmatic groups had families with asthma. Asthmatic with other atopy appeared 
to have more than 50% of their families with eczema and allergic rhinitis. Both the 
asthmatic and the asthmatic with other atopy unknown groups, reported 40% or less 
of eczema and allergic rhinitis in their families. Urticaria was present in less than 
20% of all the asthmatic groups’ families.
Statistical analyses using the Mann-Whitney U tests were carried out comparing the 
mean specific food antibody concentrations and family history of atopy. Table 3.13 
shows the specific food IgG antibodies in parents of asthmatic children with or 
without the signs and symptoms of atopic conditions such as asthma, eczema, allergic 
rhinitis and/or urticaria. The mean concentration of anti-ovalbumin IgG in both 
parents with atopy and in those with either mother or father with atopy appeared to be
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higher than with parents without any atopic conditions. A statistically significantly 
higher mean anti-ovalbumin IgG concentration was observed only in asthmatic 
children with both parents having atopy compared to both parents with no form of 
atopic conditions (P<0.05). Although the mean concentration of anti-p-lactoglobulin 
was observed to be higher in asthmatic children with atopy in both parents compared 
to both parents with no symptoms of atopy, this difference was not found to be 
statistically different. In contrast, asthmatic children with either parent having atopic 
condition(s), had a mean concentration of anti-p-lactoglobulin IgG lower than those 
children having no atopy in either parent.
Figure 3.4. Presence of atopic conditions in a family (mother, father, siblings, 
mother’s family and father’s family) of asthmatic children and asthmatic 
children with other atopic conditions
O asthmatic only n=15 
a  asthmatic with other atopy n=34
family mother father slbllng(s) mother's father's
family family
n = number
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Table 3.13. Mean anti-ovalbumin IgG and anti-g-lactoglobulin IgG 
concentrations in asthmatic children whose parents have or do not have atopic 
conditions.
(Mean+standard deviation, ranges)
Category of parents according to 
presence of atopy
n Anti-ovalbumin IgG 
concentrations
Anti-p-lactoglobulin IgG 
concentrations
Mean+SD Range Mean+SD Range
Atopy present in both parents 11 2517+1502* 1117-5756 305+213 23-678
Atopy present in mother only 18 1272+1642 1117-5756 206+305 6-1267
Atopy present in father only 7 1817+1746 283-4423 140+220 5-607
Atopy absent in either parent 12 1072+1119 14-3156 232+328 5-1067
No information on parents’ atopy 1
Total 49
n= number
* mean value of asthmatic children with atopy present in both parents was significantly 
different from that of asthmatic children with no atopy in either parents
Table 3.14 shows the frequency of allergic reactions in asthmatic children from the 3 
groups to environmental allergens which include pollens, furry animals, house dust, 
house dust mites, moulds, foggy weather, strong fumes, car exhaust fumes and 
tobacco smoke. In addition Figure 3.6, presents the percentage and number of 
children in the 3 study groups reported as having allergic reactions to various 
environmental allergens. In general as reported by parents, 21% (15 of 71) of 
asthmatic children were not affected by environmental allergens. The remaining 56 
(79%), reported allergic reaction(s) varying from one to 9 types of environmental 
allergens. The majority of the asthmatic children i.e. 80% (12 of 15) of the asthmatic 
only group; 50% (17 of 34) of the asthmatic with other atopy; and 64% (14 of 22) of 
the asthmatic with other atopy unknown group, appeared to be affected by one and up 
to 4 types of environmental allergens. All three groups reported adverse reactions to 
foggy weather. This was followed by strong fumes, tobacco smoke and car exhaust 
fiimes. Similarly, all 3 groups reported were least affected by moulds, house dust 
mites, house dust, pollens and furry animals. Table 3.15 indicates that there is no
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difference in the mean specific food IgG antibody concentrations in those who 
reported with or without allergic reactions to environmental allergens.
Figure 3.5. Family history of atopic conditions such as asthma, eczema, 
allergic rhinitis and urticaria in children who are asthmatic only, asthmatic with 
other atopic condition(s) and asthmatic with other atopy unknown
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Table 3.14. Frequency of allergy to types of environmental allergens
Study groups n Frequency of allergy to environmental allergens
0 1 2 3 4 5 6 >6
Group 1 15 3 2 4 3 3
Group 2 34 8 1 7 4 5 4 2 3
Group 3 22 4 5 5 1 3 1 2 1
Total 71 15 8 16 8 11 5 4 4
n = number
Group 1 = asthmatic only
Group 2 = asthmatic with other atopy
Group 3 = asthmatic with other atopy unknown
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Figure 3.6. Presence of personal allergic reactions to various environmental 
allergens reported in asthmatic only, asthmatic children with other atopy and 
asthmatic children with other atopy unknown
100
12 26
□ asthmatic only n=15 
O asthmatic with other atopy n=34 
■ asthmatic with other atopy unknown n=22
Table 3.15. Mean anti-ovalbumin IgG and anti-piactoglobulin IgG 
concentrations in asthmatic children with or vdthout adverse reactions to 
environmental allergens
(Mean±standard deviation, ranges)
Category of asthmatic children 
according to adverse reactions
n (%) Anti-ovalbumin IgG 
concentrations
Anti-p-lactoglobulin IgG 
concentrations
to environmental allergens Mean±SD Range Mean+SD Range
With adverse reactions 
No adverse reactions
56 (79) 
15(21)
1426+1563
1516+1345
15-5756
14-4665
180+251
237+219
5-1267
6-571
Total 71
n= number
3.3.S.2 History of food allergy
Table 3.16 details results of the frequency of allergic reactions to foods including egg, 
milk, peanut, wheat, fish, shellfish, oranges, cordials and carbonated drinks. Figure 
3.7 however, shows the percentage and number of children in the 3 study groups 
reported having reactions to the above foods or drinks. Six (8%) asthmatic children (5 
from the asthmatic with other atopy group, and one child from the asthmatic with 
other atopy unknown group) had allergic reactions to eggs as claimed by their
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parents. Twelve (17%), 7 (10%), 9 (13%), 11 (16%) asthmatic children from the 3 
groups reported having reactions to milk, peanut, oranges and cordials, respectively. 
Allergic reactions to wheat, fish, shellfish and carbonated drinks were reported in less 
than 3% of asthmatic children.
The mean anti-ovalbumin IgG concentrations in asthmatic children in Groups 1 and 2 
who reported having food allergy appeared to be higher than those who claimed 
negative reactions. However this difference was not found to be statistically 
significant (see Table 3.18).
Further examination of the questionnaire was carried out to examine appropriate 
measures taken by parents to reduce their child’s misery if any, to the reported foods. 
The questions were worded to demonstrate if parents avoided giving particular foods 
to their children to reduce symptoms of asthma. However, there was a possibility that 
parents perceived the questions differently i.e. avoiding those foods causing reactions 
to their children, which may or may not affect asthmatic conditions, but possibly 
affect others such as hyperactivity, allergic rhinitis, eczema and so forth. Irrespective 
of the perception of parents, 10 (35%) children were reported as avoiding certain 
foods or drinks shown in Table 3.18, to eleviate any adverse reactions they 
experienced. Of these 10 subjects, 5 (17%) asthmatic children had avoided similar 
foods in the past.
Table 3.19 shows in detail the results of the mean differences in specific food IgG 
antibody concentrations in children who currently avoided foods and/or drinks 
compared to their counterparts who did not avoid any foods. It appeared that children 
who currently avoided foods that gave them reactions had mean specific food IgG 
antibody concentrations to ovalbumin and p-lactoglobulin which were lower than 
children who did not avoid foods and/or drinks at all. These differences were 
however, not found to be statistically significant. Figures 3.8 and 3.9 show the 
distribution of anti-ovalbumin IgG and anti-P-lactoglobulin IgG concentrations in 
both groups of children whose parents claimed that their children avoided or
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continued to consume those foods or drinks that affected them. It appeared that 11 
(58%) asthmatic children who claimed no avoidance of any foods and drinks had 
anti-ovalbumin IgG concentrations within a similar range (between 15-2204 pg/ml) 
to those children who claimed to be currently avoiding the specific foods that they 
reacted to. It appeared that there was a trend whereby, children who abstained from 
certain foods which they reacted to, tended to have lower concentrations of the 
specific food IgG antibodies to ovalbumin and P-lactoglobulin.
Table 3.16. Frequency of foods and/or drinks causing adverse reactions as 
reported by parents of asthmatic children
Study groups n Frequency of foods and drinks 
causing adverse reactions 
0 1 2  3 4
1 asthmatic only 15 9 3 3
2 asthmatic with other atopy 34 17 8 4 2 3
3 asthmatic with other atopy unknown 22 16 3 1 1 1
1+2+3 asthmatic in general 71 42 14 8 3 4
n = number
Figure 3.7. Allergic reactions to various foods and drinks reported in children 
who are asthmatic only, asthmatic with other atopic conditions and asthmatic 
with other atopy unknown
□ asthmatic only n=15
■ asthmatic with other atopy n=34
■ asthmatic with other atopy unknown n=22
(U 20
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Table 3.17. Mean anti-ovalbumin IgG and anti-piactoglobulin IgG
concentrations in children reported as having adverse reactions to food(s)
(Mean+standard deviation, ranges)
Study groups n (%) Anti-ovalbumin IgG 
concentrations (pg/ml)
Anti-p iactoglobulin IgG 
concentrations (pg/ml)
Mean+SD Range Mean+SD Range
Group la 6(40) 2997+2340 176-5756 358±330 5-678
Group lb 9(60) 842+932 108-2617 124+161 6-523
Group 2a 17(50) 1547+1241 15-4423 152+151 5-425
Group 2b 17(50) 1492+1572 14-5273 2951369 8-1267
Group 3a 6(27) 529+557 75-1467 78+93 5-262
Group 3b 16 (73) 1387+1563 91-4665 141+141 10-535
Group la  = asthmatic only, with adverse reactions to food 
Group lb  = asthmatic only, with no adverse reactions to food or don’t know 
Group 2a = asthmatic with other atopy, with adverse reactions to food 
Group 2b = asthmatic with other atopy, with no adverse reactions to food or don’t know 
Group 3a = asthmatic with other atopy unknown, with adverse reactions to food 
Group 3b = asthmatic with other atopy unknown, with no adverse reactions to food 
or don’t know
n = number
Table 3.18. Current and past avoidance of foods and/or drinks in asthmatic 
children who reported having adverse reactions to food(s)
Study groups n,(%) Avoided foods and/or drinks 
for purpose of asthma 
current past
1 asthmatic (n=15) 6(40) 1 (17%) 0
2 asthmatic with other atopy (n=34) 17(50) 8(47%) 5(29%)
3 asthmatic with other atopy unknown (n=22) 6(27) 1 (17%) 0
1+2+3 asthmatic in general 29 (41) 10 (35%) 5 (17%)
n = number of children
nj = number of children with adverse reactions to food(s)
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Table 3.19. Mean anti-ovalbumîn IgG and anti-(3-lactoglobulin IgG 
concentrations in asthmatic children who avoided foods that affected them for 
the period of this study
(Mean+standard deviation, ranges)
Asthmatic children currently n, Anti-ovalbumin IgG Anti-(3-lactoglobuIin IgG
who did/did not avoid foods concentrations (p-g/ml) concentrations (|ig/ml)
causing them reactions Mean+SD Range Mean+SD Range
Avoiding foods 10 962+734 15-2204 115+157 5-425
Not avoiding foods 19 1991+1831 52-5756 213+229 5-678
n, = number of children with adverse reactions to food(s)
Figure 3.8. Mean anti-ovalbumin IgG concentrations in asthmatic children 
who avoided or did not avoid foods that affected them for the period of this 
study
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Figure 3.9. Mean anti-(3-lactoglobulin IgG concentrations in asthmatic 
children who avoided or did not avoid foods that affected them for the period of 
this study
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3.3.S.3 Breast and formula feeding
The question on breast-feeding was aimed firstly at examining the differences in 
breast-feeding patterns between asthmatic and non-atopic children; and secondly, if 
there are any differences between the specific food antibody concentrations in 
asthmatic children who were totally breast-fed, those who received mixed feeding 
(breast-milk and infant formula) and those fed on infant formula. Of the 71 asthmatic 
children, 50 (70%) were breast-fed. Of these 12 (80%), 23 (68%), 15 (68%) were 
from the asthmatic only, asthmatic with other atopy and asthmatic with other atopy 
unknown groups, respectively. Results as shown in Table 3.20 indicate that 50 
asthmatic children were breast-fed, 24 (48%) were exclusively breast-fed for 4 
months or more, 26 (52%) asthmatic children received mixed feeding i.e. not only 
were they breast-fed, but they were also fed on infant formula from birth and to 3 
months of age and 21 (30%) of the asthmatic children were not breast-fed at all. The
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trend towards breast-feeding appeared to be similar in non-asthmatic children. Of the 
11 mothers in the non-atopic group who responded to this question, 8 (73%) were 
breast-fed, however, only 2 (25%) were exclusively breast-fed for at least 4 months 
compared with 48% of asthmatic children, 6 (75%) had mixed milk feeding and 3 
(27%) were exclusively fed on infant formula from birth. The mean duration of 
breast-feeding was longer in non-atopic children i.e. 10.9+7.0 (1-24) months 
compared with the asthmatic children 6.8±6.7 (0.3-36) months. But the number of 
non-atopic children who were exclusively breast-fed for a minimum of 4 months was 
only 25% compared with 48% of asthmatic children. The majority of non-atopic 
children (75%) was breast-fed as well as bottle-fed. The proportion of non-atopic 
children (27%) fed on formula from birth was similar to the asthmatic children 
(30%). Non-atopic children were observed to be fed on formula at a much earlier 
mean age than asthmatic children. Formula feeding was introduced to non-atopic 
children at 0.7±1.9 (birth-7) months of age, compared with the mean age of 1.8± 2.1 
(birth-7) months in the asthmatic group; 1.4+2.4 (birth-10) months in asthmatic with 
other atopy; and 2.1±.2.9 (birth-9) months in asthmatic with other atopy unknown. 
Although follow-up formula was supposedly introduced to older infants, it appeared 
that a child in the asthmatic only group, was given infant formula at birth and the 
mother switched to follow-up formula when he was one month of age. The remaining 
children were given follow-up formula after 4 months of age in all groups.
Anti-ovalbumin IgG and anti-p-lactoglobulin IgG concentrations were examined in 
relation to the type of milk given to these asthmatic children after birth. Table 3.21 
relates to this data. The mean specific food antibody concentrations did not appear to 
be different in the asthmatic children who were exclusively breast-fed up to 4 months 
of age compared with those who were either fed on breast-milk along with formula, 
or fed exclusively on formula milk from birth. However, the usefulness of this data is 
limited to a retrospective study at birth and followed-up at 4 months of age and later, 
and related to the development of atopy in the children being studied.
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Table 3.20. Mean duration (months) of breast-feeding in children who are 
asthmatic only, asthmatic with other atopy and asthmatic with other atopy 
unknown
(Mean+standard deviation, ranges)
Study groups n
ni
(%)
Breast-fed 
Duration (months) 
Mean+SD Range
Asthmatic only 15 12 (80) 5.5+4.2 1-12
Asthmatic with other atopy 34 23 (68) 7.7+ 8.4 0.3 - 36
Asthmatic with other atopy unknown 22 15(68) 7.3 + 6.1 0.5 -18
Asthmatic in general
• exclusive breast-feeding for 4 months
• mixed feeding from birth
• exclusive formula feeding from birth
71
24(48%)
26(52%)
21(30%)
50(70%) 6.8±6.7 0.3-36
Non-atonic children 11 8(73%) 10.9 + 7.0 1 -2 4
• exclusive breast-feeding for 4 months
• mixed feeding
• exclusive formula feeding from birth
2(25%)
6(75%)
3(27%)
n = number of children n, = number of children breast-fed
NB Totals do not always add up to 90 (total sample) as data is missing in some cases. See text
for details.
Table 3.21. Mean anti-ovalbumin IgG 
concentrations in asthmatic children according
(Mean+standard deviation, ranges)
and anti-piactoglobulin IgG 
to categories of breast-feeding
Categories of breast-feeding in first year Number Specific IgG concentrations (pg/ml)
of life of asthmatic children: (%) Mean+SD Range
Anti-ovalbumin IgG concentrations:
• exclusive breast-feeding for 4 months 24(48%) 1589+1765 60-5756
• mixed feeding from birth 26(52%) 1212+1157 91-4629
• exclusive formula feeding from birth 21(30%) 1569+1618 14-4609
Anti-p-lactoglobulin IgG concentrations:
• exclusive breast-feeding for 4 months 24(48%) 250+317 5-1267
• mixed feeding 26(52%) 128+119 8-425
• exclusive formula feeding from birth 21(30%) 203+257 5-1067
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3.3.S.4 Introduction of weaning foods in first year of life
The introduction of weaning foods was assessed by requesting parents to tick boxes 
for the age (never, from birth, from one month and up to eleven months, and a box 
for age after one year) of the child when various listed food items were first 
introduced. These foods included breast milk, infant formula, follow-up formula, 
normal cows’ milk, goats’ milk, soya milk, infant cereals, breakfast cereals, bread, 
rice, beef, chicken, cheese, yoghurt, eggs, vegetables, finit, legumes/beans and 
peanut. Full fat cows’ milk was introduced at a mean age of between 8.6 months and
10.2 months in all groups. One mother reported that she gave her non-atopic infant 
normal cows’ milk from birth. She specifically crossed the ‘never’ boxes, for breast- 
milk, formula and follow-up formula, and specifically wrote code number for ‘from 
birth’ for normal cows’ milk box. The mother appeared to be a full-time housewife; 
the father was a window cleaner, and both parents had not reached GCSE CSE level 
of education. As for goats’ milk and soya milk, only 4 (12%) and 6 (18%) 
respectively, of asthmatic children with other atopy reported consuming the 
aforementioned products. Of these, one child was given soya based formula milk at 2 
months of age. Others were possibly given normal soya milk after 4 months of age.
There appeared to be no marked differences in the pattern of the introduction of 
weaning foods to asthmatic children compared with the non-atopic children (see 
Table 3.23). Infant cereals were observed to be introduced at a mean age of 3.9±1.9 
(range 2-8) months, in asthmatic children >vith other atopy unknown. However, other 
groups were introduced to infant cereals only after 4 months of age. Nevertheless, a 
number of children were weaned onto solids from as early as one and 2 month(s) of 
age in all study groups.
Cereals which include breakfast cereals and breads were introduced at a mean age of 
6.9 months or older. Children appeared to be weaned onto rice presumably rice based 
cereals, between a mean age of 5.9 and 6.9 months. Protein foods such as beef, 
chicken, cheese, yoghurt and eggs were introduced to all study groups at a mean age
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of between 5.8 months and 8.4 months. The mean age of introduction to fruit was no 
different from vegetables in all study groups i.e. between 5.2 and 6.7 months of age. 
Beans were given to most children at about the same mean age as when animal 
proteins were introduced. Approximately only 20% or less of children from all study 
groups were introduced to peanut in the form of peanut butter at a mean age of 10 
months or later. Several mothers reported that immediate rashes developed as soon as 
peanut butter was introduced to the asthmatic children during the first year of life. 
They immediately withdrew peanut butter from the child’s diet.
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3.3.5.S Frequency of consumption of allergenic, alternative and preventive foods.
Parents and older children were questioned on the frequency of consumption with 
regard to 11 food items (egg, milk, cheese, yoghurt, chocolate, fresh fruit, fresh citrus 
fruit, fruit juice, soya milk, goats’ milk and nuts) and 2 supplements (vitamin and 
mineral). The foods were then put into 7 categories i.e. eggs; milk and milk products; 
soya milk, goats’ milk, peanuts, fruits and nutrient supplements as shown in Tables 
3.23 - 3.30. These categories were chosen as they reflect potent allergenic foods such 
as egg, milk and peanut; alternative choices such as soya and goats’ milk as perceived 
by parents to replace cows’ milk; and preventive foods such as fruits and vitamin 
supplements.
Goat’s milk was only consumed by two children, one child from the asthmatic only 
group (consumed goats’ milk 1-2 times per week) and the other from the asthmatic 
with other atopy group (consumed goats’ milk 3-5 times per week). Two asthmatic 
with other atopy reported consuming soya milk with consumption frequency of 3-5 
times per week for one child and only occasionally for the other child. There 
appeared to be no marked differences in relation to the pattern or frequency of 
consumption of specific foods in any one group. Irrespective of whether they were 
asthmatic with or without other atopic conditions or non-asthmatic children, the 
majority of children consumed eggs 1-2 times per week and consumed milk daily. Of 
the 69 asthmatic children who responded to the question on his/her current frequency 
of egg consumption, 15 (22%) claimed abstinence from eggs (see Table 3.23). In 
addition, one non-atopic also claimed no current consumption of eggs. Tables 3.24 
and 3.26 show in detail the food specific IgG antibody concentrations in asthmatic 
children who claimed having reactions to eggs (6 asthmatic children) and milk (12 
asthmatic children) in relation to consumption frequency of the related allergenic 
foods. It appeared that the mean anti-ovalbumin IgG concentrations for the 4 
asthmatic children who claimed no current consumption of eggs at all was shown to 
be lower [1291+521 (645 -1822) pg/ml] than the one asthmatic child who consumed 
eggs rarely [2204 pg/ml) (see Table 3.24). However, this was not consistent with the
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anti-ovalbumin IgG concentration in one asthmatic child who consumed eggs 1-2 
times per week (75 pg/ml). The mean anti-P-lactoglobulin IgG in 2 children who 
currently avoided milk and milk products appeared to have lower values [124±28 
(104-144) pg/ml] compared with those who consumed daily, 3-5 times per week or 
rarely (see Table 3.25). However, the results also appeared to be inconsistent as one 
child who consumed milk and milk products 1-2 times per week had the lowest anti- 
P-lactoglobulin IgG concentration (5 pg/ml). Those children who reported no adverse 
reactions to either eggs and/or milk had the highest food specific IgG concentrations 
compared with their counterparts (see Tables 3.24 & 3.26).
The majority of children in all groups consumed fi*esh fimits and/or juice daily and the 
rest consumed finits either 3-5 times per week or 1-2 times per week (see Table 3.27). 
Table 3.29 shows in detail the specific food IgG antibody in relation to the fi*equency 
of jfruit consumption in 29 asthmatic children who reported having adverse reactions 
to food and/or drinks. It appeared that the food IgG antibody levels for egg and milk 
in these children were statistically significantly lower for those who consumed firuits 
daily (P<0.05) and 3-5 times per week (P<0.05) compared with their counterparts 
who consumed fiiiits 1-2 times per week. Forty-seven (66%) asthmatic children 
claimed not consuming peanuts currently although only 7 (10%) asthmatic children 
reported having adverse reactions to peanuts (see Table 3.29, Figure 3.7). The 
question on peanuts may not have been specific and it might have been interpreted 
differently. Thus, responses could have excluded information on peanut butter or 
other foods containing peanuts.
The majority of the asthmatic only (60%) and asthmatic with other atopy unknown 
(86%) groups reported not taking any vitamin or mineral supplements. However, 59% 
of the asthmatic with other atopy and 42% of the control groups were given either 
vitamins with or without mineral supplements. These children were given vitamin 
supplements either daily, 3-5 times per week or 1-2 times per week; and mineral 
supplements were consumed in conjunction with vitamin supplements. Only one child
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(asthmatic with other atopy) reported taking mineral supplements occasionally and 
without the vitamin supplements.
Table 3.23. Frequency of egg consumption by asthmatic only, asthmatic with 
other atopy, asthmatic with other atopy unknown and non-atopic children
Study groups n(%) Frequency of egg consumption n(%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
Group 1 15 (100) 0 1(7) 8(53) 2(13) 4(27)
Group 2 34 (100) 0 2(6) 17 (50) 6(18) 9(27)
Group 3 22 (100) 0 3(14) 10 (46) 7(32) 2(9)
Group 4 15 (79) 3(16) 2(11) 8(42) 1(5) 1(5)
Groups 1+2+3 71 (100) 0 6(87) 35 (51) 15(22) 15(22)
n = number responded to question
Group 1 = asthmatic only
Group 2 = asthmatic with other atopy
Group 3 = asthmatic with other atopy unknown
Group 4 = non-atopic children
Table 3.24. Anti-ovalbumin IgG concentrations (pg/ml) in asthmatic children 
with or without egg allergy in relation to the frequency of egg consumption
(Mean +standard deviation, ranges)
Frequency of Asthmatic children
egg Anti-ovalbumin IgG concentrations (pg/ml)
consumption Allergic to eggs Not allergic to eggs
n Mean+SD Range n Mean +SD Range
3-5 X/week 0 6 1010+936 15-2462
1-2 X/week 1 75 75 34 1517+1662 22-5273
Rarely 1 2204 2204 14 1162+1298 14-4665
None 4 1291+521 645-1822 11 1925+1843 168-5756
Total 6 65
n = number
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Table 3.25. Frequency of milk and milk products (milk, cheese, yoghurt, 
chocolates) consumption by asthmatic only, asthmatic with other atopy, 
asthmatic with other atopy unknown and non-atopic children
Study groups n
(%)
Frequency of milk consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
Group 1 15(100) 12 (80) 2(13) 1 (7)
Group 2 34 (100) 26(77) 3(9) 2(6) 1(3) 2(6)
Group 3 22 (100) 20 (91) 1(5) 1(5)
Group 4 16(84) 15 (79) 1(5)
Groups 1+2+3 71 (100) 58 4 4 1 4
n = number responded to question
Group 1 = asthmatic only
Group 2 = asthmatic with other atopy
Group 3 = asthmatic with other atopy unknown
Group 4 = non-atopic children
Table 3.26. Anti-p-lactoglobulin IgG concentrations (pg/ml) in asthmatic 
children with or without adverse reactions to milk in relation to frequency of 
milk and milk products (milk, cheese, yoghurt, chocolate) consumption
(Mean +standard deviation, ranges)
Frequency of milk 
consumption
Asthmatic children
Anti-p-lactoglobulin IgG concentrations (pg/ml)
With adverse reactions to milk 
products
No adverse reactions to milk 
products
n Mean + SD Range n Mean + SD Range
Daily 6 158 +140 5-311 52 196 ± 267 5 -1267
3-5 X/week 2 191 + 226 31-351 2 76 + 70 26 -126
1-2 X/week 1 5 5 3 188 +165 68 - 377
Rarely 1 310 310
None 2 124 + 28 104 -144 2 400 + 393 122 - 678
Total 12 59
n = number
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Table 3.27. Frequency of fruit (fresh and/or juice) consumption by asthmatic 
only, asthmatic with other atopy, asthmatic with other atopy unknown and non- 
atopic children
Study groups n Frequency of fruit consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely
Group 1 15 (100) 11 (73) 2(13) 2(13)
Group 2 34 (100) 22(67) 6(18) 5(15) 1(3)
Group 3 22 (100) 13 (59) 5(23) 4(18)
Group 4 16(84) 9(47) 4(21) 2(11) 1(5)
Groups 1+2+3 71 46 13 11 1
n = number responded to question
Group 1 = asthmatic only
Group 2 = asthmatic with other atopy
Group 3 = asthmatic with other atopy unknown
Group 4 = non-atopic children
Table 3.28. Anti-ovalbumin IgG and anti-p iactoglobulin IgG concentrations 
in relation to the frequency of fruit consumption (fresh and/or juice) in 
asthmatic children reported with adverse reactions to food and/or drinks
(Mean ± standard deviation, ranges)
Asthmatic children with adverse reactions to food and/or drinks (n=29)
Specific food IgG antibody Frequency of fruit consumption
Daily 3-5 times/week 1-2 times/week
n=19 n=4 n=6
Anti-ovalbumin IgG 1331± 1419* 944 ± 456* 3065 +1967
concentrations (pg/ml) (15 - 4630) (590 -1583) (283 - 5756)
nl9 n4 n6
Anti-p-lactoglobulin IgG 174 ± 208 156 +188 209 ± 256
concentrations (pg/ml) (5 - 676) (20 - 425) (5 - 678)
n = number of children with adverse reactions to foods and/or drinks
* mean value of anti-ovalbumin IgG in children who consumed fruit daily was significantly 
different than those who consumed fruit 1-2 times/week
* mean value of anti-ovalbumin IgG in children who consumed fruit 3-5 times/week was 
significantly different than those who consumed fruit 1-2 times/week
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Table 3.29. Frequency of peanut consumption by asthmatic only, asthmatic 
with other atopy, asthmatic with other atopy unknown and non-atopic children
Study groups n Frequency of peanut consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
Group 1 15 (100) 2(13) 5(33) 8(53)
Group 2 34(100) 3(9) 6(17) 25(74)
Group 3 22 (100) 1(5) 2(9) 5 23) 14 (64)
Group 4 15 (79) 3(16) 3(16) 3(16) 6(32)
Groups 1+2 +3 71 1 0 7 16 47
n = number responded to question
Group 1 = asthmatic only
Group 2 = asthmatic with other atopy
Group 3 = asthmatic with other atopy unknown
Group 4 = non-atopic children
Table 3.30. Frequency of vitamin and mineral consumption by asthmatic only, 
asthmatic with other atopy, asthmatic with other atopy unknown and non-atopic 
children
Study groups n Frequency of vitamin consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
Group 1 15 (100) 4(27) 1(7) 1(7) 9(60)
Group 2 34 (100) 11 (32) 2(6) 4(12) 3(9) 14 (41)
Group 3 22 (100) 1(5) 1(5) 1(5) 19 (86)
Group 4 14(73) 5(26) 3(16) 6(32)
Groups 1+2+3 71 16 4 4 5 42
n = number responded to question 
Group 1 = asthmatic only 
Group 2 = asthmatic with other atopy 
Group 3 = asthmatic with other atopy unknown 
Group 4 = non-atopic children
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3.4 Discussions
3.4.1 Recruitment of subjects and controls
Recruitment of the asthmatic children in this study posed no difficulties. In fact all of 
the 71 asthmatic children were recruited within the year of the recruitment period. As 
mentioned earlier, further recruitment of the asthmatic children had to be abandoned 
as recruitment of matched age and gender for non-atopic controls was extremely 
difficult and proved to be a great challenge.
Atopy problems in the population appear to be overwhelming. Recent accumulating 
evidence has shown that allergies in general are on the increase. It seems that as much 
as 40% of the British population was considered to be atopic and about 15% suffer 
fi*om some form of allergy (Sunday Times Magazine, 19th October, 1997). Sibbald et 
al. (1990) reported that the prevalence of positivity to at least one of the 3 common 
allergens (grass pollen, house dust and house dust mites) on skin prick testing rose 
fi"om 23% in 1974 to 46% in 1988. These studies were carried out in South West 
London in 1974 and in 1988, and compared the prevalence of atopy in two GP’s 
surgeries. It was reported that the prevalence of atopy was 46% in 1988 despite 
excluding patients with allergic rhinitis from the study. Davies & Oilier (1989) 
reported that one in five teenagers suffer fi-om allergic rhinitis and one in seven 
primary school children have asthma. Looking at the extensive problem of atopy in 
the population today, the chances of recruiting ‘clean’ healthy controls (no personal 
and close family history of atopy) appeared to be difficult especially within hospital 
premises.
In fact the majority of children who require blood investigations are likely to have 
raised levels of immunoglobulins depending on the conditions or diseases that they 
have suffered firom. Immunoglobulins may be increased non-specifically in a wide 
variety of infections and also in autoimmune diseases (Devlin, 1997). Similarly, it 
may be equally difficult to recruit healthy children fi-om schools in the community for
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fear of upsetting the doctor-children relationship and, moreover venepuncture is not a 
welcoming procedure especially in healthy children. Furthermore, the Ethical 
Committee for Research may not approve of recruiting healthy children in schools to 
protect the welfare of these children from being exploited even for the benefit of 
science. Recruitment may have been easier if several researchers had been posted full­
time daily in the hospital ward throughout the 2 year period in several hospitals.
Despite the constraints, 19 non-atopic children were successfully recruited into this 
study. Although this number is far below the expected sample size required to enable 
statistical inferences of the population at large, the study’s statistics did show, 
however significantly higher specific food IgG antibody concentrations in a sample of 
15 and 34 of the asthmatic group only and asthmatics with other atopic conditions, 
respectively compared with 19 non-atopic controls. This could possibly be due to the 
careful selection of controls carried out throughout the study period. A stringent 
criteria was adopted in the selection of these ‘clean’ controls. All controls were 
thoroughly screened for any personal or close family history of any atopic conditions 
such as asthma, eczema, allergic rhinitis, urticaria, allergic or adverse reactions to 
nickel, penicillin, food and drinks and so forth, before qualifying and being accepted 
as ‘clean’ controls. In a pilot project on “Asthma and food allergy in adults” carried 
out by Ranky (1995), no statistical difference was observed in the anti-ovalbumin IgG 
levels between the asthmatic subjects and controls matched for gender and age. Of the 
10 controls who volunteered in that study, two who were still in the University, were 
approached in the hope of recruiting them for the adult study as discussed in Chapter 
5. Unfortunately, neither of them qualified as they were identified as having allergic 
rhinitis and/or a family history of allergic rhinitis on personal interview.
The majority of the “clean” controls appeared to have anti-ovalbumin concentrations 
below 415 pg/ml. However, two ‘clean’ controls had an anti-ovalbumin IgG 
concentration higher than 415 pg/ml, one having 616 pg/ml and the other 1422 
pg/ml. If both were to be considered as outliers, the differences in the anti-ovalbumin 
IgG between the asthmatic group and the non-atopic group would have been observed
102
as being at a statistically significantly lower level than the present value (P<0.05- 
P<0.001). However, they were accepted as non-atopic on the basis of no personal or 
close family history of any atopic conditions.
3.4.2 Food specific IgG antibodies in asthmatic children
Morris (1991) and Lovegrove (1991) were the first investigators to quantify specific 
food IgG antibodies, specifically anti-ovalbumin IgG, anti-P-lactoglobulin IgG, and 
anti-gliadin IgG concentrations. Wide ranges of specific antibodies to ovalbumin and 
p-lactoglobulin were seen in all subjects of the group studied, with the concentrations 
of anti-ovalbumin IgG higher than anti-p-lactoglobulin IgG. In this study, the anti­
ovalbumin IgG concentrations in asthmatic children were in the range of 14 pg/ml 
and 5756 pg/ml, and between 18 pg/ml and 1422 pg/ml for non-atopic children.
Findings in this study showed that the mean anti-ovalbumin IgG concentrations were 
higher than the mean anti-p-lactoglobulin IgG concentrations in asthmatic children. 
As mentioned earlier, there has been no study so far reporting the concentration 
values of food specific IgG in children. However, the findings in this study were in 
agreement with findings in adults of Morris (1991), but the values for both specific 
food IgG antibodies to ovalbumin and P-lactoglobulin in some subjects were far 
higher (approximately 2.5 fold) than the findings in both studies of Morris (1991) and 
Lovegrove (1991). Hampton et al. (1990), reported anti-ovalbumin IgG values as 
high as 2.2 mg/ml in one subject. This high level of ovalbumin antibodies in serum 
was considered to be higher than the circulating levels of specific antibodies produced 
by immunisation in animals. It appeared that ovalbumin is highly antigenic and it is 
used as a carrier coupled to small molecular weight compounds in order to produce an 
immune response (Shibier et al., 1984). Another possible factor which may contribute 
to high levels of the anti-ovalbumin IgG in serum is that a large proportion of 
ovalbumin is absorbed intact due to its resistance to enzyme degradation in the gut 
(Kilshaw & Cant, 1984; Husby et d., 1985).
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Hampton et d . (1990) reported a correlation observed with specific ovalbumin IgG 
levels in serum and the daily dietary intake of eggs (obtained through a 7-day food 
inventory record). In this study however, parents of subjects recorded their child’s 
egg intake in the food fi*equency sheet ranging fi-om daily, 3-5 times per week, 1-2 
times per week, 1-2 times per month, rarely or none at all. No further information 
was asked in relation to the duration of any food not consumed or whether the child 
consumed other food that contained the food concerned. Thus, with this drawback, it 
is difficult to justify the presence of such high values of anti-ovalbumin IgG in 
asthmatic children who reported not consuming eggs, although they did not appear to 
have any adverse reactions to eggs. One possible reason is that some of these children 
may have reactions to eggs but parents are unaware of the situation. Moreover, IgG 
has a circulating half-life of 23 days and probably a residual time on the mast cells of 
2 to 3 months (El Rafei et ^ ., 1989). If this is the case, it is difficult to reach a 
conclusion on the levels of specific food IgG antibodies in those asthmatic children 
who claimed not consuming either eggs or milk products at present. Information on 
the duration of abstinence of the allergenic food is therefore crucial.
Another explanation for the presence of such high values of anti-ovalbumin IgG in 
sera of some of the asthmatic children is the possibility of crossreaction with other 
food protein which shared the same antigenic determinants. O’Neil & Lehrer (1995) 
draw attention to the presence of crossreaction of seafood allergens that has been 
demonstrated in several studies. They report that several investigators confirmed the 
presence of shared antigenic /allergenic determinants among white fish, blue crab, 
crawfish, lobster and shrimp. The firequency with which sera fi-om shrimp 
hypersensitive subjects reacts with the other three identical proteins, confirms the 
significant crossreaction among these species.
In the crossreaction analysis, in Chapter 2, it was observed that several sera, when 
mixed with other protein, had a lower percentage of crossreaction with other proteins 
compared with the plain, unmixed sera. Apparently, some subjects appeared to be 
sensitive to other similar allergenic determinants and thus their sera may have
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produced results that may well have crossreacted with other proteins having the same 
allergenic determinants as ovalbumin or P-lactoglobulin. Other similar studies have 
identified specific food IgG antibodies in atopic subjects and have reported these to 
be higher than those in non-atopic subjects; however, these values were based on 
percent of control (Dannaeus & Inganas, 1981; Finn et al., 1985; Firer et al., 1987). 
The values obtained in those studies were never scrutinised since no absolute values 
were available. Quantification of the antibody concentrations has enabled comparison 
to be made not only between the levels of specific food antibodies but also with other 
studies.
3.4.3 Comparison between food specific IgG antibodies in asthmatic and non- 
atopic children
The food specific IgG antibody for both anti-ovalbumin IgG and anti-p-lactoglobulin
IgG was detectable in all asthmatic children including non-atopic children. Several
earlier studies had reported detectable amounts of the food specific IgG antibody in
healthy non-atopic adults (Husby, 1986; Morris, 1991). The specific food IgG
antibody concentrations seen in asthmatic children and non-atopic children showed
anti-ovalbumin IgG concentrations in all groups of asthmatic children statistically
significantly higher than in non-atopic children. Although all groups of asthmatic
children had a mean anti-P-lactoglobulin IgG concentration higher than the non- 
in
atopic group, only^the asthmatic with other atopy group was this shown to be 
statistically significantly different. Apparently, some asthmatic children had food 
specific IgG concentrations similar to the non-atopic children. The lower/‘normaF 
levels of food specific IgG antibodies in some asthmatic children may indicate that 
these asthmatic children are not atopic and have no stimulatory effects towards the 
food antigens consumed.
Dockhom (1989) reported that, in a group of infants and children who had symptoms 
of food allergy (runny nose, fi*equent infections, wheezing, cough, ear infections, 
rash, gastrointestinal problems, and headache), total serum IgE levels were found to
105
be low. Specific IgE antibodies to foods demonstrated a low level of reactivity in 
these children. However, a large number of these children had high levels of antibody 
to eggs, milk, wheat and a lesser number to com (Dockhom, 1989).
Another interesting observation is that the asthmatic children who had both parents 
with atopic conditions had a significantly higher mean anti-ovalbumin IgG 
concentration than their counterparts whose parents had no signs or symptoms of 
atopy. As quoted earlier in Chapter 1, the risk of developing an allergy in a new-bom 
is 40-60% if both parents are allergic, 20-40% if one parent is allergic, and 5-15%, if 
none of the immediate family is affected (Bleumink, 1983; Weeke, 1992; Lessof,
1994). Could it be possible too that the chances of having or developing food allergy 
in asthmatic children is higher if both parents are atopic compared with if neither 
parents are atopic? This is another interesting area that needs to be looked at in future 
studies, i.e. comparing the specific food IgG concentrations and presence of food 
allergy in parents along with their asthmatic children.
Although in this study and studies carried out by Hampton et al., (1990), Morris 
(1991) and Lovegrove (1991), quantification was successful for the anti-ovalbumin 
IgG and anti-P-lactoglobulin IgG concentrations, it is extremely important that the 
findings be interpreted with caution in relation to their absolute values bearing in 
mind the possibility of crossreaction with other similar proteins. Therefore, at this 
point, it is still premature to recommend possible diagnostic or screening values for 
specific food IgG antibodies.
However, the present technique may need further refinement to establish its 
specificity and reliability if used on its own as a diagnostic tool, otherwise, it may be 
used cmdely in conjunction with a thorough clinical history of food allergy followed 
by DBPCFC if critically necessary. It is recommended that a further study be carried 
out with a larger number of asthmatic children and matched controls in a more 
representative population to help draw definitive conclusions on the absolute values 
of specific food IgG antibodies as a reliable food allergy diagnostic tool.
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3.4.4 Prevalence of asthma in relation to gender
Asthma in most cases starts in childhood or in middle-age. ‘Early onset’ asthma is 
more common in males and generally occurs in atopic individuals. More than 50% of 
asthmatic children and adolescents have been reported to have allergic rhinitis, atopic 
dermatitis (eczema) or both (Edwards & Bouchier, 1991; Smith & Melton, 1988; 
Remes & Korppi, 1996). Family history was reported in 93% and 97% of the 
asthmatic children with no other atopic conditions (group 1) and asthmatic children 
with other atopic conditions (group 2), respectively. It appeared that practically all of 
the asthmatic children categorised into groups 1 and 2 have a family history of atopy 
and the ratio of male : female asthmatic children participating in this study is 1:0.5. 
The ratio of asthmatic children with and without other atopic conditions is 1:0.4. This 
study shows similar findings in relation to the ratio of gender and presentation of 
other atopic conditions in asthmatic children. This study also reinforces other studies 
in that children with a family history of atopy seem to have genetic predisposition to the 
asthmatic condition.
In this study, the mean concentration of anti-ovalbumin IgG was significantly higher 
in asthmatic children with both parents, higher but not statistically significant in one 
parent reported with atopy, compared with the asthmatic children with no 
presentation of atopy in either parent. Therefore, it seems reasonable to believe that 
the asthmatic children with both parents having atopic conditions are more 
immunologically active and prone to react to possible food antigens, thus increasing 
their immunoglobulin synthesis.
3.4.5 Growth in asthmatic children
The birth weight of asthmatic children in this study is no different from that of non- 
atopic children. All groups of asthmatic children had a lower mean percentile weight 
and height compared with non-atopic children. However, the mean percentile weight 
and height for the asthmatic children with no other atopic condition (group 1) was
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higher than the asthmatic children with other atopic conditions (group 2). It appeared 
that delay in growth and puberty is one of the features of asthma, eczema and allergic 
rhinitis, suggesting an association between atopy and delayed growth (Crowley et al.,
1995). Growth retardation may have occurred independently of asthmatic severity but 
is exaggerated in those with severe disease, because of oral treatment with 
corticosteroids (Murray et 1976; Ferguson et ah, 1982; Chang et ah, 1982; 
Crowley et aL, 1995).
This study shows that the majority of asthmatic children had height for age, weight 
for age and weight for height between 15th and the 85th percentile which is classified 
as average weight and growth status. Similarly, the majority of non-atopic children 
had height for age and weight for age similar to the asthmatic children. However, the 
majority of non-atopic children’s weight for height was between 15.1 and the 95th 
percentile which was classified as average and above average.
The results of this study in relation to the weight and height of the asthmatic children, 
appeared to support the findings in the study carried out by Klein et al. (1991). They 
reported that non-steroid dependent asthmatic children do not demonstrate growth 
retardation in height and weight compared with non-asthmatic children. Russell
(1993), reviewed various studies on the relationship between asthma and growth. He 
reported that in a study carried out by Norman (1965), at the Great Ormond Street 
Hospital, of 33 asthmatic children, 27% lay below the 10th percentile and 15% were 
below the 5th percentile, height for age, even before receiving steroid treatment. He 
also reported that in a similar study carried out by Smith (1965) in Birmingham, of 65 
asthmatic children about to receive steroid treatment, 43% of the height of these 
children was below the 10th percentile. He pointed out that it was by no means 
universally agreed that asthma impaired growth at that point in time.
Murray et al., (1976), reported that of the children attending their asthma clinic and 
who never received corticosteroids, 37% had a height below the 25th percentile, and 
7% had a height below the 3rd percentile. In other words, the proportion of small
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children was about twice as great as in a normal healthy population. They deduced 
that the important factors relating to growth retardation were (a) onset of asthma 
before the age of 3 years; (b) chronic hypoxaemia; and (c) poor appetite and low milk 
intake. There was no association between growth retardation and low birth weight. In 
a subsequent paper from the same group (Ferguson et d., 1982), the author reported 
that growth retardation reflects the atopic state in general and is not specific to 
asthma. Kuzemko (1976), reported that in the absence of steroid treatment, the height 
of asthmatic children is normal, although many are relatively light for their height.
In the present study, weight and height of the asthmatic children were taken only at a 
single point; detailed information on asthma treatment and current food intake was 
not gathered as the food frequency question was focused on consumption of 
allergenic food. Despite the limitations of this study, and although the birth-weight of 
asthmatic children is comparable to that of non-atopic children, they however 
appeared to be shorter and leaner than their non-atopic counterparts, which is in 
agreement with other studies (Murray et 1976; Chang et ah, 1982; Balfour-Lynn, 
1986; Crowley et 1995).
3.4.6 Breast-feeding and introduction of weaning foods
It has been reported that atopic women have higher food IgG antibodies compared 
with non-atopic women (Falth-Magnusson et M., 1987a) and that atopic women 
appear to transfer milk and egg antibodies to the fetus whereas non-atopic women do 
not (Dannaeus et d., 1978). The beneficial effects of a maternal milk-free diet during 
late pregnancy and lactation were observed (Lovegrove et al., 1994). Lovegrove et al.
(1994) reported that the allergy incidence in infants whose atopic mothers (atopic-diet 
group) followed a strict milk-free diet during late pregnancy and lactation was 
significantly lower than those atopic mothers (non-diet atopic group) who received 
cows’ milk during late pregnancy and lactation. In addition, the majority of infants 
were breast-fed up to 4 months although, the mean duration of breast-feeding in the 
atopic-diet group was longer than the non-atopic and non-diet atopic groups.
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In the present study, 70% of asthmatic children were breast-fed and 49% were 
exclusively breast-fed for 4 months. Although 73% of the non-atopic children were 
breast-fed, only 25% were exclusively breast-fed for 4 months. Although the majority 
of both groups of children were breast-fed, mothers of the asthmatic children seem to 
favour exclusive breast-feeding compared with mothers of the non-atopic children. It 
would have been interesting to enquire why breast-feeding was chosen.
The introduction of weaning foods including cows’ milk, cheese and yoghurt, was not 
significantly different between the four groups. However, 4 (12%) and 6 (18%) of 
group 2 children appeared to be receiving either goats’ milk or soya formula/milk 
between 2 and 12 months of age. This indicates that, mothers who had a personal or 
family history of atopy have been aware of the benefits of exclusive breast-feeding. 
Several mothers even attempted feeding their infants with either goats’ milk or soya 
formula/milk in order to manage either the asthmatic conditions and even more so, 
other atopic conditions (such as eczema) present in their children during the first year 
of life. However this study was limited, as no information was gathered on: (a) 
reasons for choice of infant feeding (breast or formula); (b) parents’ knowledge or 
attitudes in relation to food and atopic conditions; and (c) any avoidance of food by 
mothers during pregnancy and while breast-feeding the participating child, in order to 
obtain knowledge on sensitisation of food allergens to fetus and infants via the 
mother’s diet.
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Chapter 4
Impact of dietary intervention in the treatment of asthma in young
children
4.0 Introduction
Asthma affects approximately 9-12 million people in the United States, with asthma 
related health care expenditure estimated at $6.2 billion in 1990 (Weiss et al., 1992). 
In the United Kingdom it is estimated that there are over 3 million people with 
asthma and in 1993, the NHS allocated approximately £350 million to the 
prescription of drugs used in its treatment (Levy & Hilton, 1993; DoH, 1995).
In adults and children the asthmatic response can be triggered by a wide variety of 
agents including allergens, viral infections, exercise, exposure to fumes and other 
irritants, certain drugs, food, drink and food additives (Kay, 1992). The specific 
allergen in particular individuals may be detected from the clinical history. However 
sometimes the clinical history does not point to the specific allergen. In asthmatic 
children aged less than two years, the adverse reaction to cows’ milk is reported to be 
the most common “allergic reaction” followed by an adverse reaction to eggs (Weeke, 
1992).
The prevalence of asthma is increasing. What is the explanation for the substantial 
increase in asthma over recent decades despite effective medication and widely used 
(but not necessarily successful) preventive measures? As mentioned in Chapter 1, 
Anderson (1991) commented that little research had been directed towards the 
possible role of foods in the provocation of atopic asthma.
Few clinical studies for the improvement of atopy development in infants and 
children below 2 years of age have been published and those which have been 
published are directed mostly towards the effectiveness of dietary intervention, during
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pregnancy and the lactation period, (Cant et al., 1986; Chandra et al., 1986; Falth- 
Magnusson et g ., 1988; Lilja et al-, 1989; Zeiger et d., 1989; Hatevig et al., 1990; 
Kemeny et al., 1991; Arshad et al., 1992; Lovegrove et al-, 1994; Kajosaari, 1994; 
Zeiger et al., 1995). A literature search for studies that have focused on the role of 
diet in the reduction of the burden of asthma particularly in the paediatric population, 
has failed. This study was undertaken in the hope of determining the potential 
benefits of avoidance diet, particularly of eggs and milk products, in: (1) reducing the 
burden of asthma in children; (2) benefiting to parents and families; (3) benefiting to 
communities through decreased costs following reduced numbers of asthmatic 
episodes; (4) reducing visits to General Practitioners or Hospitals; but above all (5) 
benefiting to the asthmatic children themselves by enabling them to lead a complete 
life.
4.1 Aim of the study
The aim of this study was to determine the effect of a diet devoid of eggs and milk 
and their related products, on the specific food antibody levels, and the signs and 
symptoms of asthma in asthmatic children when compared with matched asthmatic 
children who continued with their customary food intake.
4.1.1 Ethical approval
Ethical committee approval was obtained fi*om the South West Surrey Regional 
Health Authority Ethics Committee (Ref. No. BG/sb dated 15 March 1995) and North 
West Surrey Local Research Ethics Committee (Ref. No. MHT/AI/AMW/PRO/71/95 
dated 10 August 1995).
4.1.2 Duration of the dietary intervention study
As mentioned earlier, the half life of IgG antibody is 23 days and the residual time on 
the mast cells is between 2 to 3 months (El Rafei et al., 1989). Therefore, to enable
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any change, a duration of 2 months' abstinence from egg and milk was observed. It 
was anticipated that compliance with such a diet might be difficult especially for 
children if the study duration were to be prolonged.
4.2 Methods
4.2.1. Subject recruitment
It is assumed that those asthmatic individuals with higher than average specific food 
IgG antibody concentrations will respond more effectively to the reduction of specific 
food IgG antibody concentrations after consuming a diet devoid of eggs and milk and 
their related products, compared with asthmatics who demonstrate low levels of the 
specific food IgG antibody. Bearing this assumption in mind, of the 71 asthmatic 
children who participated in the Children’s Observational Study (Chapter 3), 43 
(61%) were identified as possible candidates for this intervention study. These 43 
children, had anti-ovalbumin IgG concentrations above the mean anti-ovalbumin IgG 
concentration of the non-atopic children (>500 pg/ml). Attempts were then made to 
contact the parents of these children.
Of the 43 children identified as potential candidates for this dietary intervention 
study, 15 had to be eliminated as candidates, as their addresses were either unknown 
or the family had moved house and 5 declined. The remaining 23 parents volunteered. 
However 2 children did not turn up for the pre-assessment session with the clinician. 
Both children were removed from the studies after failing to attend the pre­
assessment session twice. One parent volunteered her eldest son along with the 
selected youngest son to participate in this study. The mother claimed that her eldest 
son had a worse asthmatic condition than the selected youngest son, although the 
eldest son did not participate in the earlier Children’s Observational Study. The final 
total number of children recruited for this dietary intervention study was therefore 22 
asthmatic children. Parents were given the option of being in the diet-group (DG) or 
non-diet group (NDG). Twelve parents volunteered on behalf of their 13 children
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(one parent volunteered both children) to be in the diet-group and 9 parents opted for 
the non-diet group as they foresaw the difficulty involved in ascertaining a diet 
devoid of eggs and milk for 8 weeks. Most parents who volunteered to be in the DG 
claimed that their children did not drink large amounts of milk anyway except with 
cereals, and they were keen to see whether diet avoidance could help reduce the 
burden of asthma in their children. This in itself presents one of the crucial motivating 
factors for parents to ensure that their children follow a strict diet devoid of eggs and 
milk and their related products for 8 weeks.
Diet group (DG): Children in this group were assigned an intervention diet devoid of 
eggs and milk and their related products for 8 weeks.
Non-diet group (NDG): Children in this group were requested to continue their 
customary food intake.
This study is a ‘single blind prospective study’. Parents and children were aware of 
the study group that they were in (DG or NDG). However, the clinicians were blinded 
in relation to the study groups the children were allocated to, during the pre-dietary 
and post-dietary intervention assessments. The flow of the study is shown in Figure
4.1 (see also Appendix 5).
4.2.2 Dietary assessments
All parents were requested to record their children’s daily food intake for the first, 
fourth and eighth week in a 7-day estimated “food diary”, developed and validated by 
the Dunn Clinical Nutrition Centre, Cambridge, U.K (see Appendix 10, placed in 
pocket of thesis). The food diary had been validated by the U.K. European 
Prospective Investigation of Cancer and Nutrition (EPIC) studies comparing various 
dietary assessment methods in nutritional epidemiology, these include weight records, 
24 hr recalls, food fi-equency questionnaires and estimated-diet records (Bingham et 
d., 1994, 1995). The food diary contained colour photographs of small, medium and
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large portions of 17 foods pictured on a 10 inch dinner plate. Parents could choose 
one of the amounts shown in the photograph or indicate that their children consumed 
less than the smallest or more than the largest amount shown. Parents were 
encouraged to weigh foods using their home kitchen scales (not validated) if any food 
consumed was not available or no similar food available in the pictures. They were 
also requested to record weight of the commercial foods as stated on food packages. 
Parents were given stamped addressed envelopes to mail the completed food diaries 
to the researcher.
4.2.2.1 Assessment of non-compliance
The food diary had dual purposes. Firstly, it was used for assessing nutrient intake 
and secondly it was used to monitor non-compliance in the diet-group. Another subtle 
way of monitoring non-compliance in the diet-group was to request parents to record 
the date and type of egg and/or milk products consumed by accident, on a form (see 
Appendix 8). This method appeared to be a non-threatening way of monitoring non- 
compliance in the children. The researcher kept a regular contact with parents through 
phone calls and home-visiting. This was to ensure that the morale of parents and 
children especially in the diet-group were high throughout the 8 weeks dietary 
intervention period. Food intake records were checked as soon as the diaries were 
received and any queries were clarified immediately with parents.
The amount of food consumed, recorded in the food diaries, was either computed 
directly in portion size or converted into weight (g) using Food Portion Sizes (MAFF, 
1997) on computer programme, Comp-eat 4.0 (Lifeline Ltd, London). Nutrient 
analysis was undertaken using this programme and compared with the Dietary 
Reference Values for Food Energy and Nutrients for the United Kingdom (DoH, 
1991).
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4.2.3 Clinical assessment
All children who participated in the dietary intervention study were invited to Frimley 
Park Hospital or Frimley Children’s Centre for clinical assessment carried out by a 
Paediatrician or a trained Registrar who were responsible for running the Out-patient 
Paediatric Asthma Clinic at the Frimley Children’s Centre. The Paediatrician and the 
Registrar were both involved in the design of this intervention study and the 
parameters used during the pre-dietary and post-dietary intervention clinical 
assessment. Subjects were assessed twice i.e. before commencing the dietary 
intervention study and 8 weeks later after completing the dietary intervention study 
period.
On both occasions, one of the two clinicians, without knowledge of the children’s 
study group, evaluated the children using a standard form for current signs and 
symptoms of asthma including presence of coughing; nocturnal coughing; presence of 
wheezing; number of asthmatic episodes in the last 8 weeks; current medication 
including type, dose and frequency of medication and respiratory rate. Additional 
questions were included in the post-dietary intervention assessment i.e. presence of 
diurnal coughing, nocturnal coughing, sleep pattern, wheezing and other changes 
related to the well-being of the children between the first and second assessment (see 
Appendices 6 & 11).
4.2.3.1 Peak expiratory flow rate
All children were assessed for their capabilities in performing the PEFR. Those 
children who were able to perform the PEFR correctly, were given a Mini Wright 
Peak Flow Meter (Clement Clarke International Ltd, U.K.) if they did not own one. 
Children who were able to perform PEFR correctly during the assessment were 
requested to record the best of the 3 PEFR taken twice daily (first thing in the 
morning and just before going to bed) on a fortnightly chart. These charts were 
mailed to the researcher (stamped addressed envelope provided) together with the
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food diary after the 1st and 4th week and the 8th week of the dietary intervention 
period.
4.2.3.2 Anthropometric measurements
Weight and height of all children were measured during the pre-dietary and post­
dietary assessment. For details of procedures, see Methods, Chapter 3, Section 3.2.5.
4.2.4 Dietary supplements
Children who were in the diet-group were requested to consume a daily helping of 
Marmite (4 g) for riboflavin requirement. These children were provided initially with 
2 cans (500 g powdered) of hypoallergenic milk supplement (Pepti-Junior) purchased 
from Cow & Gate, Nutricia (Trowbridge, Wiltshire, U.K.) to replace milk (Halken et 
d., 1995; Vandenplas, 1995). A recipe booklet (Cooking with Pepti-Junior - 
compliments of Cow & Gate, Nutricia) was given to parents for more versatile usage 
of the milk supplement. Parents were contacted regularly thereafter for replenishment 
of the milk supplements. Children in the diet-group were also given a calcium 
supplement in a tablet form (Calcichew, 500 mg tablet), product of Shire 
Pharmaceuticals Ltd. (Andover, Hants, U.K.) to be taken on alternate days to ensure 
meeting the calcium requirement. Since the duration of the study included the Easter 
celebration, children in the diet-group were also given a dairy free ‘Chocolate Bunny’ 
(purchased from D & D, London, U.K).
4.2.5 Guidance on egg and milk avoidance
A booklet on egg and milk free food products was produced by the researcher (see 
Appendix 9). This booklet was compiled from The British Dietetic Association’s 
booklet. Egg-free food products (July 1996) and Cows’ milk-free food products (July,
1996). This booklet lists various commercial food items that are milk and egg free 
and thus can be consumed by children in the diet-group.
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4.2.6 Questionnaire
Parents of subjects were requested to fill in a structured questionnaire (see Appendix 
7) which includes an inquiry into the personal and family history of atopic conditions; 
allergic reactions to environmental and food allergens; avoidance of any foods prior 
to the current study, number of asthmatic episodes, hospital admissions over the last 
12 months; absenteeism firom school for the current year, smokers in household.
4.2.7 Blood sampling
All children were invited to the Frimley Children’s Centre for a blood sample. 
Approximately 2 ml of non-fasting venous blood was taken from all asthmatic children 
at the start and at the end of the dietary intervention study by either one of the 
clinicians or a nurse. The blood sample was allowed to clot at room temperature, 
centrifuged, aliquoted and frozen at -20°C until completion of the dietary intervention 
study. The sera samples for both pre-dietary and post-dietary intervention were then 
analysed in the same batch for the measurement of anti-ovalbumin IgG and anti-p- 
lactoglobulin using indirect ELISA, total IgE and anti-ovalbumin IgE, using the CAP 
method (for details of procedure, see Methods, Chapter 2, Section 2.2.8).
4.2.8 Dietary intervention
Subjects in the diet group were requested to eliminate milk and egg and their products 
for a total of 8 weeks whereas there was no restriction on food intake for the non-diet 
group. Subject’s in the non-diet group were requested to continue their customary 
food intake. Parents were given an “Egg and Milk Free Food Booklet” compiled by 
the researcher to assist and reduce parents’ burden in shopping for household foods 
and to increase variety in the subject’s food intake.
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Figure 4.1. Flow of the dietary intervention study
Diet group (n=13) Non-diet group (n=9)
Preliminary screening 
(high anti-ovalbumin IgG and/or anti-B-lactoglobulin IgG)
Pre-dietary intervention assessment:
Weight and height measurement 
History, physical examination & PEFR 
In-vitro test:
(anti-ovalbumin IgG, anti-P-lactoglobulin IgG, total IgE 
& anti-ovalbumin IgE)
Post-dietary intervention assessment: 
Weight and height measurement 
History and physical examination & PEFR 
In-vitro tests:
(anti-ovalbumin IgG, anti-p-lactoglobulin IgG, 
total IgE & anti-ovalbumin IgE) 
Dietary intake records
4.2.9 Statistical analysis
The data was analysed on a Personal Computer using Statistical Package for Social 
Science (SPSS). As the data for the specific food IgG, IgE and total IgE antibodies 
were not normally distributed, despite being logarithmically transformed, statistical 
analyses were performed using the non-parametric, Mann-Whitney U tests and 
Wilcoxin Signed Rank Sum tests and parametric. Paired T-tests, to test the 
significance of the difference before and after exposure to dietary intervention in the 
diet- and non-diet groups.
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4.3 Results
4.3.1 Subjects
The number of asthmatic children recruited to the diet group and non-diet group were 
13 and 9 respectively. Table 4.1 shows the ratio of 1: 0.6 and 1:0.3 of male to female 
in the diet-group and non-diet group respectively. The mean age for all asthmatic 
children participating in this dietary intervention study was 5.9±2.6 years (range 3- 
14). However, the mean age for the diet-group was slightly older than the non-diet 
group i.e. 6.5±2.9 (4-14) years and 5.0+1.7 (3-8) years, respectively, but this was not 
a significant difference statistically. The mean pre-dietary and post-dietary 
intervention weight for the diet-group was 23.8+8.4 kg and 23.6+8.6 kg respectively. 
It appeared that there was a mean weight loss of 0.16±0.63 kg, though not statistically 
significantly different, after 8 weeks of diet devoid of eggs and milk. The mean pre­
dietary and post-dietary intervention weight for the non-diet-group however was 
21.8+3.8 kg and 22.2±3.7 kg respectively for the children who continued with their 
customary food intake. Results showed that there was a mean weight gain of 
0.34±0.53 kg after 8 weeks in the non-diet group, although not statistically 
significantly different. This mean weight gain in the non-diet group was statistically 
higher than the mean weight loss in the diet-group (P<0.05) (using Paired T-test) over 
the 8 week period.
Both groups appeared to have gained in height. The mean pre-dietary intervention 
height for the diet-group was 119.0+17.2 cm and was found to be significantly lower 
(P<0.01) than and post-dietary value of 119.7±17.0 cm. The mean pre-dietary height 
for the non-diet group was 112.1±7.9 cm and was also found to be significantly lower 
(P<0.01) than the post-dietary value of 112.6+8.2 cm. The mean height gain in the 
diet group appeared to be comparable to the non-diet group i.e. 0.63±0.56 cm and
0.5±0.40 cm respectively.
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Table 4.1. Gender and age (years) in diet- and non-diet groups of asthmatic 
children
(Mean values, standard deviation and ranges)
Study group Number Gender Age(years)
Male Female Ratio Mean ± SD Range
All children 22 15 7 1:0.5 5.9 ± 2.6 3-14
Diet group 13 8 5 1:0.6 6.5 ± 2.9 4-14
Non-diet group 9 7 2 1:0.3 5.0 ± 1.7 3-8
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4.3.2 Immunological analysis
Results for the immunological analysis are summarised in Tables 4.4-4.6. Table 4.4 
and Figure 4.2 show that after an 8 week diet devoid of eggs and milk, the mean anti­
ovalbumin IgG concentration in the diet-group was reduced from 2483±935 pg/ml to 
1876+805 pg/ml. This reduction in the anti-ovalbumin IgG concentration was found 
to be statistically significant (P<Q.G1). The pre-dietary and post-dietary intervention 
anti-ovalbumin IgG concentrations for the non-diet group were however shown to be 
increased from 1447+956 pg/ml to 1659±1033 pg/ml after the study period. This 
increase was found to be statistically significant. Similarly, as shown in Table 4.5 and 
Figure 4.3, the post-dietary intervention anti-(3-lactoglobulin IgG concentrations for 
the diet group were observed to be significantly reduced statistically from 223±182 
pg/ml to 149±108 pg/ml (P<0.05). The post-dietary intervention anti-P-lactoglobulin 
IgG concentrations for the non-diet group were increased after the study period from 
399±600 pg/ml to 415+686 pg/ml, but this increase was not statistically significant.
After the 8 week dietary intervention, there appeared to be no change in the mean 
pre-dietary and post-dietary intervention for total IgE concentrations in the diet-group
i.e. 1603±2469 kU/L and 1610±2387 kU/L respectively (see Table 4.6). Although the 
total IgE concentrations for the non-diet group showed a decreasing trend from 
851±1547 kU/L to 694+1149 kU/L after 8 weeks, this decrease was not statistically 
significant. The overall summary for anti-ovalbumin IgG, anti-p-lactoglobulin IgG 
and total IgE concentrations for both study groups before and after the study period is 
shown in Figure 4.4.
Figure 4.5 shows the individual results (with or without other atopy conditions) for 
anti-ovalbumin IgG compared with the total IgE concentration in the diet-group 
before and after dietary intervention. There appeared to be a downward trend; all 
children in the diet-group had a reduction in the anti-ovalbumin IgG concentration 
after avoiding eggs and milk for 8 weeks in their diet. No change in the total IgE was 
observed in the children with the exception of children Nos. 2 and 9. The total IgE
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was reduced in child No. 9 and increased in child No. 2. Both children had eczema 
and allergic rhinitis. Figure 4.6 shows no specific trend in the total IgE and anti­
ovalbumin IgG concentrations in the non-diet group. Children Nos. 2 and 9 showed 
no change or had little changes in both antibodies. Children Nos. I, 3, 5, 6, 7 and 8 
showed an increase in anti-ovalbumin IgG but no change was observed in the total 
IgE after the 8 week period. Child No. 4 (with other atopic conditions) showed no 
change in the specific food IgG but there was a substantial reduction in total IgE after 
the study period.
Figures 4.7 and 4.8 show in detail individuals with or without eczema in relation to 
their pre-dietary and post-dietary intervention specific food antibodies for IgG and 
IgE for ovalbumin in the diet group and non-diet group. As shown in Figure 4.7, prior 
to diet intervention, 3 children (Nos. 1, 3 and 6) had a zero (0) grading for anti­
ovalbumin IgE; 3 children (Nos. 5, 7 and 12) were positive but equivocal (grade 1); 
and the remaining 6 children were positive grade 2 and grade 3. After 8 weeks devoid 
of eggs and milk in their diet, all children showed a reduction of anti-ovalbumin IgG 
concentrations, some more than the others. As for the specific IgE test, 2 children 
with no manifestation of other atopic conditions, shifted fi-om grade 2 to grade 1 
(Nos. 4 and 10); and 2 children (with eczema) shifted fi-om grade 1 to grade 0 (Nos. 
12 and 13). Dietary intervention resulted in a decrease of the CAP grading suggesting 
some improvement in specific food IgE antibody concentrations against ovalbumin in 
several asthmatic subjects. However, all children in the diet-group showed an 
improvement using anti-ovalbumin IgG concentration as an alternative marker. In the 
control group, where all of the asthmatic children continued with their customary 
food intake, no shift of grading was observed except in one child, where the grading 
dropped fi-om grade 1 to 0 which remains unexplained. This subject had no history of 
eczema.
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Table 4.4. Mean anti-ovalbumin IgG concentrations (|ag/ml) in asthmatic
children recruited into the diet-group (DG) and non-diet group (NDG) pre­
dietary and post-dietary intervention (a diet devoid of egg and milk for 8 weeks)
(Mean ± standard deviation, ranges)
Study groups n Anti-ovalbumin IgG concentrations (pg/ml)
(asthmatic children) Mean + SD Range
1 DG pre-dietary intervention 13 2483 ± 935 999 - 3939
2 DG post-dietary intervention 13 1876 ± 805 ** 652 - 3147
3 NDG pre-dietary intervention 9 1447 ± 956 28 - 2981
4 NDG post-dietary intervention 9 1659 + 1033 * 34 - 3609
N = number
** mean value of group 2 was significantly reduced from that of group 1 
* mean value of group 4 was significantly increased from that of group 3
Figure 4.2. Anti-ovalbumin IgG concentrations (ng/ml) in asthmatic children 
recruited into the diet- and non-diet groups before and after a diet devoid of egg 
and milk for 8 weeks
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group 4 = post-dietary intervention anti-ovalbumin IgG in non-diet group
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O DO
** mean value group of 2 was significantly reduced from that of group I 
* mean value group of 4 was significantly increased from that of group 3
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Table 4.5. Mean anti-p-lactoglobulin IgG concentrations (|a,g/ml) in asthmatic
children recruited into the diet-group (DG) and non-diet group (NDG) pre­
dietary and post- dietary intervention (a diet devoid of egg and milk for 8 weeks)
(Mean + standard deviation, ranges)
Study groups 
(asthmatic children)
Number Anti-p-lactoglobulin IgG 
concentrations (p,g/ml)
Mean + SD Range
1 DG pre-dietary intervention 13 223 ± 182 13 - 567
2 DG post-dietary intervention 13 149 ± 108 * 8-343
3 NDG pre-dietary intervention 9 399 ± 600 31 - 1886
4 NDG post-dietary intervention 9 415 ± 686 53 - 2198
mean value of group 2 was significantly reduced from that of group 1
Figure 4.3. Anti-p-lactoglobulin IgG concentrations (|o,g/ml) in asthmatic 
children recruited into the diet-group (DG) and non-diet group (NDG) pre­
dietary and post-dietary intervention (a diet devoid of egg and milk for 8 weeks)
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Table 4.6 Mean total IgE concentrations (kU/L) in asthmatic children 
recruited into the diet-group (DG) and non-diet group (NDG) pre-dietary and 
post-dietary intervention (a diet devoid of egg and milk for 8 weeks)
(Mean ± standard deviation, ranges)
Study groups Number Total IgE concentrations (kU/L)
(asthmatic children) Mean ± SD Range
1 DG pre-dietary intervention 13 1603 ± 2469 4 - 4096
2 DG post-dietary intervention 13 1610 ± 2387 8 - 7258
3 NDG pre-dietary intervention 9 851± 1547 13 - 4794
4 NDG post-dietary intervention 9 694 ± 1149 7 - 3545
Figure 4.4. Mean anti-ovalbumin IgG (pg/ml), anti-p iactoglobulin IgG 
(pg/ml), and total IgE (kU/L) concentrations in asthmatic children recruited into 
the diet-group and non-diet-group pre-dietary and post-dietary intervention (a 
diet devoid of egg and milk for 8 weeks)
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Figure 4.5. Pre-dietary intervention and post-dietary intervention total IgE
(kU/L) and anti-ovalbumin IgG (|o,g/mI) concentrations in asthmatic children
recruited into the diet-group
10000 m
d  8000 .D
(A
C
o 6000 I
S 4000 .
o
c
o
 ^ 2000  ■ O)
(D
O Post-DI
 .  O  Pre- DI
4000
-2000
1000 2000 3000
Anti-ovalbumin IgG concentrations (ug/ml)
DI = dietary intervention a = allergic rhinitis & eczema present
Figure 4.6. Pre-dietary and post-dietary intervention total IgE (kU/L) and 
anti-ovalbumin IgG (|ig/ml) concentrations in asthmatic children recruited into 
the non-diet group
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Figure 4.7. Pre-dietary intervention and post-dietary intervention anti-
ovalbumin IgE (grade) and anti-ovalbumin IgG(^ig/ml) concentrations in
asthmatic children recruited into the diet-group
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Figure 4.8. Pre-dietary and post-dietary intervention anti-ovalbumin IgE 
(grade) and anti-ovalbumin IgG(|ig/ml) concentrations in asthmatic children 
recruited into the non-diet group
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4.3.3 Peak expiratory flow rate before and after dietary intervention
Of the 22 asthmatic children participating in the dietary intervention study, 11 (50%) 
children were able to perform PEFR correctly (6 in DG and 5 in NDG). Table 4.7 and 
Figure 4.9 show mean pre-dietary and post-dietary intervention PEFR in the diet- 
group and non-diet group. The mean pre-dietary PEFR in the diet-group was 255+87 
(180-380) L/min and the mean post-dietary intervention PEFR was 301+74 (230-420) 
L/min. After 8 weeks, the post-dietary PEFR showed a mean percentage increase of 
22±15 (0-41), which was found to be statistically significant (P<0.05). In the non- 
diet-group, the mean pre-dietary intervention PEFR value was 228+51 (170-280) 
L/min and the post-dietary intervention value was 222±41 (170-280) L/min. After the 
8 week period, the mean percentage decrease in PEFR was negative, i.e. -0.6+17 
[(-25)-(22)]%. The decrease in PEFR was found not to be statistically significant. 
However, it appeared that one child had a percentage PEFR decrease of -25% which 
may indicate a forthcoming asthmatic attack within the next few days.
4.3.3.1 Relationship between peak expiratory flow rate and food specific IgG and 
IgE antibodies
Figures 4.10-4.15 show comparison between individual pre-dietary and post-dietary 
intervention PEFR values against the specific food IgG antibodies in both study 
groups. Figure 4.10 shows that all but one (No. 7) of the asthmatic children were able 
to perform PEFR correctly, had an increased PEFR reading along with a reduction in 
the anti-ovalbumin IgG concentration after avoiding eggs and milk for 8 weeks. 
Figure 4.11 shows a different picture when comparing these children’s PEFR to anti­
ovalbumin IgE (grade). It appears that there was no shifting of grade seen in any of 
these children in relation to the anti-ovalbumin IgE although an improvement was 
observed in the PEFR and anti-ovalbumin IgG concentrations after avoiding eggs and 
milk in their diet for 8 weeks. This result tends to indicate that the anti-ovalbumin 
IgG concentration may be more sensitive and better reflect changes compared with 
anti-ovalbumin IgE concentration (grade).
130
Figures 4.12 and 4.13 show a comparison between the PEFR (pre-dietary & post­
dietary interventions) and anti-ovalbumin concentration of the non-diet group. As 
discussed earlier in section 4.3.2, the mean anti-ovalbumin IgG concentration in 
asthmatic children who continued vrith their customary food intake appeared to 
increase after the dietary intervention study. The individual values are demonstrated 
in Figure 4.12. Examining the individual values, of the 5 children in the non-diet 
group who were able to perform PEFR correctly, 4 children were observed to have an 
increase in the anti-ovalbumin IgG concentration, and 3 children had no change in 
their PEFR readings. However, child No. 5’s PEFR dropped from 270 L/min to 200 
L/min. Child No. 2, however, had an anti-ovalbumin IgG concentration slightly 
reduced from 2726 pg/ml to 2618 pg/ml after the study period. In addition, this 
particular child’s PEFR increased from 180 L/min to 220 L/min (22% increase). 
When comparing the PEFR value with anti-ovalbumin IgE (grade), of the 5 children, 
one child’s (No. 3) grading for the anti-ovalbumin IgE shifted from equivocal (grade 
1) to negative (grade 0). The reason for the shifting of the anti-ovalbumin IgE result, 
from grade 1 to 0 is uncertain, as the child continued vrith his customary food intake, 
his anti-ovalbumin increased slightly and his PEFR remained unchanged after the 
dietary intervention period.
Figures 4.14 and 4.15 show comparison between PEFR and anti-P-lactoglobulin IgG 
concentration in the diet group and non-diet group. All the 6 children had a reduction 
in the anti-P-lactoglobulin IgG concentration and similarly all these children with the 
exception of one child (No. 7) had an increase in their PEFR values. However, in the 
non-diet group no specific trend was observed in relation to the anti-p-lactoglobulin 
IgG concentration and PEFR. The anti- P-lactoglobulin IgG concentration appeared to 
increase in child No.6; reduce in child No 2; and remain unchanged in Children No. 
3, 5e and 8e. It is interesting to note that child No. 2 had a reduction in both anti­
ovalbumin IgG and anti-p-lactoglobulin IgG concentrations and his PEFR increased 
by 22%. Since no dietary intake information was available prior to the study period, 
this reduction in the specific food IgG antibodies and the increased PEFR value 
remains unexplained. However, it could be possible that the child’s intake of eggs and
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milk had reduced over the study period as the mother was aware of the objective of 
the study when deciding the group opted for. Table 4.8 gives an overall summary of 
an individual’s results prior to and after the dietary intervention study period.
Table 4.7. Mean pre-dietary and post-dietary intervention peak expiratory 
flow rate (PEFR) (L/min) in asthmatic children recruited into the diet-group 
(DG) and non-diet-Group (NDG) before and after dietary intervention (a diet 
devoid of egg and milk for 8 weeks)
(Mean+standard deviation, ranges)
Peak expiratory flow rate 
(L/min)
Diet-group Non-diet group
n Mean+SD Range n Mean+SD Range
Pre-dietary intervention PEFR 6 255+87 180 - 380 5 228+51 170 - 280
Post-dietary intervention PEFR 6 301+74* 230 - 420 5 222+41 170 - 280
I PEFR after 8 weeks 6 47+29 0 -9 0 5 -8+46 (-70)-(40)
% 1 PEFR after 8 weeks 6 22±15 0-41 5 -0.6+17 (-25) - (22)
n = number 
I =  increase or decrease
* post-dietary intervention mean value PEFR was significantly increased from that pre-dietary 
intervention mean value PEFR for diet-group
Figure 4.9. Mean peak expiratory flow rate (PEFR) in asthmatic children 
recruited into the diet-group (DG) and non-diet-group (NDG) before and after 
dietary intervention (a diet devoid of egg and milk for 8 weeks)
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Figure 4.10. Pre-dietary and post-dietary intervention PEFR (L/min) and anti­
ovalbumin IgG (|ig/ml) in asthmatic children recruited into the diet-group
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Figure 4.11. Pre-dietary and post-dietary intervention PEFR (L/min) and anti­
ovalbumin IgE (grade) in asthmatic children recruited into the diet group
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Figure 4.12. Pre-dietary and post-dietary intervention PEER (L/min) and anti­
ovalbumin IgG (|ig/ml) in asthmatic children recruited into the non-diet group
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Figure 4.13 Pre-dietary and post-dietary intervention PEFR (L/min) and anti­
ovalbumin IgE (grade) in asthmatic children recruited into the diet group
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Figure 4.14. Pre-dietary and post-dietary intervention PEFR (L/min) and and
(3-lactoglobulin IgG (jiig/ml) in asthmatic children recruited into the diet-group
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Figure 4.15. Pre-dietary and post-dietary intervention PEFR (L/min) and anti-
p-lactoglohulin IgG (fig/ml) in asthmatic children recruited into the non-diet 
group
3001
280'
5e
260.
c
E 240.
£  220.
CL
2 0 0 '
ISO.
Post-DI
160 B  Pre-DI
500 1000 1500 2000 2500
Anti-B-lactoglobulin IgG concentrations (ug/ml) 
DI = dietary intervention e = eczema present
135
I
I
Ii
5
I
f
I
I
1
I
I
%
I
%
%
1 1
«  5
%sa,
à
1 1
IÎ
â I
n
1 1
1
t
Ï
I
M <- M <-
Z, Z Z, £ z z  z
M M M M M M M
z  z  z  z  z  z  z
.a
t
I
00 ^ r) 1/1 xe m wi 00
3 3 3 " ' 3 S 3
N 11 */>
2 .H .H r>
a
m
4.3.4 Analysis of questionnaire
4.3.4.1 Personal history of asthma and other atopic conditions
the i
Table 4.9 shows^duration of the atopic conditions in the study groups. Of the 13 
asthmatic children in the diet-group, 6 (39%) had asthma only (no other atopy) and 
the remaining 7 children, had either eczema alone [2 (15%)] or eczema with allergic 
rhinitis [5 (39%)]. For the non-diet group, 2 (22%) children had asthma only and 7 
(78%) children had asthma with eczema and/or allergic rhinitis and/or urticaria. In the 
diet-group, the mean duration for asthma was longer than the mean duration for either 
eczema or allergic rhinitis conditions. It appeared that asthma was diagnosed in 
several children from the first year of life in both study groups. The mean age range 
for the diet-group was 3-14 years and 3-8 years for the non-diet group.
Table 4.9. Presence and duration of personal history of atopic conditions 
(years) in the diet- and non-diet groups
(Mean+standard deviation, ranges)
Atopic conditions Duration of atopic conditions (years)
Diet-group Non-diet group
n(%) Mean±SD Range n(%) Mean±SD Range
Asthma 13 4.7±2.9 1.6-13.3 9 3.8+1.5 2.G-7.2
Asthma with no other atopy 6(39) 5.4+4.0 2.0-13.3 2(22) 3.5+G.7 3.G-4.G
Eczema &/or allergic rhinitis 7(54) 7(78)
Eczema 7(54) 4.1±2.1 G.1-6.3 6(67) 4.1+1.8 2.G-7.2
Allergic rhinitis 5(39) 3.0+2.5 l.G-6.0 1(11) 2.G
Urticaria 1 2(22) G.5
n = number
4.3.4.2 Family history of atopy
Ninety-two per cent of children in the diet-group and 100% in the non-diet group in 
the dietary intervention study had a history of atopy in their close family (see Table 
4.10). Atopy in both parents was observed in 32% of subjects. However, the ratio of 
atopy in the mother was slightly higher than in the father i.e. 1.1:1.0. Of the 17
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children with siblings, 8 (47%) children had siblings with asthma, with or without
other atopic conditions. It appears that asthma is more frequently presented than other 
atopic conditions in families of these asthmatic children.
Table 4.10. Family history of atopic conditions in asthmatic children recruited 
into the diet- and non-diet groups
History of atopy in the General atopic Asthma Eczema Allergic Urticaria
following families: condition n(%) n(%) n(%) rhinitis n(%) n(%)
All asthmatic children n=22
Family in general 21(95) 16(73) 16(73) 17(77) 3(14)
Both parents 4(18)
None in both parents 7(32)
Mother 10(45) 4(18) 4(18) 4(18) 2(9)
Father 9(41) 7(32) 2(9) 3(14) 1(5)
Ratio atopy mother:father 1.1:1.0
Sibling n=17 8(47) 8(47) 5(29) 4(24) 0
Mother’s family 15(68) 12(55) 6(27) 8(36) 0
Father’s family 10(45) 7(32) 5(23) 4(18) 0
Mother & mother’s family 17(77)
Father & father’s family 15(68)
Diet-Grouv n=13
Family in general 12(92) 10(77) 9(69) 10(77) 3(23)
Both parents 3(23)
None in both parents 3(23)
Mother 7(54) 4(31) 3(23) 1(8) 2(15)
Father 6(46) 4(31) 2(15) 2(15) 1(8)
Sibling n= 11 6(55) 6(55) 3(27) 4(36) 0
Mother’s family 8(62) 7(53) 4(31) 5(39) 0
Father’s family 4(31) 4(31) 3(23) 1(8) 0
Mother & mother’s family 10(77)
Father & father’s family 8(62)
Non-diet sroup n=9
Family in general 9(100) 6(67) 7(78) 7(78) 0
Both parents 1(11)
None in both parents 4(44)
Mother 3(33) 0 1(11) 3(33) 0
Father 3(33) 3(33) 0 1(11) 0
Sibling n=6 2(33) 2(33) 2(33) 0 0
Mother’s family 7(78) 5(56) 2(22) 3(33) 0
Father’s family 6(67) 3(33) 2(22) 3(33) 0
Mother & mother’s family 7(78)
n = number
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4.3.4.3 History of adverse reactions to environmental allergens
Table 4.11 shows the frequency of allergic reactions to environmental allergens in 
children participating in the dietary intervention study. The majority of children in the 
diet-group were reported by parents to be affected principally by foggy weather 
followed by fiirry animals, strong fumes and tobacco smoke. The majority of the non­
diet group were affected mostly by house dust mites then by foggy weather, tobacco 
smoke and furry animals. Neither groups were affected by moulds. Of the 22 
asthmatic children in this study, 3 reported not being affected by any environmental 
allergens. The remaining 19 children reported being affected by one or more 
environmental allergens (see Table 4.12).
Table 4.11. Adverse reactions to environmental allergens in asthmatic 
children recruited to the diet-and non-diet groups
Adverse reactions
to the following environmental
allergens
Study groups
Diet group n=13 
nl(%)
Non-diet group n=9 
nl(%)
Grass pollen 4(31) 1(11)
Tree pollen 4(31) 1(11)
Fnrry animals 8(62) 4(44)
Honse dnst 4(31) 2(22)
Honse dnst mites - 2(15) 8(89)
Moulds 0 1(11)
Foggy weather 9(69) 6(67)
Perfumes 3(23) 2(22)
Strong fumes 6(46) 2(22)
Car exhaust fumes 3(23) 3(33)
Tobacco 6(46) 5(56)
n = number of asthmatic children in the study groups 
nl = number of asthmatic children with adverse reactions to environmental allergens
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Table 4.12. Frequency of reactions to types of environmental allergens
Study groups n Frequency of reactions to environmental allergens
0 1 2 3 4 >4
Diet-Group 13 2 2 0 1 3 5
Non-diet group 9 1 2 1 3 1 1
Total 22 3 4 1 4 4 6
4.3.4.4 History of adverse reactions to food allergens
Of the 22 children, 10 children did not appear to have any adverse reaction or allergy 
to foods as reported by their parents (see Table 4.14). Very few children were 
affected by more than one type of food. The 12 asthmatic children who reported 
having adverse reactions to food were affected mostly by oranges; followed by 
peanuts; eggs; cordials and carbonated drinks; milk; wheat, beans and fish (see Table 
4.13).
Table 4.13. Presence of personal history of adverse reactions to foods in the 
asthmatic children recruited to the diet-group (DG) and non-diet group (NDG)
Adverse reactions to 
the following foods
Study groups
Diet group n=13 
n,(l%)
Non-diet group n=9 
n, (%)
Combined DG & NDG n=22 
n, (%)
Eggs 3(23) 1(11) 4(18)
Milk 2(15) 1(11) 3(14)
Peanut 4(31) 1(11) 5(23)
Oranges 4(31) 2(22) 6(27)
Wheat 1(8) 0 1(5)
Beans 1(8) 0 1(5)
Cordials 3(23) 1(11) 4(18)
Carbonated drinks 2(15) 2(22) 4(18)
Fish 0 1(11) 1(5)
n = number Hi = number having adverse reaction to the specific food
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Table 4.14. Frequency of adverse reactions to types of food allergens
Study groups n Frequency of reactions to food allergens
0 1 2 3 4 >4
Diet-group 13 5 3 1 2 1 1
Non-diet group 9 5 3 0 0 0 1
Total 22 10 6 1 2 1 2
4.3.4.S Specific food IgG and IgE antibodies and PEFR in 4 children vdth egg 
and milk allergies (DG n=3) (NDG n=l)
Figures 4.16 and 4.18 illustrate pre-dietary and post-dietary intervention anti­
ovalbumin IgE (grade), IgG concentrations and PEFR in the 4 asthmatic children 
reported with adverse reactions to eggs. None of the 4 children had been clinically 
diagnosed as allergic to eggs. Nevertheless, the 3 children in the diet-group who 
reported having egg allergy showed a fall in anti-ovalbumin IgG concentrations (see 
Figure 4.16). Two children with egg allergy in the diet-group who were able to 
perform PEFR, had an increase in PEFR readings along with a reduction in anti­
ovalbumin IgG concentrations at the end of the dietary intervention study (see Figure 
4.17). The child with egg allergy in the non-diet group had a reduction in his PEFR 
reading and a slight increase of anti-ovalbumin IgG concentrations after the study 
period. The anti-ovalbumin IgE results showed that only one child (No. 10) had a 
grading shifted from grade 2 to 1 (see Figure 4.16). This child (No. 10) was reported 
to have undisturbed sleep, a week after commencing on the egg and milk free diet 
right to the end of the study period. The child’s mother reported that this undisturbed 
sleep had not happened previously. A month after completion of the dietary 
intervention study, the mother reported that her child had reverted back to the 
disturbed sleep pattern after going back to her normal diet with eggs and milk. This 
child however was only 4 years old and could not perform PEFR correctly. However, 
no change was observed in the anti-ovalbumin IgE results in the remaining 3 children 
[Nos. 3 and 11 (DG) and No. 5 (NDG)], (see Figures 4.16 & 4.18).
Figure 4.19 shows the pre-dietary and post-dietary intervention anti-p-lactoglobulin 
IgG concentrations and PEFR readings in 2 asthmatic children (1 DG and 1 NDG)
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reported with milk allergy. Although there were 3 children reported with milk allergy, 
only 2 children could perform the PEFR correctly. Child No. 11 was in the diet-group 
whereas child No. 5 was in the non-diet group. Child No. 11 (DG) had a reduction in 
the anti-p-lactoglobulin IgG concentrations and an increase in PEFR after avoiding 
milk and eggs for 8 weeks. Child No. 5 (NDG) who continued with customary food 
intake was observed to have an increase in anti-P-lactoglobulin IgG concentrations 
and simultaneously a decrease in PEFR. When comparing these 2 children with 
adverse reactions to milk, it appeared that an improved clinical picture was observed 
with milk avoidance in contrast to the child who continued his customary food intake.
Figure 4.16. Pre-dietary and post-dietary intervention anti-ovalbumin IgG 
(pg/ml) and IgE (grade) concentrations in asthmatic children with egg allergy 
recruited into the diet- and non-diet groups
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overlapped in the figure.
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Figure 4.17. Pre-dietary and post-dietary intervention peak expiratory flow
rate readings (L/min) and anti-ovalbumin IgG concentrations (|Lig/mI) in
asthmatic children with egg allergy recruited into the diet- and non-diet groups
300
250cI
0:
L L
HiQ_ 2 0 0 .
150 
500
5z(NDG)
11z(DG)
5z(lÿ)G)
11zg)G)
3z^G)
3z^G)
1500 2500
Anti-ovalbumin IgG concentrations (ug/ml)
#  Post-DI 
_ e  Pre-DI
3500
z = allergic to eggs 
DG = diet-group n=2
DI = dietary intervention 
NDG = non-diet group n=I
Figure 4.18. Pre-dietary and post-dietary intervention peak expiratory flow 
rate readings (L/min) and anti-ovalbumin IgE (grade) in asthmatic children 
with egg allergy recruited into the diet- and non-diet groups
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Figure 4.19 Pre-dietary and post-dietary intervention anti-p-lactoglobulin IgG
concentrations (jiig/ml) and PEFR in asthmatic children with milk allergy
recruited into the diet- and non-diet groups
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4.3.4.Ô Burden of asthma
Table 4.15 shows the burden of asthma before and after dietary intervention in both 
the diet-group and non-diet group. Of the 11 children in the diet-group who had at 
least one acute asthmatic attack in the last 12 months, 9 (70%) had 4 or more 
asthmatic attacks in the last year alone; 5 (38%) reported seeing their GPs 4 times or 
more for their asthmatic condition; 4 (31%) were warded because of asthmatic attack 
and 3 (25%) were absent from school more than 6 times although the number of days 
of absenteeism was not identified.
Information was also gathered in relation to the number of asthmatic episodes 2 
months prior to the dietary intervention study. Four children (30%) had between 1 
and 6 asthma attacks in the previous 2 months before commencing the dietary 
intervention study. After avoiding egg and milk and related products for 8 weeks, the 
same 4 children reported having only one asthmatic episode during the study period.
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In the non-diet group, 6 (67%) reported having between 2 and more than 6 acute 
asthmatic attacks within the last 12 months; 6 (67%) claimed seeing their GPs more 
than 3 times for their asthmatic conditions and only one child was admitted into 
hospital for asthma. Prior to the dietary intervention study, 8 (89%) children from the 
non-diet group reported no asthmatic attack and one child reported 3 asthmatic 
attacks within the last 2 months. However, after the dietary-intervention study period, 
3 (33%), children reported having between 1 and 2 asthmatic attacks and 6 (67%) 
claimed no asthmatic attack at all. It appears that the asthmatic episodes in children, 
who were in the diet-group, had reduced while on the egg-free and milk-free diet. In 
contrast, two of the 8 asthmatic children in the non-diet group, who reported not 
having asthmatic episodes in the previous 2 months prior to the study period, had one 
asthmatic attack during the study period.
4.3.4.7 Medication
One child from the diet group and non-diet group had reduced intake of P2-agonist 
over the course of the study. Both children had an improvement in their PEFR 
readings; reduced concentrations of anti-ovalbumin IgG, anti-P-Iactoglobulin IgG and 
total IgE; no change in anti-ovalbumin IgE. The child in the diet group reported 
improved “well-being” especially when engaged in sporting activities.
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Table 4.15 Burden of asthma in the asthmatic children recruited to the diet-
and non-diet groups
Burden of asthma Frequency (%)
0 1 2 3 4-6 >6
Diet group tn=13):
Asthmatic attack (previous 12 mth) 2(15) 1(8) 1(8) 4(31) 5(39)
Visit GP for asthma (previous 12 mth) 3(23) 2(15) 2(15) 1(8) 2(15) 3(23)
Hosp. admission for asthma (previous 12 mth) 9(69) 2(15) 1(8) 1(8)
Absence from school for asthma (n,=12) 4(33) 1(8) 4(33) 3(25)
Asthmatic attack (previous 2 mth before DI) 9(69) 2(15) 1(8) 1(7)
Asthmatic attack (previous 2 mth during DI) 9(69) 4(31)
Change in medications no yes
Reduction in Pj-ngonists (n2= ll) 10(91) 1(9)
Reduction in inhaled steroids (0^=11) 10(91) 1(9)
Burden of asthma Frequency (%)
0 1 2 3 4-6 >6
Non-diet grouu tn=9):
Asthmatic attack (previous 12 mth) 3(33) 1(11) 3(33) 1(11) 1(1
1)
Visit GP for asthma (previous 12 mth) 2(22) 1(11) 1(11) 5(56)
Hosp. admission for asthma (previous 12 mth) 8(89) 1(11)
Absence from school for asthma (Oi=9) 5(56) 2(22) 1(11) 1(11)
Asthmatic attack (previous 2 mth before DI) 8(89) 1(11)
Asthmatic attack (previous 2 mth during DI) 6(67) 2(22) 1(11)
Change in medications no yes
Reduction in p^-agonist (n2=7) 6(86) 1(14)
Reduction in inhaled steroids (n2=7) 7(100) 0
111 = number of children attending school
TI2 =  number of children taking medications
mth = months
Hosp. = hospital
DI = dietary intervention
GP = General Practitioners
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4.3.4.S Compliance with egg-free and milk-free diet
Of the 13 children who were in the diet-group, 6 children appeared to have 
inadvertently consumed small amounts of egg and milk products during the study 
period. These foods were in the form of cakes and consumed either once or twice in 
family gatherings. The remaining 7 children followed a strict egg-free and milk-free 
diet for the whole 8 weeks duration. No statistical differences were observed between 
the reduced concentrations of food IgG antibodies in those who complied frilly or 
partially to the egg-free and milk-free diet. Levels of ovalbumin and P-lactoglobulin 
antigen were not measured in this study.
4.3 4.9 Intake of nutrient supplements
Tables 4.16-4.20, show the daily nutrient intake of the asthmatic children in the diet- 
group and non-diet group calculated from the 21 days food record. None of the 
asthmatic children in the non-diet group took vitamin or mineral supplements. All 
children in the diet-group were supplemented with 250 mg calcium daily and two 
children took multivitamin supplements (vitamin A, D, E, C, Bj, B2, niacin, Bg, and 
panthothenic acid) daily. Two children in the diet group consumed large amounts of 
soya milk. The hypoallergenic formula (Pepti-Junior) was not popular among the 
children as a milk alternative eaten with cereals with the exception of 3 children. It 
was reported that Pepti-Junior was unpalatable when ingested unadulterated with 
cereals. One child complained of being sick after consuming the alternative milk and 
another child refused to drink it after tasting it for the first time despite mother 
masking it with flavourings. Three children requested additional supplies of the 
hypoallergenic formula after the first consignment. Although these 3 children 
tolerated Pepti-Junior in the first few weeks, it was then rejected towards the end of 
the study period. Mothers utilised the hypoallergenic formula in cooking with the 
help of the recipe provided.
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4.3.5 Analysis of nutrient intake
4.3.5.1 Asthmatic children 4-6 years of age:
4.3.5.1.1 Male asthmatic children (n=8)
The mean calorie intake for the 3 male asthmatic children who avoided milk and eggs 
for 8 weeks, was 77+20% RNI which was significantly lower (P<0.05) than their 
counterparts in the non-diet group (n=5) (see Table 4.16). The weight gain for the 
non-diet group (0.5±0.7 kg) of these children was observed to be significantly higher 
than their counterparts (-0.4+0.5 kg) who followed a milk and egg firee diet for 8 
weeks. Of the 6 male asthmatic children aged 4-6 years who were in the diet-group, 5 
children lost weight (ranges between 0.1-1.2 kg) and the remaining child gained 0.1 
kg. Of the 5 male asthmatic children who were in the non-diet group, 4 children 
gained weight (between 0.3 kg and 1.2 kg), and the remaining child lost 0.6 kg. It was 
also observed that the intake of the nutrients zinc (73+44% RNI), iodine (39+27% 
RNI) and vitamin A (61 ±46% RNI) in the diet-group were far below the RNI 
compared with the non-diet group.
4.3.5.1.2 Female asthmatic children (n=3)
The diet-group (n=2) had low nutrient intakes of energy (76+2% RNI), zinc (73±4% 
RNI), iodine (69+21% RNI) and vitamin A (65±9% RNI) (see Table 4.17). Similarly, 
the child’s nutrient intake in the non-diet group was observed to be low in energy 
(84% RNI), zinc (68% RNI), iodine (55% RNI) and vitamin E (76% RNI). This 
child’s vitamin B12 and vitamin A intake was four fold % RNI. It was identified that 
this child consumed 9.5 servings of liver pate (40 g per serving) in the 21 days of 
food records. Although both children in the diet-group had energy intake between 75 
and 78% RNI, one child had a weight loss of 0.2 kg and the other child had a weight 
gain of 0.6 kg. The child who continued her customary food intake appeared to have a 
weight gain of 0.2 kg.
148
4.3.5.2 Asthmatic children 7-10 years and 11-14 years of age 
4.3.5.2.1.Male asthmatic children (n=3)
The mean energy intake of the asthmatic children aged 7-10 years in the diet-group 
and non-diet group were comparable (see Table 4.18). In the non-diet group, one 
child had no weight changes and the other child had a weight gain of 0.2 kg after the 
study period. However, the child in the diet-group had a weight loss of 1.0 kg. The 
child’s nutrient intake for most nutrients was above the RNI, however the energy 
intake was 95% RNI; iodine (64% RNI) and vitamin E (72% RNI). This particular 
child had vitamin supplement aside from the calcium supplement provided. Although, 
the mean nutrient intake in the non-diet group met the RNI, one child’s nutrient 
intake only satisfied 60% of the RNI for calcium and 70% for iodine.
The 14 year old boy’s nutrient intake in the diet-group was observed to be deficient in 
many nutrients including energy (80% RNI), calcium (60% RNI), iron (89% RNI), 
zinc (77% RNI), iodine (59% RNI), nicotinic acid (80% RNI), vitamin C (81% RNI), 
vitamin A (81% RNI), and vitamin E (52% RNI). Other nutrients however appeared 
to be adequate for his age group. This particular child had a weight gain of 1.2 kg 
after abstinence from egg and milk for 8 weeks and despite a consumption of only 
80% of RNI for energy.
4.3.5.2.2 Female asthmatic children (n=3)
Both groups of children in the 7-10 years and 11-14 years of age were in the diet- 
group. Dietary record showed that the 3 children’s energy intake satisfied 90% or 
more of the RNI (see Table 4.19). However, there appeared to be no weight changes 
in one child, 7-10 years of age and the child in 11-14 age group had a weight loss of 
0.3 kg. The 11 year old child had a weight loss of 0.6 kg after the 8 weeks study 
period and her nutrient intake appeared to be deficient in calcium (69% RNI), iron 
(64% RNI), zinc (59% RNI), selenium (73% RNI), iodine (21% RNI), folate (89%
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RNI) and vitamin A (36%). As for the children aged 7-10 years, it was observed that 
their nutrient intake appeared to be adequate with the exception of zinc and iodine 
and one of them had a low intake of vitamin E (43% RNI).
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Table 4.20 Summary of percentage of recommended nutrient intake of
asthmatic children recruited in the diet-group and non-diet group.
(Mean±standard deviation, ranges)
Nutrients Percentage of recommended nutrient intake
Diet-group Non-diet group
Mean ± SD Range Mean ± SD Range
Energy 84 ± 14* 55 -105 100 ± 11 84 -113
Carbohydrate 116 ± 9 103 -131 106 ± 4 99 - 111
Protein 182 ± 60 106 - 319 251 ± 52 197-356
Fat 102 ± 9 88 -115 116 ± 7 108 -125
Calcium 109 + 30 61 -149 155 ± 63 60 - 275
Iron 125 ±57 60 - 249 133 ± 18 113 -165
Zinc 77 + 32 31 -138 95 ±20 68 -119
Selenium 135 + 45 60 -195 168 ± 56 106 - 277
Iodine 47 + 22 10-84 122 ± 89 55 - 330
Thiamine 227 + 86 134 - 345 172 ±36 130 - 240
Riboflavin 155 + 89 49 - 287 189 ±55 129 - 279
Nicotinic acid 213 + 41 125 - 266 189 ± 28 150 - 230
B6 238 ±82 145 - 421 193 ±43 134 - 260
B12 188 ±49 90 - 255 339 ±97 180 - 456
Folate 137 ±66 73 - 298 171 ±53 115 - 263
Vitamin C 274 ± 153 117-517 241 ±91 157 - 376
Vitamin A 75 ±39 10-147 171± 114 93 - 435
Vitamin E 113 ±50 43-213 116 ±33 76 -168
mean value in diet-group was significantly lower firom that of non-diet group
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4.4 Discussions
An asthma attack precipitated by wine was noted in 1679 by Thomas Willis (cited in 
Frick, 1988). Salter (1860) (cited from Frick, 1988) observed sneezing, rhinorrhea, 
nasal congestion, coughing, and wheezing after ingestion of certain foods including 
old cheese, preserved nuts, and malt liquor and milk.
In 1948, Rowe (cited from Frick, 1988) conducted a survey on 1,491 asthmatic 
patients. He reported that 40% of children <5 years old, 25% of children 5 to 15 years 
old, 20% of adults 15 to 55 years old, and 40% of adults >55 years old, had asthmatic 
episodes only with foods. These results were based on history, skin tests, and 
response to the Rowe 1-2-3 elimination diets. He was convinced that if physicians 
were more concerned, they would find that half the cases of allergic asthma and 
psychogenic asthma in adults were caused by allergy to foods.
Frick (1988) reported that Van Metre et al., (1968), evaluated the Rowe’s cereal-free 
diets 1, 2 and 3 along with a high allergenic food diet in double-blind crossover 
fashion on 18 randomly selected asthmatic adults with no history of diagnosed food 
allergy. No difference in the frequency or severity of asthmatic symptoms was 
observed in these subjects after the 3 week period following Rowe’s cereal-free diet
1,2 and 3. However, Rowe (1968) commented that the duration of Van Metre’s 
subjects on the Rowe cereal-free diet trial period was too short i.e. 3 weeks. The body 
requires a longer period of time to clear antibodies and antigens before expecting any 
change in the subject’s respiratory symptoms to occur.
In this prospective, single blind dietary intervention study, the duration of the trial 
period was longer i.e. 8 weeks of diet devoid of eggs and milk, than that of Van 
Metre, and findings are in agreement with those of Rowe who suggested that the body 
requires several weeks to clear the specific antibody before any improvement can be 
seen. In this study, a significant improvement of peak expiratory flow rate in 
asthmatic children on the intervention dietary was observed compared with the
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asthmatic children who continued with their customary food intake. In addition, it 
appeared that there was an improvement in the eczema conditions and improvement 
in the general well-being in several of children in the Diet-Group. The 8 week study 
period was calculated on the basis that the half life of IgG is 23 days and the residual 
time of IgG on the mast cells is between 2 to 3 months (El-Rafei et al., 1989). 
Although a study period of diet devoid of eggs and milk for 3 months would have 
been ideal, the compliance of the diet would be difficult in subjects particularly 
asthmatic children. In addition, children may be nutritionally deprived of an adequate 
diet due to eggs and milk being a ubiquitous food item (see nutritional results. Section 
4.3.4.8). It was also observed that there was a significant weight loss in the diet-group 
compared with the non-diet group, thus indicating that children in the diet-group were 
not consuming sufficient food intake. Foods served during the study period may be 
different in taste, texture and variety especially the favourite foods such as desserts 
and snacks including cheese, ice-cream and yoghurt. Milk and eggs not only enhance 
the flavour but also enhance the texture of most commercial and home-prepared 
foods. Poor nutritional status is a big worry, particularly when weight loss occurs in 
asthmatic children.
4.4.1 Study groups
The parents of the asthmatic children recruited in this dietary intervention study were 
a well-motivated group. This is mostly due to their hope of reducing the burden of 
asthma on their children. The children in the diet-group were briefed prior to the 
study on the importance of maintaining a milk-fi-ee and egg-firee diet throughout the 8 
week period. This strategy of involving the children in discussions and obtaining their 
consent, proved to be beneficial. Several parents reported that the children themselves 
(as young as 4 years of age) refused any egg and milk products when offered by 
grandparents or others, and the children consulted their parents if unsure of the 
contents of a particular food. However, 2 children, both girls appeared to have 
consumed some milk products at school and 4 other children had a small amount of 
cakes during holiday trips and visits to their extended families. Seven children
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maintained a strict egg-free and milk-free diet throughout the study period. It 
appeared that mothers and children complied with the egg-free and milk-free diet 
diligently and without many deviations.
4.4.2 Problems encountered in implementing the dietary regimen
Dietary restriction in children is not only a laborious procedure for the parents but 
frustrating on the part of the children. It is made even worse when they have siblings. 
When a child is on a modified diet, he/she needs the full support of the whole family. 
Siblings can be demoralising occasionally, one mother reported her son being called a 
“baby” by the other siblings for consuming a ‘baby’ hypoallergenic formula (Pepti- 
Junior). Peer pressure in schools can be another demotivating factor. Festive seasons 
which include the Easter celebration, birthday parties and holiday trips also appeared 
to be a great challenge in this dietary intervention study. Several mothers prepared 
some egg and milk free snacks and brought them to parties to encourage their 
children to lead a normal life and not feel segregated by the diet regimen. Parents 
even went out of their way to get milk and egg free foods which were only available 
in Supermarkets some distance away from their home and such foods may even be 
more expensive than the foods normally purchased [e.g. milk free chocolate, rice milk 
(non-dairy), ASDA bread].
A close rapport was maintained between the researcher and the children and appeared 
to be beneficial. Many incentives were given to the children during home visits and 
after venepuncture such as bravery awards, various stickers, badges, egg and milk 
free food including Easter eggs, biscuits, cereal bars, raisins and fiuit juice. Such 
close rapport between the researcher and the children, meant that all children looked 
forward to their first and follow-up visits to the clinics with the exception of 3 
children, who disliked the venepuncture procedure.
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4.4.3 Nutritional effects of a milk-free and egg-free diet
The nutritional consequences of any dietary intervention regime must be critically 
assessed where children are concerned particularly children with conditions including 
asthma. It is documented that asthmatic children have a slower growth rate compared 
with healthy non-atopic children (see Chapter 3). This study however has limitations. 
Firstly, healthy non-atopic children were not recruited to compare their nutrient 
intake, weight and height gain against the diet- and non-diet groups. Secondly, a 
minimum of 3 days’ food record prior to the dietary intervention study would have 
been useful in the diet-group to see any marked reduction of nutrient intake especially 
the energy intake. In the non-diet group, the 3 days’ food record prior to the study 
period, could have been used to identify if the children had reduced their milk and 
egg consumption during the study period following parents’ knowledge of the 
objectives of the study.
Bearing in mind these limitations, it was observed that the mean energy intake of the 
asthmatic children in the diet-group was lower than the dietary reference value (DRV) 
(DoH, 1991) for the United Kingdom (RNI) and the non-diet group. It appears that 
the mean energy intake in the non-diet group was adequate, based on DRV (DoH, 
1991). The other crucial nutrients that need assessment in a milk and egg free diet are 
calcium and riboflavin. The mean calcium intake in the diet group met the RNI 
though not through diet, but through calcium supplements. All children in the diet- 
group were supplemented with 250 mg of calcium per day (Calcichew) irrespective of 
age. It was expected that Pepti-Junior would have compensated the remaining calcium 
requirement. However, Pepti-Junior was not acceptable to all children although 
mothers attempted to mask its flavour. Two mothers in the diet group ensured that 
their children consumed at least a serving of the formula which they added in cooked 
food, towards the end of the study period. Initially these 2 children accepted the 
alternative formula in their cereals but gave it up after several weeks.
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It is recognised, therefore, that the calcium intake of the children should have been 
assessed weekly and the supplement increased to 500 mg per day especially in older 
children who refused the alternative milk supplement to ensure an adequate intake of 
daily calcium requirement. Riboflavin intake appeared to be adequate, possibly due to 
the suggestion to parents that children be given a teaspoon of Marmite daily.
The importance of calcium supplement in subjects on a milk-free diet even with 
cows’ milk substitute is crucial (Devlin et al., 1989). Calcium supplement was given 
routinely in a milk free diet (Falth-Magnusson et al., 1987b); Lilja et ah, 1988; Zeiger 
et ak, 1989; Hattevig et ah, 1990; Lovegrove et ah, 1994). Alternative hydrolysate 
formula such as Pepti-Junior tends to leave an after taste. This milk substitute may be 
suitable for infants who have not developed a sense of taste for certain specific foods. 
Pre-school and older children have a mind of their own and can be rebellious. 
Therefore, calcium supplements may be a better alternative to meet calcium 
requirement in children prescribed with a milk-free diet compared with the protein 
hydrolysate formula, unless the taste is improved.
A 7-day food diary has its drawbacks. This includes an estimation of weight of food 
based on the pictures provided. Foods not shown in pictures may be either under or 
over-estimated compared with if it is weighed. There could also be a possibility of 
failure to record other foods (especially snacks) eaten by the children unknown by the 
mother. The subjects in this study were asthmatic children. Children’s eating habits 
especially the younger children can be erratic. The quality and quantity of food intake 
can change on a day-to-day and week-to-week basis. In addition, modification of the 
normal diet can have a psychological impact on children especially asthmatic 
children.
Few studies have been published which can directly compare the nutrient intake and 
its relationship to the growth rate of asthmatic children. Most studies have focused on 
the effect of asthma treatment such as inhaled and oral corticosteroids on the growth 
of asthmatic children(Russell, 1993; Crowley et d., 1995). Klein et al. (1991),
160
conducted a study in the United States on the growth and the nutritional status of non­
steroid dependent asthmatic children. He reported that there was no significant 
difference observed for the growth of asthmatics and non-asthmatic children. He also 
reported that children age 4-6, 7-10 and 11-14 years old consumed more than 100% 
of the Recommended Daily Allowance (RDA) for protein, calcium and vitamins (A, 
Bj, B2 and C). However, the 4-6 year old group consumed less than the RDA for 
energy and less total energy than the control group. The 7-10 and 11-14 years old, 
exceeded the 100% RDA of recommended energy.
In the study reported in Chapter 3, it was observed that asthmatic children were 
shorter and leaner than the non-atopic children which agrees with other studies of this 
type (Murray et ah, 1976; Chang et ah, 1982; Crowley et 1995). The children in 
the Observational Study (Chapter 3) were referred by their GPs to hospital 
consultants, which may indicate an unstable asthmatic condition, and the majority 
were using inhaled corticosteroids and some were on oral steroids. However, the 
asthmatic subjects reported by Klein et d . (1991) were not dependent on steroids. 
Several studies have shown that inhaled steroids are associated with short-term 
growth of the lower leg (Price, 1997). The anthropometric measurements (pre-dietary 
and post-dietary intervention weight and height) taken in this study, were primarily to 
observe if the prescribed diet regimen (egg-ffee and milk-fi*ee diet for 8 weeks) 
affected the nutritional status in the diet group versus the non-diet group.
In this study, a comparison was made of the nutrient intake between the diet- and 
non-diet groups as healthy non-atopic children were not recruited. The result of this 
study, using DRV as a guide to represent nutritional requirements for general health 
plus a safety factor, indicates that asthmatic children who continued their customary 
food intake consumed adequate nutrients daily. However, the mean energy intake was 
inadequate in the diet-group. Consequently, a significant mean weight loss was 
observed in the diet group compared with the non-diet group.
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In addition, the iodine intake of children in the diet-group appeared to be 
comparatively low compared with that of the non-diet group. Long term low intake of 
iodine may affect the growth status of these asthmatic children. Therefore, it is crucial 
that iodine intake should also be closely monitored along with the energy, riboflavin 
and calcium intake of all children who are prescribed with any form of elimination 
diet.
The total energy consumption of the non-diet group asthmatic children did not greatly 
exceed nutrient intake recommendations and is consistent with a previously reported 
study (Murray et al., 1976). That study indicates that asthmatic children have a poorer 
appetite than non-asthmatic children. However, the energy intake of the asthmatic 
children, if placed on a special diet regimen, without any consultation or advice from 
the dietitian, is at risk of being inadequate, thus exposing these children to growth 
retardation and/or nutritional deprivation. Therefore, the involvement of a dietitian is 
crucial to tailor an appropriate adequate diet regimen prescribed to any asthmatic 
children.
4-
4.4.4 Immunological effect of a milk and egg free diet
In this study, it was observed that all children in the diet-group had a significantly 
reduced concentration of specific food IgG antibody to ovalbumin and P- 
lactoglobulin after 8 weeks on a diet devoid of eggs and milk compared with the non­
diet group. However, results of total IgE, specific IgE for ovalbumin, PEFR and 
feedback from mother and children were not as clear cut as the specific food IgG 
concentrations. However, on examining individual results using various indicators, 
several interesting findings were observed. Of the 6 children in the Diet-Group who 
were able to perform PEFR, 5 children had significantly improved in the post-PEFR 
compared with their pre-PEFR. Two children claimed that their general well-being 
had improved and this was confirmed by the Paediatric Consultant. The same children 
claimed they were “less chesty” when engaged in sporting activities, thus requiring 
less treatment of P2-agonist. One child reported an improvement in the eczema 
condition. None of the 5 children had a change of grading in their specific food IgE 
results.
4.4.5 Clinical outcomes
Unfortunately, of the 4 children who were observed to have a shift of grading from 
either 2 to 1 or 1 to 0 grade for specific IgE for ovalbumin, none of the 4 children
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were able to perform PEFR correctly because of their age. Although, Shapiro et al. 
(1997) indicated that children above 5 years of age can be taught to perform PEFR 
readings correctly, the majority of young children in this study had no such exposure. 
All children participating in future dietary intervention study should attend several 
training sessions in PEFR reading techniques prior to the study period. Bearing in 
mind this limitation of the present study, one child was observed to have undisturbed 
sleep throughout the study period after one week on the restrictive diet and another 
child’s eczema condition had improved. None of these children claimed a direct 
improvement in their asthmatic condition. However, after the trial period, several 
mothers whose children were in the diet-group reported one or more of the following: 
one child had an asthmatic attack after consuming a piece of cake (time between 
consumption and episode of asthma was not identified), 2 children required frequent 
P2-agonist while engaged in sporting activities, 3 children had worsened eczema 
conditions and the child with undisturbed sleep reverted to her earlier disturbed sleep 
pattern after the trial. In addition, the number of asthmatic episodes during the trial 
period (8 weeks) in the diet-group children was less compared with children in the 
non-diet group.
Of the 3 children in the diet-group who reported having egg allergy, the 2 children 
who were able to perform PEFR were observed to have improved by 20% or more on 
the pre-dietary intervention PEFR. An improvement of more than 10% PEFR is 
considered as a positive improvement (Mallik, Personal communication). Only one 
child with egg allergy who was in the diet-group had a shifting of the CAP grading 
from grade 2 to 1, although all 3 had reduction in the anti-ovalbumin IgG 
concentration. A conflicting result was observed between the anti-ovalbumin IgE and 
anti-ovalbumin IgG in children who reported having allergic reactions to eggs. The 
child with 0 grade for anti-ovalbumin IgE had the highest anti-ovalbumin IgG 
concentration, whereas the child with the highest anti-ovalbumin IgE, grade 3 had the 
lowest anti-ovalbumin IgG concentrations. This conflicting result remains 
unexplained.
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Of the 9 children in the non-diet group, it was observed that only one child had a 
slight reduction in the anti-ovalbumin IgG and Total IgE concentrations, improved 
PEFR readings and reduced usage of P2-agonist. Since no information regarding the 
intake of egg and milk was obtained prior to the study, this improvement remains 
unexplained, although there is a possibility of the child consuming less than the 
normal allergenic food during the study period as parents were aware of the 
objectives of the study. In addition, another child had a shift of grading for specific 
IgE for ovalbumin fi*om 1 to 0 grade, but no other improvement was observed in this 
child in relation to other indicators.
4.4.6 Markers of food allergy
The results of this study provide evidence which tends to favour the beneficial effect, 
either directly or indirectly, on asthmatic conditions in children who follow a diet 
devoid of eggs and milk. The results showed that specific food IgG antibodies may be 
a useful screening marker for the assessment of food allergy. In addition, results from 
other markers such as total IgE and specific food IgE antibody appeared to be 
inconsistent.
To enable confirmation of the presence of food allergy in the subjects participating in 
this study, and to confirm the various diagnostic methods employed, the children in 
the diet-group should undergo DBPCFC upon completion of the post-assessment. 
However, the food challenge is not possible in this study due to logistic constraints, 
which include time, personnel, finance and risk of exposing these children to acute 
asthmatic episodes or anaphylaxis. Obviously, further research is required in this area 
on asthmatic adults using similar protocols as the present study and including the 
DBPCFC immediately after the 8 weeks trial period on diet devoid of milk and eggs.
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4.4.7 Asthma and associated food allergy
Asthmatics can be divided into the “Good and Bad responders” (Sabbah & Drouet, 
1991). They claimed that SPT in practice is unreliable: <50%; RAST is slightly more 
reliable than SPT.
Food allergy is one of the causes of atopic dermatitis (AD), of acute urticaria, of 
reactions of the gastrointestinal tract, and of acute anaphylaxis, but its role in asthma 
appears to be less clear (Businco et al., 1995). Businco and colleagues claimed that 
the prevalence and incidence of subjects with food-induced wheezing have not been 
well studied. Children with asthma, who are allergic to foods, present some particular 
features such as eczema and a related significantly elevated total serum IgE level. 
Alternatively, food allergy may occur in patients who are “high responders” and more 
prone to becoming sensitive to many allergens including foods. They recommended 
that children with asthma and a history of eczema and/or elevated total serum IgE 
level should be carefully assessed for food allergy. It would have been ideal if the diet 
group in this study could have been challenged with egg and milk following the diet 
devoid of egg and milk for 8 weeks. In addition, clinical assessment was carried out 
at the beginning and at the end of the study period but not in between, to assess the 
point at which improvement started with dietary avoidance in the children. However, 
judging from the recordings of PEFR in older children, improvement in PEFR was 
observed towards the end of the 8 weeks’ study period. All children with eczema 
reported an improvement in eczema conditions during the 8 week study period. 
However, no information was gathered fi*om the diet-group children with eczema to 
indicate the time when improvement in their condition began i.e. dates in the study 
period.
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Chapter 5
Adult Observational Study: Differences in specific food IgG antibody 
levels in asthmatic, eczematous and healthy non-atopic adults
5.0 Introduction
one
The field of food allergy has been reported to be f^of the most frustrating disciplines of 
immunology as it involves many controversial issues (de Week, 1996). De Week 
(1996) reported that in a population believed to suffer fi*om some form of “food 
allergy” or “intolerance”, the DBPCFC will confirm this in about 10-20% of the 
cases.
An adverse reaction to food involving the immune system is one of the causes of 
atopic dermatitis, urticaria, reactions of the gastrointestinal tract, and acute systemic 
anaphylaxis, but its role in the aetiology of asthma appears to be less clear (cited fi*om 
Buscinco et al., 1995). Onorato et al. (1986) studied 300 patients with asthma (7 
months-80 years). They reported that the prevalence of asthma induced by food was 
low (2%), in a population attending a speciality (allergy) clinic.
The prevalence and incidence of infants, children and adults who have food-induced 
asthma has not been comprehensively reported. Food allergy may trigger allergic 
respiratory symptoms through two main routes: ingestion and inhalation. Businco et 
al. (1995) reported that children with asthma, who are allergic to foods present some 
typical features. The affected individuals are usually young children and adolescents, 
and who have eczema and have been reported to have a significantly elevated mean 
total serum IgE level. The reason for the elevated IgE level is not completely known, 
but may be related to the presence of eczema (Buscinco et al., 1995). Alternatively, 
“food allergy” may occur in individuals who are “high IgE responders” and more 
prone to becoming sensitive toward many allergens, including foods.
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One of the aims of the studies discussed in Chapter 3 (Section 3.1) and Chapter 4 
(Section 4.1) was to determine the use of specific food IgG antibody as an alternative 
marker to total or specific IgE in the diagnosis of food allergy. The Child 
Observational Study: Differences in specific food IgG antibody levels in asthmatic 
children and non-atopic children (Chapter 3) however, highlighted the difficulties 
involved in the recruitment of healthy non-atopic children as the matched control 
group against asthmatic subjects. Because of the small number of controls recruited in 
the Child Observational Study, it was necessary to undertake a similar study on 
asthmatic adults. The findings in both study groups (children and adults) have 
facilitated the comparison and assessment of the use of specific food IgG antibody as 
an alternative marker to IgE for adverse reactions to foods involving the immune 
system.
5.1 Aim of the study
The aim of the study was to determine the food IgG antibody concentration 
specifically anti-ovalbumin IgG and anti-P-lactoglobulin IgG in asthmatic, 
eczematous and matched for gender and age, healthy non-atopic adults. The results 
also provided the basis for comparison of the specific food IgG antibodies to 
ovalbumin and P-lactoglobulin between asthmatic children and asthmatic adults.
5.1.1 Ethical approval
Ethical approval was obtained from the Advisory Committee on Ethics, University of 
Surrey (ref ACE/94/17/SBS dated 12th October 1994).
5.2 Methods
5.2.1 Sampling size
The sample size was determined using the computer programme InStat. The sample 
size for this study was determined and calculated as for the paediatric study (see
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section 3.2.1). based on previous data of Morris et al. (1992) comparing the anti­
ovalbumin IgG concentrations in atopic adults with matched for age and gender 
healthy non-atopic adults. The anti-ovalbumin IgG concentrations of atopic and 
healthy non-atopic adults reported in Morris et d . (1992) study was 369 ± 394 pg/ml 
(mean ± SD) of the atopic and 169 ± 131 pg/ml of the healthy non-atopic groups. The 
minimum difference of anti-ovalbumin IgG between the means of the 2 groups 
(atopic and non-atopic) detected as significant was estimated at 200 pg/ml anti­
ovalbumin IgG. The sample size calculated was 101 subjects in each group using a 
power index of 95% with a P<0.05.
5.2.2 Subject recruitment
Recruitment of adult subjects (atopic and matched for gender and age healthy non- 
atopic adults) took place on the University of Surrey premises (staff and students) 
over the period from December 1995 to May 1997. Initially, posters regarding the 
study were placed throughout the University, an advertisement was placed in “Surrey 
Matters”, the University of Surrey’s official newsletter, running for 3 consecutive 
months and also in “Barefacts”, the University of Surrey Students’ Union official 
publication. Seven volunteers responded via the aforementioned methods.
In May 1996, an alternative strategy was adopted. The researcher contacted the South 
London Blood Transfusion Team who kindly agreed to take an extra 5 ml of blood 
fi*om volunteer donors who met the criteria for this study on the University of 
Surrey’s premises. Recruitment of subjects was successful through personal contact 
and liaison with the National Blood Donor Unit, South London Blood Transfusion 
Services, which comes twice a year to the University of Surrey.
A total of 81 clinically diagnosed atopic adults, 21 males and 69 females participated 
in the study. At the initial stage of the study (approximately after 6 months of 
commencing the study), it was unexpectedly discovered through preliminary analysis, 
that 62% (23/37) of the “control” adults who were recruited had either some form of
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adverse reactions to food, allergic rhinitis or close family history of atopic conditions. 
Preliminary analysis of the specific food IgG and IgE antibody for ovalbumin was 
carried out on 37 asthmatic adults and matched for gender and age, healthy controls. 
Preliminary results showed that several healthy controls had specific food antibody 
concentrations higher than the atopic subjects. The controls were selected based on no 
personal history of asthma and/or eczema. On examining the questionnaire of the 37 
controls recruited, 23 were identified as having allergic rhinitis, or family history of 
atopic conditions. These subjects were removed fi*om the study.
Further recruitment of healthy non-atopic controls continued with greater care 
ensuring that subjects had no personal or family history of atopy through personal 
interview and using a structured questionnaire before a random blood sample was 
taken. Although a total of 62 adults with no personal or family history of any atopic 
diseases or adverse reactions to foods was successfully recruited, only 44 of these 
non-atopic adults were eligible and accepted in this study as they matched closely 
(within 5 years of age) for gender and age to the atopic subjects in the study. The 
remaining 18 healthy controls had to be removed as the majority did not match 
gender and the few that matched gender had an age range difference of more than 5 
years.
5.2.3 Questionnaire to assess allergy and family patterns of allergy
5.2.3.1 Questionnaire design and pre-testing
The questionnaire for this adult study was designed at the same time as the paediatric 
questionnaire (see section 3.2.3.1). Adult subjects who volunteered for the study 
completed a similar questionnaire to the paediatric study with the exception of 
questions on breast-feeding and age of introduction of weaning foods (see Appendix 
12). However, additional questions were included which enquired about personal 
atopic conditions such as asthma, eczema, allergic rhinitis, urticaria and other
169
allergies, as subjects were recruited on the basis of having asthma or eczema or both 
conditions.
5.2.4 Blood sampling and immunological analysis
Approximately 5 ml of non-fasting venous blood was taken from all subjects and 
controls by the researcher, and by Dr. J.B. Morgan, Dr. S.M. Hampton, Dr. P. 
Kwasowski and staff of the blood donor transfusion team. The blood sample was 
allowed to clot at room temperature, centrifuged, aliquoted and frozen at -20“C until 
completion of subject and control recruitment.
The sera samples were analysed in one batch using indirect ELISA (as discussed in 
Chapter 2), for the measurement of anti-ovalbumin IgG and anti-g-lactoglobulin IgG 
levels.
5.2.5 Anthropometric measurements
5.2.5.1 Weight
Subjects were asked to remove their shoes. A digital balance or a beam balance (Seca, 
CMS Weighing Equipment Ltd, U.K.) accurate to about 5 kg was used. The scales 
were re-zeroed before each weighing. Weights were taken to the last completed 0.1 
kg.
5.2.5.2 Height
The subject was instructed to stand (without shoes) with heels and back in contact 
with an upright wall or scale (Seca, CMS Weighing Equipment Ltd, U.K.). The head 
indicator was slid down the wall/scale until the bottom surface touched the subject’s 
head and measurement was recorded to the last 0.5 cm.
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5.2.5.3 Body mass index (BMI)
The BMI is calculated as the weight in kilograms divided by the square height in 
meters (weight (kg) / height^ (cm) (Garrow & Webster, 1985).
5.2.6 Statistical analysis
The data was analysed on a Personal Computer using the Statistical Package for 
Social Sciences (SPSS). As the data for the specific food IgG antibodies was not 
normally distributed, despite being logarithmically transformed, statistical analyses 
were performed using the non-parametric, Mann-Whitney U tests, to test the 
significance of the difference between the asthmatic groups and their matched 
controls.
5.3 Results
5.3.1 The subjects
The clinical categorisation of the atopic group is shown in Figure 5.1. Of the 81 
atopic adults recruited, 38 (47%) had asthma only, 21 (26%) had asthma with 
eczema, and 22 (27%) had eczema but no asthmatic condition. These groupings are 
used for the purposes of statistical analysis and discussions. Forty-four controls were 
selected in this study to match closely (gender and within 5 years of age) all the 81 
atopic adults. Several controls were matched either once, twice or three times to the 3 
groups of atopic adults.
Tables 5.1 and 5.2 show the details of subjects by gender and age respectively. The 
majority of subjects participating in this study were female. The mean age of the 
atopic subjects was similar to the matched non-atopic subjects in all the study groups. 
The mean age of the asthmatic and control groups were 30.5±(SD) 11.5 years (range 
19-60) years and 30.2±11.2 (18-57) years, respectively. Similarly, the mean age of
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the asthmatic with eczema and control groups were 28.6±9.0 (19-48) years and 
28.5±8.8 (19-48) years, respectively. The mean age of the eczematous and control 
groups were 26.6±8.7 (19-55) years and 25.1+8.0 (19-53) years, respectively.
Table 5.3 shows the mean heights for all the study groups were comparable with one 
another and their matched non-atopic groups. The mean BMI for all study groups 
with the exception of asthmatic with eczema group, was within the normal weight 
(BMI 20-24.9). The asthmatic with eczema group had a mean BMI of 26.0, which is 
considered as overweight. This value was found to be significantly higher statistically 
than the matched control group (P<0.01); asthmatic group (P<0.05) and eczematous 
group (P<0.01).
Table 5.4 shows the educational levels and smoking habits of the 3 groups and their 
matched controls. The majority of the atopic and non-atopic adults had reached 
higher education. This is not surprising as the subjects were recruited Jfrom the 
University premises. The remaining 13% of asthmatics only, 8% matched non-atopic 
for asthmatics only, 24% asthmatics with eczema, 9% matched non-atopic for 
asthmatics with eczema, 18% eczematous and matched non-atopic for eczematous 
had received education up to either O or A level. Very few, i.e. 8%, 10%, 5% and 5% 
asthmatics only, matched non-atopic for asthmatics only, matched non-atopic for 
asthmatics with eczema and matched non-atopic for eczematous respectively had 
education lower than O level. The majority of the atopic and non-atopic adult subjects 
were non-smokers (see Table 5.4).
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Figure 5.1. Distribution of atopic adult subjects
eczematous
27%
asthmatic 
with eczema 
26%
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only
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Table 5.1. Gender of asthmatic only, asthmatic with eczema, eczematous 
adults and matched for gender and age healthy non-atopic adults
Study groups (atopic adults) Number
Male
Gender
Female Ratio
la asthmatic only 38 12 26 1:2.2
lb matched non-atopic for group 1 38 12 26
2a asthmatic with eczema 21 5 16 1:3.2
2b matched non-atopic for group 2 21 5 16
3a eczematous 22 4 18 1:4.5
3b matched non-atopic for group 3 22 4 18
Total (la+2a+3a) 81 21 60 1:3.5
Table 5.2. Age of asthmatic only, asthmatic with eczema, eczematous adults 
and matched for gender and age healthy non-atopic adults
(Mean+standard deviation and ranges)
Study groups (atopic adults) Number Age (years)
Mean ± SD Range
la asthmatic only 38 30.5 ± 11.5 19-60
lb matched non-atopic for Group 1 38 30.2 ± 11.2 18-57
2a asthmatic with eczema 21 28.6 ± 9.0 19-48
2b matched non-atopic for Group 2 21 28.5 + 8.8 19-48
3a eczematous 22 26.6 ± 8.7 19-55
3b matched non-atopic for Group 3 22 25.1 ± 8.0 19-53
Total (la+2a+3a) 81
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5.3.2 Anti-ovalbumin IgG and anti-g-lactoglobulin IgG concentrations
Tables S.5-5.6 show the mean concentrations of anti-ovalbumin IgG and anti-P- 
lactoglobulin IgG within the serum samples. These concentrations are also shown 
graphically in Figures 5.2-5.S. Anti-ovalbumin IgG and anti-P-lactoglobulin IgG 
were detected in all atopic and non-atopic subjects. It was observed that the mean 
anti-ovalbumin IgG concentrations in all the 3 groups of atopic adults were 
significantly higher statistically compared with their matched for gender and age non- 
atopic adult subjects. All three atopic groups with the exception of the asthmatic with 
eczema had a mean anti-P-lactoglobulin IgG concentration significantly higher 
statistically compared with their non-atopic groups (P<0.01 and P<0.05, 
respectively). The asthmatic only and eczematous groups appeared to have a 
comparable mean anti-ovalbumin IgG i.e. 818+735 pg/ml and 883±766 pg/ml, 
respectively. The asthmatic with eczema group appeared to have the lowest specific 
food IgG antibody for ovalbumin (574+647 pg/ml) and anti-P-lactoglobulin (61 ±68 
pg/ml) of the 3 atopic groups. One asthmatic only adult (see group la, Figures 5.3 & 
5.4) had anti-P-lactoglobulin IgG concentration value of 2705 pg/ml which was a 
level way above the norms and might be considered as an outlier. The remaining 37 
asthmatic adults (group la) had anti-p-lactoglobulin IgG concentration between 2-568 
pg/ml. By excluding this highest value, it enables the expansion of the vertical axis of 
Figure 5.3 (see Figure 5.4). The majority of the asthmatic with eczema and 
eczematous adults appeared to have anti-P-lactoglobulin IgG concentration below 100 
pg/ml. However, the majority of the asthmatic only adults had anti-p-lactoglobulin 
IgG concentration below 200 pg/ml.
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Table 5.5. Anti-ovalbumîn IgG concentrations (|ag/ml) in serum of asthmatic 
only, asthmatic with eczema, eczematous adults and their matched for age and 
gender healthy non-atopic adults
(Mean values, standard deviation, ranges)
Study group (atopic adults) Number Anti-ovalbumin IgG (pg/ml)
Mean + SD Range
la asthmatic only 38 818+735*** 64-2662
lb matched non-atopic for group 1 38 263 ± 162 5-694
2a asthmatic with eczema 21 574 + 648** 26-3100
2b matched non-atopic for group 2 21 194 +103 5-384
3a eczematous 22 883 + 766*** 58-2887
3b matched non-atopic for group 3 22 241+138 45-537
* * *
* *
* * *
mean value of group la was significantly different from that of group lb 
mean value of group 2a was significantly different fi*om that of group 2b 
mean value of group 3a was significantly different fi-om that of group 3b
Table 5.6 Anti-p iactoglohulin IgG concentrations (pg/ml) in serum of 
asthmatic only, asthmatic with eczema, eczematous adults and their matched for 
gender and age healthy non-atopic adults.
(Mean+standard deviation and ranges)
Study group (Adults) Number Anti-p-Iactoglobulin IgG (pg/ml)
Mean + SD Range
la asthmatic only 38 156 + 439** 2-2705
lb matched non-atopic for group 1 38 37 + 48 2-210
2a asthmatic with eczema 21 61 + 68 5-292
2b matched non-atopic for group 2 21 46.1 + 54 2-210
3a eczematous 22 96 +129* 8-516
3b matched non-atopic for group 3 22 39 ±48 5-210
* *
*
mean value of group la was significantly different fi-om that of group lb 
mean value of group 3a was significantly different from that of group 3b
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Figure 5.2. Anti-ovalbumin IgG concentrations (pg/ml) in asthmatic only, 
asthmatic with eczema, eczematous adults and their matched for age and gender 
healthy non-atopic adults
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O  Atopic-1000
la*** Ih 2a** 2b 3a*** 3b
la  = asthmatic only n=38 Ih = matched non-atopic for group la  n=38
2a = asthmatic with eczema n=21 2h = matched non-atopic for group 2a n=21
3a = eczematous n=22 3h = matched non-atopic for group 3a n=22
*** mean value of group 1 was significantly higher fi-om that of group la 
mean value of group 2 was significantly higher fi-om that of group 2a 
mean value of group 3 was significantly higher fi-om that of group 3a
* *
* * *
Figure 5.3. Anti-g-lactoglohulin IgG concentrations (pg/ml) in asthmatic only, 
asthmatic with eczema, eczematous adults and their matched for gender and age 
healthy non-atopic adults
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3a = eczematous n=22 3h = matched non-atopic for group 3a n=22
** mean value of group la was significantly higher from that of group lb
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Figure 5.4. Anti-p-lactoglobulin IgG concentrations (^g/ml) in asthmatic only, 
asthmatic with eczema, eczematous adults and their matched for gender and age 
healthy non-atopic adults
Figure 5.4. is modified from Figure 5.3. The highest value o f anti-p-lactoglobulin 
IgG concentration (2705 jug/ml) is excluded to enable a better view o f the 
distribution o f antibody concentrations in the lower range
O 2705 |a.g/ml
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la = asthmatic only n=38 lb= matched non-atopic for group la n=38
2a = asthmatic with eczema n=21 2b = matched non-atopic for group 2a n=21
3a = eczematous n=22 3b = matched non-atopic for group 3a n=22
** mean value of group la was significantly higher from that of group lb
* mean value of group 3a was significantly higher from that of group 3b
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5.3.3 Questionnaire analysis
5.3.3.1 History of atopy
Figure 5.5 shows the presence of atopic conditions in families of the asthmatic only, 
asthmatic with eczema and eczematous groups. A family history of atopic conditions 
such as asthma, eczema, hay fever and urticaria was present in 84% of asthmatics 
only, 81% of asthmatics with eczema and 91% of eczematous adults. Seven 
asthmatics only, 4 asthmatics with eczema and 2 eczematous adults reported that they 
were unaware of the presence of any atopic conditions listed in the questionnaire 
(asthma, eczema, urticaria, hay fever, other allergies) in their close family members. 
Sixty one per cent of asthmatic only, 57% of asthmatic with eczema and 90% of 
eczematous adults, reported that asthmatic conditions did exist in their close families. 
Similarly, 63% of asthmatic, 52% of asthmatic with eczema and 55% of eczematous 
adults claimed having close family members with allergic rhinitis. Eczema was 
present in 29% of asthmatics only, 62% of asthmatics with eczema and 77% of 
eczematous adults. Urticaria was present in less than 20% of close family members of 
all the atopic groups. All matched controls had no personal or family history (close 
family members) of any atopic conditions or any forms of adverse reactions.
Figure 5.6 shows the numbers and percentages of the 3 atopic groups reported as 
having allergic reactions to the environmental allergens. More than ninety per cent of 
the asthmatic and asthmatic with eczema groups compared with only 55% of 
eczematous adults reported being affected by one or more environmental allergens. 
All 3 groups appeared to be affected mostly by grass pollen, followed by furry 
animals, house dust, tobacco smoke, strong fumes and car exhaust fumes. They were 
least affected by foggy weather, moulds and house dust mites. All matched control 
groups reported not being affected by any of the environmental allergens.
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Figure 5.5. Presence of atopic conditions (asthma, eczema, urticaria and 
allergic rhinitis) in close family members of the asthmatic only, asthmatic with 
eczema and eczematous adults
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Figure 5.6. Allergic reactions to environmental allergens in asthmatic only, 
asthmatic with eczema and eczematous adults
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5.3.3.2 History of food allergy
Table 5.7 shows the reported frequency of adverse reactions to food including eggs, 
milk, wheat, peanuts, beans, fish, shellfish, spinach, fruits and drinks in the atopic 
groups. All control groups reported no “adverse reactions to food or drinks. Fifty-five
180
per cent of the asthmatic only, 57% of the asthmatic with eczema and 41% of the 
eczematous groups reported adverse reactions to foods and/or drinks. Of the 81 atopic 
adults (combining all atopic groups), 5 (6%) claimed to be adversely “affected” by 
eggs; 10 (12%) “affected” by milk; 2 (3%) had “adverse reactions” to wheat; 4 (5%) 
had peanut “allergy”; 5 (6%) “affected” by seafood, 3 (4%) had “adverse reactions” 
to spinach; 4 (5%) were “affected” by oranges, 3(4%) were “affected” by lemons and 
5(6%) had “adverse reactions” to cordials (see Table 5.7). Other foods reported to 
cause adverse reactions in 1% (1 of 81) of the subjects included foods such as 
benzoate, garlic and pork. All control groups reported no adverse reactions to any of 
the foods or drinks.
Table 5.8 shows the number of food and/or drinks affecting the asthmatic only, 
asthmatic with eczema and eczematous groups. It appeared that the majority of those 
who claimed having adverse reactions to food were affected by either one type or two 
types of food/drink.
Table 5.7. “Adverse reactions” to various food allergens in asthmatics, 
asthmatics with eczema and eczematous adults
Type of food/drink Study groups (Atopic adults) n (%)
Asthmatic only 
n = 38
Asthmatic with 
eczema n= 21
Eczematous 
n = 22
Combined all 3 
groups n = 81
Food/drink 21(55) 12(57) 9(41) 42(52)
Egg 1(3) 2(10) 2(9) 5(6)
Milk 5(13) 1(5) 4(18) 10(12)
Wheat 1(3) 0 1(5) 2(3)
Peanut 2(5) 1(5) 1(5) 4(5)
Bean 0 1(5) 0 1(1)
Fish 0 0 1(5) 1(1)
Seafood 2(5) 1(5) 2(9) 5(6)
Spinach 2(5) 0 1(5) 3(4)
Orange juice/drink 2(5) 1(5) 1(5) 4(5)
Lemon drink 1(3) 2(10) 0 3(4)
Cordials 0 3(14) 2(9) 5(6)
n = number
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Table 5.8. Frequency of types of food and/or drink as reported by atopic 
subjects
Study groups n Frequency of types to food and drink
0 1 2 3 4
la  asthmatic only 38 22 10 5 0 1
2a asthmatic with eczema 21 10 6 4 0 1
3a eczematous 22 15 3 1 2 1
Asthmatics (la+2a) 59 32 16 9 0 2
Total (la+2a+3a) 81 47 19 10 2 3
n = number
5.3.3.3 Frequency of consumption of allergenic, alternative and preventive foods
Adult subjects were questioned on the frequency of consumption with regard to 13 
food items (eggs, milk, yoghurt, cheese, chocolate, soya milk, goats’ milk, peanuts, 
fresh fruit, fresh citrus fruit, fruit juice, fish, shellfish) and 2 supplements (vitamins 
and minerals). The foods were then placed into 8 categories i.e. eggs, milk and milk 
products, soya milk, goats’ milk, peanut, fiuit, fish, seafood and nutrient supplements 
as shown in Tables 5.9 - 5.16. As in the Child Observational Study (Chapter 3), these 
categories were chosen as they reflect potent allergenic and preventive foods.
There appeared to be no marked difference in the frequency pattern of consumption 
of allergenic foods in the atopic adults compared with the non-atopic adults (see 
Table 5.9-5.14). Seven atopic adults (1 asthmatic; 5 asthmatic with eczema and 1 
eczematous) reported not consuming any eggs and none of the atopic adults 
consumed eggs daily. However, no information was obtained with regard to 
consumption of foods that contained eggs. The majority of adults irrespective of 
atopic or non-atopic adults, reported that they consumed eggs 1-2 times per week (see 
Table 5.9). In contrast, as shown in Table 5.10, all subjects in this study (atopic or 
non-atopic) consumed milk and milk products (cheese, yoghurt, chocolate) and the 
majority reported that they consumed it daily. Alternative milk, such as soya milk, 
was consumed frequently by only 3 asthmatic only adults (daily by one adult and 3-5
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times per day by 2 adults) and 2 non-atopic adults (consumed 3-5 times per week). 
The majority of adults in all groups, reported not consuming soya milk at all (see 
Table 5.11). Similarly, goats’ milk was consumed by 2 eczematous adults (consumed 
rarely) and 2 non-atopic adults (consumed 1-2 times per week).
Although only 4 atopic adults reported being clinically diagnosed with peanut allergy, 
16 atopic adults (8 asthmatic only, 4 asthmatic with eczema, and 4 eczematous) 
claimed no consumption of peanuts at all. No information was obtained as to whether 
the 12 atopic adults who abstained from peanuts, avoided all foods containing peanuts 
(see Table 5.12). Tables 5.13 and 5.14 show the consumption of fish and seafood 
consumed by the atopic and non-atopic adults. The majority of atopic and non-atopic 
adults with the exception of eczematous adults consumed fish 1-2 times per week or 
rarely. Seafood (prawns or shellfish) was either not consumed at all or consumed 1-2 
times per week or rarely by the majority of adults. However, 37% (14) of the 
asthmatic only group claimed that they consumed seafood 3-5 times per week (see 
Table 5.14). This could possibly be due to the term “seafood” being interpreted as 
another family of fish.
All adult subjects consumed fi*uit. The majority of them reported consuming finit 
daily or 3-5 times per week (see Table 5.15). The majority of subjects (atopic and 
non-atopic) claimed not to take vitamin and mineral supplements although 46% (10) 
of eczematous adults claimed taking them daily (see Table 5.16).
The questionnaire revealed that 5 atopic subjects reported having adverse reactions to 
eggs which accounts for an incidence of 6% in this study (see Table 5.7 and 5.17). 
Analysis revealed that the mean anti-ovalbumin IgG concentration in these 5 subjects 
was 1175.8+723.6 pg/ml (range 779-1983) and it was found to be significantly higher 
statistically (P<0.05) than the mean anti-ovalbumin IgG concentration of 69 atopic 
adults (733.2±715.6 pg/ml, range 26-3100) who reported no adverse reactions to 
eggs. The mean anti-ovalbumin IgG concentration in the 69 atopic adults 
(733.2±715.6 pg/ml, range 26-3100) who reported no adverse reactions to eggs was
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comparable to the 7 atopic adults (870.1±919.8 pg/ml, range 215-2887) who were 
unsure if they had any adverse reactions to eggs.
Table 5.9. Frequency of egg consumption by asthmatic only, asthmatic with 
eczema, eczematous and their matched for gender and age non-atopic adults
Study groups (adults) n
Frequency of egg consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 3(8) 27(71) 7(18) 1(3)
lb matched non-atopic for group 1 38 1(3) 8(21) 23(61) 6(16)
2a asthmatic with eczema 21 2(10) 11(52) 3(14) 5(24)
2b matched non-atopic for group 2 21 1(4.8) 6(29) 10(48) 4(19)
3a eczematous 22 1(5) 14(64) 627) 1(5)
3b matched non-atopic for group 3 22 1(5) 4(18) 12(55) 5(23)
n = number
Table 5.10. Frequency of milk and milk products (cheese, yoghurt, chocolates) 
consumption by asthmatic only, asthmatic with eczema, eczematous and their 
matched for gender and age non-atopic adults
Frequency of milk consumption n(%)
Study groups (adults) n DaUy 3-5 times 
per week
1-2 times 
per week
Rarely
la asthmatic only 38 28(74) 5(13) 5(13)
lb matched non-atopic for group 1 38 28(74) 5(13) 5(13)
2a asthmatic with eczema 21 18(86) 2(10) 1(5)
2b matched non-atopic for group 2 21 16(76) 3(14) 2(10)
3a eczematous 22 21(96) 1(5)
3b matched non-atopic for group 3 22 17(77) 3(14) 2(9)
n = number
Table 5.11. Frequency of soya consumption by asthmatic only, asthmatic with 
eczema, eczematous and their matched for gender and age non-atopic adults
Frequency of yoghurt consumption n(%)
Study groups (adults) n Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 1(3) 2(5) 1(3) 2(5) 32(84)
lb matched non-atopic for group 1 38 1(3) 2(5) 3(8) 32(84)
2a asthmatic with eczema 21 1(5) 1(5) 19(91)
2b matched non-atopic for group 2 21 1(5) 2(10) 18(86)
3a eczematous 22 1(5) 21(96)
3b matched non-atopic for group 3 22 1(5) 3(14) 18(82)
n = number
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Table 5.12. Frequency of peanut consumption by asthmatic only, asthmatic 
with eczema, eczematous and their matched for gender and age non-atopic 
adults
Study groups (adults) n Frequency of peanut consumption n(%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 1(3) 1(3) 15 (40) 13 (34) 8(21)
lb matched non-atopic for group 1 38 2(5) 9(24) 19 (50) 6(16) 3(8)
2a asthmatic with eczema 21 1(5) 8 (38) 8(38) 4(19)
2b matched non-atopic for group 2 21 14(67) 6(28) 1(5)
3a eczematous 22 1(5) 2(9) 5(23) 10 (45) 4(18)
3b matched non-atopic for group 3 22 12 (55) 9(41) 1(5)
n = number
Table 5.13. Frequency of fish by asthmatic only, asthmatic with eczema, 
eczematous and their matched for gender and age non-atopic adults
Study groups (adults)
3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 6(16) 22 (58) 8(21) 2(5)
lb matched non-atopic for group 1 38 4(11) 26 (68) 7(18) 1(3)
2a asthmatic with eczema 21 13 (62) 6(28) 2(10)
2b matched non-atopic for group 2 21 3(14) 12(57) 5(24) 1(5)
3a eczematous 22 4(18) 8(36) 8 9(36) 2(9)
3b matched non-atopic for group 3 22 17(77) 3(14) 2(9)
n = number
Table 5.14. Frequency of seafood by asthmatic only, asthmatic with eczema, 
eczematous and their matched for gender and age non-atopic adults
Study groups (adults) n Frequency of seafood consumption n(%)
3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 14(37) 11 (29) 4(11) 9(24)
lb matched non-atopic for group 1 38 1(3) 10(26) 19 (50) 8(21)
2a asthmatic with eczema 21 5(24) 8(38) 8(38)
2b matched non-atopic for group 2 21 1(5) 7(33) 7(33) 6(29)
3a eczematous 22 4(18) 6(27) 6(27) 6(27)
3b matched non-atopic for group 3 22 7(32) 9(41) 6(27)
n = number
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Table 5.15. Frequency of fruit (fruit juice and/or fresh fruit) consumption by 
asthmatic only, asthmatic with eczema, eczematous and their matched for 
gender and age non-atopic adults
Study groups (adults) Frequency of fruit consumption n(%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely
la asthmatic only 38 22(58) 10(26) 5(13) 1(3)
lb matched non-atopic for group 1 38 16 (42) 12 (32) 9(24) 1(3)
2a asthmatic with eczema 21 14(67) 4(19) 2(10) 1(5)
2b matched non-atopic for group 2 21 8(38) 9(43) 3(14) 1(5)
3a eczematous 22 14(67) 6(27) 2(9)
3b matched non-atopic for group 3 22 7(32) 11 (50) 4(18)
n = number
Table 5.16. Frequency of vitamin & mineral supplement by asthmatic only, 
asthmatic with eczema, eczematous and their matched for gender and age non- 
atopic adults
Study groups (adults) Frequency of vitamin supplement & mineral 
consumption n (%)
Daily 3-5 times 
per week
1-2 times 
per week
Rarely None
la asthmatic only 38 11 (29) 2(5) 2(5) 4(10) 19 (50)
lb matched non-atopic for group 1 38 10(26) 4(11) 1(3) 23 (61)
2a asthmatic with eczema 21 5(24) 1(5) 3(14) 12(57)
2b matched non-atopic for group 2 21 3(14) 4(19) 1(5) 13 (62)
3a eczematous 22 10 (46) 2(9) 2(9) 2(9) 6(27)
3b matched non-atopic for group 3 22 2(9) 4(18) 1(5) 15(68)
n = Number
Table 5.17. Anti-ovalbumin IgG concentrations (pg/ml) in groups of atopic 
adults with, without and those unsure of any adverse reaction to egg
(Mean+standard deviation, ranges)
Study group (atopic adults): Number Anti-ovalbumin IgG (pig/ml)
Mean ± SD Range
With adverse reaction to eggs 5 1175.8 ± 723.6* 779-1983
Without adverse reaction to eggs 69 733.2 + 715.6 26-3100
Unsure of any adverse reaction to eggs 7 870.1+ 919.8 215-2887
mean value of atopic adults with adverse reactions to eggs was significantly different 
from that of atopic adults with no adverse reaction to eggs
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5.3.4 Specific food antibody levels in asthmatic children and adults
Results for this section are derived from Chapter 3, Section 3.3.4 (Children 
Observational Study) and Chapter 5, Section 5.3.2 (Adult Observational Study). This 
section compares the results of the specific food IgG antibody levels for ovalbumin 
and p-lactoglobulin in children and adults for purposes of speculating and 
determining the normal reference values of the aforementioned food IgG antibodies in 
individuals. _________
5.3.4.1 Comparison of specific food antibody IgG levels between asthmatic 
children and adults
Tables 5.18-5.19, and Figures 5.7-5.8 show the comparison of specific food IgG 
antibody levels to ovalbumin and p-lactoglobulin in asthmatic children and adults. 
The mean anti-ovalbumin IgG concentrations in asthmatic children with no other 
atopic conditions was higher, though not significantly different statistically, than their 
counterpart adults’ which were 1704+1910 pg/ml and 81&+735 pg/ml, respectively. 
The mean anti-ovalbumin IgG concentrations in asthmatic children with other atopy 
was 1520+1395 pg/ml and this value was found to be statistically significant different 
(P<0.01) compared with that of the adults mean value of 574+648 pg/ml. The mean 
anti-ovalbumin IgG concentrations in asthmatic children with or without other atopy 
was significantly higher statistically than the adult values which were 1576±1552 
pg/ml and 731±709 pg/ml respectively (P<0.05).
The mean anti-p-lactoglobulin IgG concentrations in asthmatic children with no other 
atopic conditions (group 1) appeared to be higher (though not significantly different 
statistically) compared with that of the adult values which were 218±261 pg/ml and 
1561439 pg/ml, respectively. The mean anti-p-lactoglobulin IgG concentrations in 
asthmatic children with other atopy was 2241288 pg/ml, which was found to be 
significantly higher statistically (P<0.01) than the adult value of 61168 pg/ml. The 
mean anti-P-lactoglobulin IgG concentrations in asthmatic children with or without
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other atopy of 222+227 pg/ml was significantly higher statistically than the adult 
value of 122+355 pg/ml (P<0.01).
Table 5.18. Anti-ovalbumin IgG concentrations in asthmatic only, asthmatic 
with other atopy and asthmatic with other atopy unknown, children and adults
(Mean+standard deviation)
Study groups Anti-ovalbumin IgG (pg/ml) 
Children Adults
n Mean+SD n Mean+SD
I asthmatic only 15 1704+1910 38 818+735
2 asthmatic with other atopy 34 1520+1395** 21 574+648
3 asthmatic with other atopy unknown 22 - -
1+2 asthmatic with or without other atopy 49 1576+1552* 59 731+709
* *
*
mean value of group 2 (children) was significantly different from that of group 2 (adult) 
mean value of groups 1+2 (children) was significantly different from that of groups 1+2 
(adult)
Figure 5.7. Anti-ovalbumin IgG concentrations in asthmatic children and 
adults
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1 = asthmatic children with no other atopic conditions n=15
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4 = asthmatic adult with no other atopic conditions n=38
5 = asthmatic adult with other atopic conditions n=21
** mean value of group 2 was significantly different from that of group 5
188
Table 5.19. Antî-p-lactoglobulin IgG concentrations in children and adults 
with asthma only, with asthma and other atopy and with asthma but other atopy 
unknown
(Mean+standard deviation)
Study groups Anti-p iactoglobulin IgG (p,g/ml)
Children Adults
n Mean+SD n Mean+SD
1 asthmatic only 15 218.1+261.0 38 156+439
2 asthmatic with other atopy 34 223.8+287.6** 21 61+68
3 asthmatic with other atopy unknown 22 124.1+130.9 - -
1+2 asthmatic with or without other atopy 49 222+277** 59 122+355
* *
* *
mean value of group 2 (children) was significantly different from that of group 2 (adult) 
mean value of groups 1+2 (children) was significantly different from that of groups 1+2 
(adult)
Figure 5.8. 
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1 = asthmatic children with no other atopic conditions n=15
2 = asthmatic children with other atopic conditions n=34
3 = asthmatic children with other atopic conditions unknown n-22
4 = asthmatic adult with no other atopic conditions n=34
5 = asthmatic adult with other atopic conditions n=21
** mean value of group 2 was significantly different from that of group 5
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5.3.4 2 Comparison of specific food antibody IgG levels between non-atopic 
children and adults
Figures 5.9-5.10 show the specific food IgG antibody concentrations to ovalbumin 
and p-lactoglobulin in 19 non-atopic children and 49 non-atopic adults. Table 5.20 
shows the anti-ovalbumin IgG and anti-p-lactoglobulin IgG concentrations in 19 non- 
atopic children and 49 non-atopic adults. The normal reference values for anti­
ovalbumin IgG concentrations and anti-p-lactoglobulin IgG concentrations are 
calculated based on Mean±2SD (Varley et 1980). This formula is then used as a 
basis for speculating the normal reference values. The calculated normal reference 
range for anti-ovalbumin IgG concentration are equal to or less than 920 pg/ml for 
children and equal to or less than 558 pg/ml for adults. Although one non-atopic child 
had an anti-ovalbumin IgG value of 1422 pg/ml, and appeared to be an outlier (see 
Figure 5.9), this value is accepted on the basis of no personal or family history of any 
atopic conditions (see also Section 3.4.1). The calculated normal reference range for 
anti-p-lactoglobulin IgG concentration are equal to or less than 210 pg/ml for 
children and equal to or less than 130 pg/ml for adults.
Figure 5.9. Anti-ovalbumin IgG concentrations (pg/ml) in non-atopic children 
(n=19) and adults (n=49)
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Figure 5.10, Anti-p-lactoglobulin IgG concentrations (|ig/ml) in non-atopic
children (n=19) and adults (n=49)
300
O)
200
1 0 0 'o>
o>
O Adults 
O Children<  -100
Table 5.20. Speculated normal reference values for anti-ovalbumin IgG and 
anti-p-lactoglobulin IgG concentrations (pg/ml)
(Mean±standard deviation)
Non-atopic Anti-ovalbumin IgG (pg/ml) Anti-p-lactoglobulin IgG (|ig/ml)
Mean±SD Speculated reference 
normal value (Meanl2SD)
MeanlSD Speculated reference 
normal value (Meanl2SD)
Children n=19 3001310 UD-920 66172 UD - 210
Adult n=49 2501154 UD-558 40145 UD - 130
UD = undetected
5.3.4.3 Prevalence of adverse reactions to foods using proposed normal reference 
range of specific food IgG antibodies.
Table 5.21 shows the comparison of prevalence of adverse reactions to foods based 
on clinical history and specific food IgG antibody concentrations. In the 
questionnaire, of the 6 children who reported having adverse reactions to eggs, 4 
(67%) appeared to be confirmed as using anti-ovalbumin IgG concentrations of 
values undetected (UD) - 920 pg/ml as the speculated normal reference range.
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However, of the 65 asthmatic children who reported having no adverse reactions to 
eggs, 31 (48%) appeared to have anti-ovalbumin IgG concentrations more than the 
speculated normal reference values. The speculated normal reference values for anti- 
ovalbumin IgG concentrations are between UD (undetected) - 558 pg/ml in adults. In 
the adult asthmatic subjects, all those claiming adverse reactions to eggs (5 adults) 
had anti-ovalbumin IgG concentrations above than the speculated normal reference 
range of UD - 558 pg/ml. Of the 69 adult asthmatics who reported no adverse 
reactions to eggs, 40 (58%) had lower anti-ovalbumin IgG concentrations and 29 
(42%) had values higher than the proposed normal reference values. Of the 7 
asthmatic adults who were unsure of any adverse reactions to eggs, 4 (57%) had 
values higher than 558 pg/ml.
In the questionnaire, of the 12 children who reported having adverse reactions to 
milk, 5 (42%) appeared to be confirmed as using anti-P-lactoglobulin IgG 
concentrations of values of UD - 210 pg/ml. However, of the 59 asthmatic children 
who reported having no adverse reactions to milk, 16 (27%) appeared to have anti-p- 
lactoglobulin IgG concentrations more than the proposed normal reference range. The 
proposed normal reference range for anti-P-lactoglobulin concentrations are UD - 210 
pg/ml.
Of the 10 adult asthmatics who claimed having adverse reactions to milk, only 2 
(20%) had anti-p-lactoglobulin IgG concentrations higher than the speculated normal 
reference range of UD - 130 pg/ml. Of the 67 adult asthmatics who reported no 
adverse reactions to milk, 53 (79%) adults and 14 (21%) adults had anti-p- 
lactoglobulin IgG concentrations lower and higher, respectively than the speculated 
normal reference values. Of the 4 asthmatic adults who were unsure of any adverse 
reactions to milk, all had values lower than 210 pg/ml. Adverse reaction to milk was 
confirmed in only 20% of adults using speculated normal reference values of anti-P- 
lactoglobulin IgG.
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Table 5.21. Comparison between self-perceived adverse reactions to eggs and 
milk compared with the proposed normal values of the specific food IgG 
antibodies in atopic children and adults
Self-perceived adverse 
reactions to foods
Food specific IgG antibodies
Anti-ovalbumin IgG 
concentration (pg/ml)
Anti-p-lactoglobulin IgG 
concentration (pg/ml)
Children: n <920 >920 n <210 >210
with reaction to foods 29 12 (41%) 17 (59%) 29 19 (66%) 10 (35%)
no reaction to foods 42 24 (57%) 18 (42%) 42 31 (73%) 11 (26%)
Total 71 36 35 71 50 21
with reaction to eggs 6 2 (33%) 4 (67%)
no reaction to eggs 65 34 (52%) 31 (48%)
Total 71 36 35
with reaction to milk 12 7 (58%) 5(42%)
no reaction to milk 59 43 (73%) 16 (27%)
Total 71
Adults: n <558 >558 n <130 >130
with reaction to foods 42 26 (62%) 16 (38%) 42 34 (81%) 8 (19%)
no reaction to foods 39 17(44%) 22 (56%) 39 31 (80%) 8 (20%)
Total 81 81
with reaction to eggs 5 5 (100%)
no reaction to eggs 69 40 (58%) 29 (42%)
Total 81
with reaction to milk 10 8 (80%) 2 (20%)
no reaction to milk 67 53 (79%) 14 (21%)
Total 81
n = number
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5.4 Discussions
5.4.1 Recruitment of subjects and controls
Recruitment of subjects on the University premises appeared to be slow at the initial 
phase of the recruitment period. Responses were poor to the University newsletter, 
Student Union flyers and posters placed at every available notice board around the 
University premises. Responses through personal contact were successful, however 
the numbers were insufficient (37 subjects) compared with the calculated sample size 
of 101 (see Section 5.2.1). The poor response of volunteers to advertisements could 
be for the following reasons: 1) students and staff expected some form of monetary 
incentive as the majority of advertisements in the University for research purposes 
offered remuneration to volunteers and 2) there were too many notices on the boards 
to attract any attention.
Recruitment of matched for gender and age controls was equally difficult on the 
University premises. Initially 37 matched controls (no personal history of asthma and 
eczema) were successfully recruited through personal contacts. Preliminary analysis 
on anti-ovalbumin IgG and IgE; anti-p-lactoglobulin IgG and IgE were carried out. It 
was found that the majority of the matched healthy controls had equally high levels of 
the aforementioned antibodies as the atopic groups.
The questionnaires were scrutinised and revealed that 23 “controls” either had 
personal histories of allergic rhinitis or a family history of asthma; eczema; allergic 
rhinitis; urticaria; adverse reactions to penicillin, nickel, environmental allergens, 
food allergens and so forth. These 23 “controls” were removed from the study. It is 
important that the controls recruited should be free from any personal or family 
history of atopic conditions as this study firstly  ^ aims to observe if there is any 
difference between the food specific IgG antibody in subjects with either asthma 
and/or eczema versus the non-atopic controls, and secondly, aims to establish a 
normal range for specific food IgG antibodies to act as an alternative marker or
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screening tool for food allergy. Any form of adverse reaction or allergy present in the 
control subjects, or their close family, may alter or give false cut-off values to the 
specific food antibody levels. It may be possible that some controls have no 
knowledge of the existence of any family history of allergies or adverse reactions (in 
themselves or in their close families), equally, they or members of their close family 
may have atopic constitutions, but no manifestation of the conditions. To improve the 
methodology for future studies, all controls should undergo a combined interview 
sessions with the questionnaire, skin prick testing and total IgE to confirm their non- 
atopic status.
The researcher also approached the University of Surrey Student Health Centre to 
obtain lists of students with asthma and eczema, but this was rejected for confidential 
reasons. The nursing staff suggested leaving flyers in the Health Centres but the 
researcher was not convinced that this method would be successful. By chance, the 
researcher found a flyer posted in the library requesting blood donor volunteers. The 
researcher then contacted the South London Blood Transfusion Team Co-ordinator 
who kindly agreed to let the Blood Donor Team take an extra 5 ml of blood from 
volunteer donors who met the criteria for this study on the premises of the University 
of Surrey, on the understanding that their workload was not interrupted. The National 
Blood Donor Unit, of the South London Blood Transfusion Services, comes twice a 
year to the University of Surrey. This strategy proved to be an effective method of 
subject and control recruitment. Care had to be taken to avoid recruiting the same 
subjects and/or controls on the subsequent visits.
A total of 81 clinically diagnosed asthmatic and eczematous adults (21 males and 69 
females) were recruited. Sixty-two “clean controls” were successfully recruited but 
only 44 were accepted as they matched for gender and age (within 5 years). The 
blood donor team suggested that the researcher should follow them and continue the 
recruitment of subjects and controls in the vicinity of Guildford. However, this was 
not possible as ethical approval was obtained only on the University of Surrey
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premises. In future, further research with a larger sample size could be extended to 
the Guildford area via the Blood Transfusion Team.
Initially, the study intended to include other analyses such as total IgE and specific 
food IgE antibodies to ovalbumin and P-lactoglobulin. However, after the preliminary 
analysis, it was discovered that the majority of the 37 atopic subjects had negative 
(grade 0) or equivocal (grade 1) results for anti-ovalbumin IgE and anti-P- 
lactoglobulin IgE. Further testing of total IgE and food specific IgE was therefore not 
carried out. Thus preliminary results of these tests in the 37 atopic adults were not 
included in the analysis of the Adult Observational Study.
The sample size calculation of numbers needed appeared to be over-estimated (see 
Section 5.2.1). As discussed in the Child Observational Study (Section 3.4.1, Chapter 
3), an estimation of a minimum difference of 300-500 pg/ml of the anti-ovalbumin 
IgG concentrations between the means of the 2 groups of asthmatic adults and non- 
atopic adults would have sufficed to make a statistically significant difference. As 
estimated, a minimum difference of 200 pg/ml of anti-ovalbumin IgG concentrations 
between the two groups was too conservative and led to an unnecessary over­
estimation of sample size. However, the standard deviations of the specific food IgG 
antibodies were large for both of the Children and Adults Observational Studies. A 
larger sample size would be required in future studies to confirm and establish rnd the 
normal reference range for diagnostic purposes that can be extrapolated to the 
population. In addition, a larger sample size will provide a more accurate normal 
reference range, and a smaller standard deviation for specific food IgG antibodies.
5.4.2 Incidence of adverse reactions to food
The prevalence of food-induced asthma is not known. Reports differ considerably 
because of the controversy that exists about food intolerance and food allergy 
(Novembre et al., 1988). The differences in the prevalence of food-induced asthma in 
adults range from 0.5% to 57%, thus some investigators estimate food induced 
asthma to be a very frequent phenomenon, whereas others consider it to be
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insignificant (Pelikan & Pelican-Filipek, 1987; Onorato et al., 1986; Young et al., 
1994). In the present study, based on subjects’ perception of adverse reactions to 
foods, 42% (34 of 81) of the atopic adults (combining the 3 atopic groups) reported 
having adverse reactions to either foods and/or drinks which induced asthmatic 
episodes and aggravated the eczema condition. This result appeared to be in the 
higher range of those reported.
Results revealed that 5.3% (2 of 38) of asthmatics only; 4.8% (1 of 21) of asthmatics 
with eczema; 9.1% (2 of 22) of eczematous adults currently avoided the foods and/or 
drinks affecting either their asthma or eczema. In contrast, a higher percentage of 
subjects, in the past avoided foods and drinks i.e. 7.9% (3 of 38) of asthmatic only 
and 18.2% (4 of 22) of eczematous adults. The asthmatic adults with eczema reported 
no avoidance of foods and/or drinks in the past.
The findings in the present study obtained through questionnaires showed that despite 
the few subjects who claimed to avoid foods and/or drinks for their atopic conditions, 
only one asthmatic adult [1.7%; (1 of 59) (asthmatic only and asthmatic with eczema 
adults)] and one eczematous adult [2.3%; (1 of 43) (asthmatic with eczema and 
eczematous adults)] reported that his/her asthma or eczema improved with dietary 
avoidance. No information was gathered in relation to the duration of iW abstinence 
from foods. The child dietary intervention study, as discussed in Chapter 4 revealed 
that, the asthma condition of the children improved after an 8 week period of the 
avoidance of potent food allergens.
It is possible that the adult subjects at some point prior to the recruitment of this study 
avoided a suspect food or foods to improve either their asthma or eczema, but as 
improvement was not apparent, subjects could have been deterred from continuing 
this self avoidance. The majority of atopic adults who avoided food and/or drinks 
were either self-motivated or did so on their family’s advice. Only one asthmatic and 
one eczematous adult (at the time of recruitment), and 1 asthmatic and 4 eczematous 
adults (in the past), reported being advised to avoid a suspected food by their doctor.
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Young et al. (1994) also reported that a substantial number of severe adverse 
reactions to food had been self-managed without seeking medical advice.
Doctors are perceived to be an authority on the health of individuals. However, our 
understanding of adverse reaction to food in relation to treatment is still in its infancy 
and considered as one of least priority in preventive medicine unless involving 
anaphylaxis. The majority of clinicians is not convinced that diet plays a role in the 
treatment of asthma, and this may reflect their indifferent attitudes towards the 
complaints of patients in relation to any adverse reaction to foods. Moreover, self­
motivated patients on an elimination diet may not have sufficient knowledge with 
regard to eliminating the offending food in their diet. Dietitians play an important role 
involving any form of elimination diet. Any form of elimination diet has a tendency 
to be inadequate in certain nutrients. In addition, elimination diets can themselves 
impose considerable physical and emotional strain on the individual and the family. 
Major difficulties can range fi*om purchasing to preparation of meals and social 
isolation as meals cannot be consumed away fi*om home. Thus, the dietitian is 
required to assess the patients’ nutritional status, requirements and provide 
appropriate alternative choice to the individual for an adequate diet.
5.4.3 Adverse reactions to food versus environmental allergens
The majority of the atopic adults reported being affected by environmental allergens. 
In contrast less than 50% of atopic adults reported being affected by food allergens. 
Adverse reactions to milk appeared to be at the top of the list of the offending foods, 
followed by eggs, shellfish, cordials, peanuts and orange juice/drink. The incidence of 
adverse reactions to the aforementioned food in this study was observed to be 
between 5% and 14%.
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5.4.4 Food specific IgG antibody levels in adults
Anti-ovalbumin IgG and anti-p-lactoglobulin IgG were detected in all atopic and 
healthy non-atopic subjects. This finding is not in agreement with other previous 
studies. Morris (1991) and Husby et M. (1985) observed that anti-ovalbumin IgG was 
detected in 90% of subjects whereas Barnes et al. (1983) reported that the antibody 
was detected in only 10% of the subjects studied. This difference could be due to the 
different assays employed, and the sensitivity of each assay may differ considerably.
Wide ranges of specific antibodies against ovalbumin and P-lactoglobulin were 
observed in all groups studied; generally the level of anti-ovalbumin IgG was higher 
than that of anti-p-lactoglobulin IgG concentration. The highest level of anti- 
ovalbumin IgG in this study was 3100 pg/ml although the individual concerned 
reported no adverse reactions to eggs. Adverse reactions to eggs was reported in 5 
atopic individuals and their anti-ovalbumin IgG concentration ranged fi*om 779-1983 
pg/ml. The 5 atopic subjects with “adverse reactions” to eggs had anti-ovalbumin IgG 
levels higher than the highest levels of healthy non-atopic subjects (694 pg/ml). The 
highest level of anti-P-lactoglobulin IgG in this study was 2700 pg/ml and the 
individual concerned reported no adverse reactions to milk. The 11 atopic subjects 
who reported having adverse reactions to milk had mean anti-P-lactoglobulin IgG 
concentrations of 70±52 pg/ml (range of 14-177), which was observed to be lower 
than those who reported no adverse reaction to milk (mean 124+335 pg/ml, range 2- 
2705).
Bames et d . (1983), reported that a proportion of healthy non-atopic individuals may 
be genetically high responders to dietary antigens presented via the gut although, no 
manifestation was observed of any atopic conditions in the individual or close family 
members. This could possibly be the explanation for the high levels observed in 
several healthy non-atopic individuals or in atopic individuals with no manifestation 
of signs or symptoms of adverse reaction to eggs. Firer et al. (1981), commented that 
the presence of specific food antibodies appears to reflect immune responses, with
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symptoms occurring if values fall above or below a threshold level. To date, no 
threshold values have been published. In addition, each individual may respond to 
different threshold values depending on genetic predisposition and constant exposure 
to specific allergens. High antibody concentrations in hypersensitive individuals may 
indicate differences in: (1) permeability, or (2) immunological reactivity of the gut 
(May, 1977). Finn et d . (1985) suggested that the elevated food antibody 
concentrations in individuals with food allergy and eczema are due to an increased 
permeability of the gut in these subjects.
Businco et d . (1995) suggested that inhaled food allergens may reach the respiratory 
tract directly by inhalation. Food allergens, raw or cooked, may also reach the 
respiratory organ after ingestion, digestion, uptake through the intestinal mucosa and 
absorption into the bloodstream. All these steps may interfere with the 
immunogenicity and allergenicity of foods. Consequently, allergenic determinants 
may be destroyed, or hidden allergenic epitopes may be exposed. The immunogenic 
and allergenic potency of foods may thus be reduced or increased. Ordinarily, the 
amount of antigens penetrating the mucosa and the triggered immune response may 
not be sufficient to produce clinical symptoms. However, the mucosal barrier to 
antigen absorption is weakened by disease or immunologic deficiency, thus allowing 
large amounts of antigen penetration which may lead to symptomatic reactions (May 
& Bock, 1978). Businco et al. (1995), also suggested that individuals with food 
allergy my have coexisting inhalant allergies or other specific triggers such as 
pollutants, smoking, or psychological triggers such as emotions.
Foods may induce respiratory symptoms involving noreaginic mechanisms. For 
example, food substances such as eggs, milk, nuts, chocolates, and food additives 
(sulphites, benzoate, tartrazine) may cause wheezing in individuals with asthma, but 
not elicit an oral challenge reaction when ingested. These substances may enhance 
airway reactivity instead of directly provoking airway obstruction. Once airway 
reactivity is enhanced, other common triggers of asthma, such as cold air or drinks,
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exercise or other environmental factors, could readily precipitate acute 
bronchoconstriction.
5.4.5 Normal reference values for specific food antibody levels in asthmatic 
children and adults
The studies in Chapters 3 and 5 were observational, examining the specific food 
antibody IgG levels in asthmatic children and adults respectively. Results of Chapters 
3 and 5 observational studies showed statistically significantly higher food specific 
IgG to ovalbumin IgG and p-lactoglobulin IgG concentrations in asthmatic children 
and adults compared with those subjects with no history of atopy. A wide variation in 
the concentrations of specific food antibodies to ovalbumin IgG and P-lactoglobulin 
IgG in serum of asthmatic children and adults was observed between and within the 
individuals. In addition, the immune response for ovalbumin is greater than p- 
lactoglobulin in the majority of individuals irrespective of being atopic or non-atopic. 
This finding is in agreement with studies of Gallagher et d . (1983), Morris (1991) 
and Lovegrove (1991). The reasons for this great variation are partly due to the 
resistance of food proteins to enzymatic degradation during the digestion process and 
the degree of antigenicity of the different food protein and has been discussed in 
detail in Chapter 3 (see Section 3.4.2).
In general, both specific food IgG antibody levels for ovalbumin and p-lactoglobulin 
were higher in the asthmatic children compared with that of the asthmatic adults (see 
Figures 5.7-5.9). The asthmatic adults with no other atopic conditions appeared to 
have both the anti-ovalbumin IgG and anti-P-lactoglobulin IgG concentrations higher 
than in the asthmatic groups with eczema. However, this picture is the reverse for the 
paediatric groups. This difference could be attributed to the presence of an active 
eczema condition in the children (Atherton, 1983). Eczema is reported to improve 
with age (Cant, 1991). According to Cant (1991), eczema usually starts in the first 
year of life. Approximately 12 per cent of pre-school children suffer from eczema 
(Taylor et al., 1984). In only 5 per cent of cases does eczema continue into adult life
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(Atherton, 1982). Although the question posed if the subject (children and adults) had 
eczema, no specific information was asked if the eczema condition was active at the 
time of recruitment. We can safely assume that the eczema is active in young children 
but we cannot assume this in adult subjects recruited. This could possibly be the 
reason for the high levels of specific food antibodies observed in the asthmatic 
children with eczema but not in adults compared with their counterparts who had 
asthma alone.
Results in this study showed the potential possibility of using the anti-ovalbumin IgG 
values as a screening tool in atopic subjects as the next step towards diagnosing 
“adverse reactions” to foods after clinical history. Those individuals with high values, 
possibly above 1,000 pg/ml of anti-ovalbumin IgG should further undergo the “gold 
standard” DBPCFC method to confirm the diagnosis of “adverse reactions to foods”.
Further work should be undertaken using a larger number of healthy non-atopic 
children of various age groups as well as adults to confirm the speculated reference 
for normal values of the food specific IgG antibody.
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Chapter 6 
Final discussions, recommendations and conclusions
6.0 Introduction
Food and the events in relation to its preparation and provision, satisfy both emotional 
and biological needs. The mother who feeds her child is expressing her love, and the 
provision of food is a basic feature of parental care. Food provides gratification and is 
associated with celebration and joy, because food plays a crucial and central role in 
life, a vast number of conditioning factors can affect attitudes to food, both normally 
and abnormally. These attitudes often condition an individual’s perception concerning 
those foods which they enjoyed, those which are disliked, those which are 
unacceptable or forbidden for religion reasons, and those which may cause unpleasant 
consequences such as ‘adverse reaction’.
Adverse reactions to foods after consumption of a specific food which involves an 
immune response, is alternatively called “food allergy ”. Clinical expressions range 
from abdominal pain and urticaria to anaphylaxis. These extreme clinical variabilities 
are the result either of the action of food directly on the gastrointestinal tract or of its 
absorption and subsequent action on organs such as the skin or the lungs. An adverse 
reaction to food is closely associated with atopic dermatitis, acute urticaria, 
gastrointestinal reactions, and acute systemic anaphylaxis, but its role in asthma 
appears to be less well established. Currently, asthma is considered nmisiif^ l in food- 
hypersensitive individuals, and asthma as a umque symptom of food allergy is rare 
(Cant, 1988; Husby et al., 1993; Buscinco et al., 1995).
Diagnosis of food allergy has been impeded because of the lack of consensus in 
relation to the definition and agreement of a simple diagnostic or screening method. 
The DBPCFC which is currently considered as the ‘gold-standard’, because it is the 
most objective method of food allergy diagnosis (May, 1976; Bock et al., 1988;
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Pastorello, 1995) requires trained personnel and clinical emergency support while 
carrying out the procedure. SPT has to be performed by experienced trained 
personnel and has to be carried out in specialist centres for allergies (Levy, 1997). 
However, measurements of total IgE and specific IgE antibodies through RAST or 
CAP are expensive (de Week, 1996). A clinical history of food allergy on its own is 
questionable, as it may reflect human attitudes to foods.
For progress in ‘food allergy’ to occur, studies carried out as part of this thesis 
examine the use of employing the novel ‘in-house’ ELISA technique to measure food 
specific IgG antibodies to eggs and milk, developed by previous students of the 
University of Surrey (Lovegrove, 1991; Morris, 1991) as an alternative diagnostic or 
screening tool for ‘food allergy’. Secondly, studies in this thesis set out to address and 
provide an opportunity to describe the role of dietary intervention in the treatment of 
asthma, i.e. the potential benefits of advocating a diet devoid of milk and eggs to 
reduce episodes of asthma, thus improving the well-being of asthmatic children.
6.1 Adverse reactions to foods and antibody levels in asthmatic children and 
adults
Although, several studies show little or no association of asthma with adverse 
reactions to food (Cant, 1988; Husby et d., 1993; Buscinco et al., 1995), Novembre 
et (1988) however, was convinced that food plays a role in manifesting respiratory 
symptoms in asthmatic children. He reported that 9.2% (13 of 140) of asthmatic 
children had respiratory symptoms (immediate or delayed-onset asthma) afi;er an 
open-food challenge test. Bock & Atkin (1990) also reported that respiratory 
manifestations i.e. asthma (wheezing) as the sole manifestation of an adverse reaction 
to food does exist, but less fi*equently compared with those induced by environmental 
allergens. Of the 408 children studied by Bock & Atkin (1990), only four asthmatic 
children with no other atopic condition (1%) showed positive reactions to DBPCFC. 
However, wheezing, Avith gastrointestinal or cutaneous symptoms, occurred in 8.8% 
(36 of 408) of children aged between 3 months and 19 years old. Of these 36
204
children, 64% had either active atopic dermatitis or a history of atopic dermatitis. The 
most frequently offending foods were milk, eggs, and peanuts. (Metcalfe, 1984; 
Sampson, 1992; Novembre et al., 1988; Bock & Atkin, 1990).
Studies in Chapter 3 (Child Observational Study) and Chapter 5 (Adult Observational 
Study) show that the prevalence of adverse reactions to food obtained from the 
questionnaire in asthmatic children and in asthmatic adults falls in the higher range of 
those reported by other investigators (Onorato et al., 1986; Pelikan & Pelican-Filipek, 
1987). This finding was not totally unexpected as clinical history or self-perceived 
adverse reactions to foods through the questionnaire were considered as unreliable on 
their own. In fact, Bindslev-Jensen & Norgaard (1992) observed that of the 19 adults 
reported with histories of immediate reaction to egg and milk, this was confirmed in 
only 46% with DBPCFC.
In using anti-ovalbumin IgG concentrations as a second screening tool, results 
appeared to produce substantial numbers of possibly false positives and false 
negatives. This could be due to the possibility of “hidden food allergy” in the false 
positives. The signs and symptoms of adverse reactions to foods observed by subjects 
with low levels of the specific food IgG antibody (false negatives) may be unrelated 
to hypersensitivity. Novembre et al. (1988) reported that many patients with asthma 
are sensitive to some food allergens, usually without symptoms. This hidden food 
allergy will only be manifested as a result of cofactors (exercise, simultaneous 
consumption of drugs, or crossreacting foods). It would be interesting to verify these 
cofactors and antigens uptake in future extensive studies. May (1977) also suggested 
that persistently elevated serum antibody levels to a food protein would not 
necessarily be accompanied by clinical evidence of type I hypersensitivity to the 
particular food.
There is a tendency for those who report adverse reactions to highly allergenic food 
such as eggs to have high levels of the anti-ovalbumin IgG antibody above the 
proposed normal reference values. Observations reported in Chapter 3 and 5 of this
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thesis suggest that anti-ovalbumin IgG has potential as a first line screening tool for 
food related hypersensitivity. The speculated normal reference value of 920 pg/ml 
and 558 pg/ml for anti-ovalbumin IgG for children and adults however, cannot be 
confirmed solely fi*om the data presented in this thesis. Low values of the anti- 
ovalbumin IgG do not exclude the existence of adverse reactions, as identified in 
several subjects who reported having adverse reactions to food (false-negative), and 
high values of the antibody must be carefully interpreted to avoid false-positives. 
Therefore, further studies should be undertaken using large numbers (n=500 or more) 
of atopic and healthy non-atopic subjects to confirm the normal reference range and 
grades of severity of the “adverse reactions”. A large sample size of more than 500 
subjects in each group will provide a greater power of 90% or more of reporting 
significance P values (Motulsky, 1995). In addition, information in relation to the 
onset and more exactly defined signs, symptoms and causes, either clinically or self­
perceived adverse reactions to foods, should be obtained jfrom the questionnaires and 
interviews to aid in the preliminary diagnosis of adverse reactions to foods involving 
hypersensitivity. All healthy non-atopic subjects should undergo the SPT and 
measurement of total IgE to confirm before qualifying as “clean controls”. 
Subsequently, atopic subjects with extremely high levels of anti-ovalbumin IgG 
should undergo the DBPCFC to confirm the diagnosis.
6.2 Role of diet in the treatment of asthma
The prevalence of asthma in children is increasing and, no one knows for sure the 
reasons for the increase. Urbanisation is thought to be one of the causative factors, but 
rural communities are not exempt. Factors before birth may influence prevalence of 
asthma. This includes maternal age, smoking during pregnancy, and allergen 
(including food allergens) exposure during pregnancy and in the early months of life. 
Atopy remains the most important risk factor for asthma. An Editorial in The Lancet 
(1996), reported a temptation to speculate that dietary factors may be relevant. No 
single factor is likely to be responsible for the increase in asthma, however and the 
contribution of other likely factors needs clarification to enable a better understanding
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of the situation before preventative measure can be undertaken to reduce the 
economic burden on the public health services.
The increased prevalence of symptoms perceived to be induced by food is reflected in 
the reported incidence of self-diagnosed food allergy and self-imposed allergy diets 
(Sloan 1986). The shift toward health promotion as a means of meeting Society’s 
increasingly complex health needs has encouraged health activism and efforts to 
control and improve the individual’s health. It is not surprising, therefore, that those 
who perceive food to be associated with physiological symptoms are attempting to 
control exposure to consumption of suspect foods and food components (Altman & 
Chiaramonte, 1996). Even though little is known about the impact of adverse 
reactions on diet, food-related complaints have important nutritional implications. 
Perceived food reactions have been reported to be an important factor affecting food 
use (Lau, 1985). Some investigators have raised concerns about the use of elimination 
diets and other forms of dietary manipulation among individuals with food-related 
health problems (May, 1985; Pearson et d ., 1985).
The dietary intervention study (Chapter 4) examined the affect of avoiding an 
offending antigen such as eggs and milk on the symptoms of asthma in children. 
There was a significant reduction in the specific food IgG antibody levels for 
ovalbumin (P<0.01) and P-lactoglobulin (P<0.05) in those children who participated 
in the diet-group (avoiding eggs and cows’ milk for 8 weeks); their PEER was 
observed to be significantly increased after the 8 week study period (P<0.05). Other 
improvements in symptoms include less number of asthmatic attack episodes, 
improved well-being such as less usage of p2-agonist while involved in sporting 
activities, uninterrupted sleep pattern, and an improvement in eczema. Negative 
outcome of dietary elimination include weight loss (though not statistically 
significant) in these children. The control group, who continued their customary diet, 
showed a significant increase (P<0.05) in their anti-ovalbumin IgG levels. The reason 
for this is not understood. No significant changes were observed in their anti-P- 
lactoglobulin IgG, PEER and body weight. However, their body weight increase over
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the 8 week study period was statistically higher (P<0.05) than their counterparts who 
were in the diet-group. From these observations it can be concluded that diet has a 
role in improving asthmatic conditions in some children who have an adverse 
reactions to certain foods. Asthmatic children who undertake any diet-elimination 
regimen should however be monitored regularly to prevent negative consequences in 
their nutritional status.
6.3 Pathogenesis of food allergy reactions
Development of allergic diseases has been closely associated with strong genetic 
components (Cant, 1991). The majority of patients are atopic i.e. have a tendency to 
produce excessive amounts of IgE from birth, as high levels of total IgE are found in 
the cord blood of individuals who later develop allergic diseases (Duchateau & 
Casimir, 1983). In addition, children bom into a family where both parents have 
atopy have about a 60 per cent risk of developing the condition themselves, whereas 
if there is no immediate family history the risk is only about 5 per cent (Cant, 1991).
The studies reported in this thesis observed that over 80% of the asthmatic children 
and adults with either asthma only or asthma with other atopy, had a strong 
immediate family history of atopy (see section 3.3.5.1, Chapter 3; section 4.3.4.1, 
Chapter 4; section 5.3.3.1, Chapter 5). Total IgE analysis was only carried out for 
those children who participated in the dietary intervention study (Chapter 4) but not 
for the Child and Adult Observational Studies (Chapters 3 and 5) because of limited 
serum and funding. Chandra et al. (1985), have shown that the presence of both a first 
degree relative with allergic disease and a high level of total IgE in cord blood, have a 
presentiment of allergic disease for over 80% of such infants unless breast-fed. 
Results of the dietary intervention study (Chapter 4) showed that 68% (15 of 22) of 
the asthmatic children had a total IgE above the mediant 1 SD (>75 kU/L) indicating 
that the majority of asthmatic children are atopic and confirming the findings of 
Chandra et al. (1985)
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6.4 Absorption of food antigens
The respiratory tract and gastrointestinal tract are two major routes for antigen entry 
into the body. Part of the macromolecules derived from foods can escape enzymatic 
breakdown in the digestive tract, and a small proportion are subsequently absorbed 
through the intestinal mucosa (Paganelli et al., 1986). These absorbed 
macromolecules, mainly proteins, are largely antigenically intact and therefore able to 
stimulate an immune response. The particular type of response to food antigens is 
regulated by repeated exposure to minute quantities and the peculiarity of the mucosal 
immune system (Paganelli et d., 1986).
The amount of undigested (or partially digested) protein absorbed is dependent on 
dietary intake, the maturity of digestive processes and the presence of structural or 
functional abnormalities in the gut. When a single protein antigen is present, the 
amount absorbed is higher when compared with the simultaneous administration of 
another protein (Roberts et al., 1981).
Novembre et al. (1988) reported that food allergens ingested are significantly 
modified (via digestion and absorption into the blood) before reaching the lungs 
compared with the inhaled food allergens which reach the bronchi directly and 
unmodified. Patients vrith food allergy mostly appear to have coexisting inhalant 
allergy with other non-allergenic factors such as pollutants, smoke, emotions, or 
substances such as food additives (sulphites, benzoate, tartrazine) or drugs 
(acetylsalicylic acid). It appears that these aforementioned non-allergenic factors may 
directly or indirectly induce further sensitivity and provoke asthmatic episodes in 
asthma patients with food allergy after ingesting the food allergens (Sheppard et al., 
1981; Mathison et al., 1985; Novembre et al., 1988). In this study, a quantified intake 
of certain allergenic foods was not obtained through the food frequency table. It 
would be interesting to undertake future studies to examine the value of a minimum 
7-day quantified food record providing a more complete information of allergenic 
foods consumed. In addition, analysis of food specific antigens in serum should be
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carried out to provide a better understanding in relation to the consumption,
absorption of the antigen and to the production of specific food IgG antibodies.
6.5 Recommendations
1. More carefully controlled studies in the future with a larger number of children 
and adults should be directed towards identifying the role of food sensitivity in the 
pathogenesis of asthma and in the outcome of an exclusion diet specifically eggs, 
milk and peanuts.
2. Further studies should include the DBPCFC at the end of the eight week 
elimination diet and analysis of the food specific IgG antibodies after DBPCFC. 
This will allow a comparison of the specific food IgG antibody prior to the study, 
after the 8 week clinical trial devoid of eggs and milk, and after food introduction 
through the DBPCFC. This will avoid criticism of the study’s design (Chapter 4) 
and strengthen the possible use of specific food IgG antibody as an alternative 
diagnostic or screening marker and/or as a predictor of ftiture food allergy 
development (Chapters 3 & 5). A larger sample size (n>500) of asthmatic and 
healthy non-atopic children and adults will provide invaluable data and a basis for 
the recommendation of the diagnostic marker cut-off value of food allergy as 
originally calculated.
3. Future studies on the involvement of food specific IgG subclasses would be of 
value as apparently the food specific IgGj and IgG^ subclasses have been closely 
link with food allergy (Roitt, 1997). In addition, analysis of the food specific 
antigens in serum would also provide valuable and interesting data in relation to 
the amount of antigens consumed, absorbed, circulated in the serum of individuals 
and the outcome of the signs and symptoms of asthma.
4. All asthmatic children subjects selected for future dietary elimination study should 
be older than 7 years of age unless an easy method of the measurement of lung
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capacity can be exploited. Young asthmatic children aged less than 7 years are 
incapable of performing the peak expiratory flow rate (PEFR) correctly. PEFR if 
done and recorded correctly twice a day can be a useful monitoring tool for the 
asthmatic condition. However, there is a 4-year old child in this study who was 
able to perform PEFR correctly. According to Shapiro et al., 1997, children aged 5 
years and above can be trained to perform the PEFR correctly using a party toy 
that can make a whistling sound. This was overlooked in the present study. Future 
similar studies should include several training sessions and a minimal of one 
month monitoring of PEFR readings for all children including the 4 year old 
children, prior to the study period.
5. Future dietary-intervention studies should include consideration of seasonal 
variations to avoid confounding variables and cofactor and confirm the 
effectiveness of the elimination diet. Asthmatic episodes in children can be 
triggered by many factors including foggy weather and tree or grass pollens. In 
addition, the diet pattern of individuals varies with seasonal variations for example 
more ice-creams and take-away foods are consumed during spring and summer 
compared with home-cooked meals in winter.
6. Finally, since any dietary intervention study will affect the quantity and quality of 
food intake particularly in asthmatic children who are in danger of an inadequate 
diet, the involvement of dietitians is crucial in any dietary elimination study. A 
recommended menu outline should be provided to parents along with calcium 
carbonate supplements appropriate for the age group unless the alternative milk 
product (hydrolysed soya milk) palatability is improved.
6.7 Conclusions
The quantitation of anti-ovalbumin IgG and anti-P-lactoglobulin IgG in sera standards
and the sensitive and specific ELISA developed by Lovegrove (1991) and Morris
(1991) was reproducible and provides valuable semi-quantitative measurements of the
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specific food IgG antibodies in asthmatic children and adults. Results fi*om the 
Children’s Observational Study (Chapter 3) and Adults’ Observational Study 
(Chapter 5) provide unique data on specific food IgG antibody levels for ovalbumin 
and p-lactoglobulin in asthmatic and non-atopic individuals and thus provide us with 
the opportunity to recommend an arbitrarily proposed normal reference range.
The asthmatic children with high levels of anti-ovalbumin IgG who followed a strict 
exclusion diet of eggs and milk for 8 weeks reduced circulating levels of the specific 
food IgG antibody for ovalbumin and milk; increased their lung capacity via an 
increase in PEFR; reduced the number of asthmatic episodes and improved their 
general well-being. Therefore, a strict exclusion diet of potent food allergens plays an 
important role in the treatment of asthma under the proper dietetic supervision.
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Appendix 1 
Recipes for buffers
Recipes for buffers
0.05 M Phosphate buffer saline (PBS)
8 g sodium chloride 
0.2 g potassium chloride
0.2 g potassium hydrogen phosphate 
2.9 g sodium hydrogen phosphate (anhydrous) 
1 litre H2O (pH 7.4)
Citrate buffer
7.1 g sodium hydrogen phosphate 
5.22 g citric acid 
—^  1 litre H2O
Casein buffer
9 g sodium chloride
5 g casein
5 g lOmM Tris/IM HCl (pH 7.6)
0.2 g thiomersal (0.02%)
1 litre H2O
PBSGTpH7.4
0.5 ml Tween 20 
1 g gelatine
lL0.05M PBS(pH7.4)
Tetra-methyl benzidine substrate (TMB)
100 pi TMB stock (20mg/ml TMB in DMSO). 
10 pi H202(30%)
20 ml citrate buffer
0.1 M bicarbonate/carbonate buffer pH 9.6
3.18 g sodium carbonate 
5.88 g sodium hydrogen carbonate 
1 litre H2O
Appendix 2
Information sheet and consent form for 
Children Observational Study
U niversity 
o f  S urrey
ASTHMA AND FOOD ALLERGY IN CHILDREN '
INFORMATION SHEET
Dear Parents / Guardian
The University of Surrey and The Royal Surrey County Hospital and Frimley Park 
Hospital are conducting a collaborative study on “Asthma and Food Allergy in 
Children”, We would very much appreciate if you would consent for your child to 
participate in this study.
Eggs, fish, nuts, dairy products, wheat and chocolate are among the foods which are 
known to cause acute allergic reactions in some individuals. We hope that the outcome of 
the study will help in the understanding of the relationship between food(s) and its 
consequences to asthmatic children.
Please note that participation in this study is entirely voluntary and you may withdraw 
fi*om this study at any time without giving explanation.
I f  you asree to participate we would appreciate if you could undertake the following 
tasks while you are visiting the Outpatients clinic:
1. sign the attached “Consent form” and return it to the doctor.
2. complete the attached “Questionnaire form”. If there are any questions you feel 
unable to answer or any matters you wish to discuss further please contact Noor Aini 
at the University of Surrey, telephone (01483) 259713. Please mail the completed 
form to Noor Aini.
In the Outpatients clinic your doctor shall collect a small blood sample fi-om your child.
By using an anaesthetic cream this will not be painfiil. The cream will be provided for
your child. University of Surrey
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
All information collected during the study will be treated in strict confidence and your 
child will be identified by a reference number only.
Your cooperation is very much appreciated. If there are any queries, please do not 
hesitate to contact one of us:
Noor Aini Mohd Yusoff 
Principle Local Investigator 
School of Biological Sciences 
University of Surrey 
Guildford, Surrey 
GU2 5XH
Telephone (01483) 300800 Ext.9713
Dr. Jane B. Morgan 
Senior Lecturer in Nutrition 
School of Biological Sciences 
University of Surrey 
Guildford, Surrey 
GU2 5XH
Telephone: (01483) 300800 Ext.2520
Department of Paediatrics 
Children’s Unit
The Royal Surrey County Hospital 
Egerton Road, Guildford 
Surrey GU2 5XX 
Telephone (01483) 571122
Department of Paediatrics 
Children’s Unit 
Frimley Park Hospital 
Portsmouth Road, Frimley 
Surrey GUI6 5UJ 
Telephone(01276) 692777
ASTHMA AND FOOD ALLERGY IN CHILDREN UlllVerSlty
o f  Surrey
INFORMATION SHEET
Dear Parents / Guardian
The University of Surrey and The Royal Surrey County Hospital and Frimley Park 
Hospital are conducting a collaborative study on ‘‘Asthma and Food Allergy in 
Children”. However, we also require children who are non-asthmatics to act as control 
in our studies. We would very much appreciate if you would consent for your child to 
participate in this study.
Eggs, fish, nuts, dairy products, wheat and chocolate are among the foods which are 
known to cause acute allergic reactions in some individuals. We hope that the outcome of 
the study will help in the understanding of the relationship between food(s) and its 
consequences to asthmatic children.
Please note that participation in this study is entirely voluntary and you may withdraw 
fi*om this study at any time without giving explanation.
I f  you aeree to participate we would appreciate if you could undertake the following 
tasks while you are visiting the Outpatients clinic:
3. sign the attached “Consent form” and return it to the doctor.
4. complete the attached “Questionnaire form”. If there are any questions you feel 
unable to answer or any matters you wish to discuss further please contact Noor Aini 
at the University of Surrey, telephone (01483) 259713. Please mail the completed 
form to Noor Aini.
In the Outpatients clinic your doctor shall collect a small blood sample jfrom your child.
By using an anaesthetic cream this will not be painful. The cream will be provided for 
your child.
University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
All information collected during the study will be treated in strict confidence and your 
child will be identified by a reference number only.
Your cooperation is very much appreciated. If there are any queries, please do not 
hesitate to contact one of us:
Noor Aini Mohd Yusoff 
Principle Local Investigator 
School of Biological Sciences 
University of Surrey 
Guildford, Surrey 
GU2 5XH
Telephone (01483) 300800 Ext.9713
Department of Paediatrics 
Children’s Unit
The Royal Surrey County Hospital 
Egerton Road, Guildford 
Surrey GU2 5XX 
Telephone(01483)571122
Dr. Jane B. Morgan 
Senior Lecturer in Nutrition 
School of Biological Sciences 
University of Surrey 
Guildford, Surrey 
GU2 5XH
Telephone: (01483) 300800 Ext.2520
Department of Paediatrics 
Children’s Unit 
Frimley Park Hospital 
Portsmouth Road, Frimley 
Surrey GUI6 5UJ 
Telephone(01276) 692777
U niversity
ASTHMA AND FOOD ALLERGY IN CHILDREN o f  SurrC y
C O N S E N T  F O R M
I............................................................   (BLOCK CAPITALS) agree that
my child ...............................................   will take part in the research
project entitled ‘ Asthma and food allergy in children’.
I have read the information sheet and understand that participation in this 
project is entirely voluntary.
Signed 
Date...
.(Parent or guardian)
Witnessed b y ................................................ (BLOCK CAPITALS)
Signature of witness....................................
Date
Reference number
University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
Appendix 3
Questionnaire for Children Observational Study
University of Surrey
U niversity 
o f  S urrey
Asthma and Food Allergy in Children
QUESTIONNAIRE
Reference number
Questionnaire answered by: Mother Q  i Father 2
Guardian |2 ] 3 Subject 4
Date: / /199 University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
Please answer all Questions and tick your answer in the appropriate box. Your responses will 
help us determine i f  there is any relationship between asthma and food allergy. A ll questions 
are directed to you or your child.
Section A
Child^s particulars
1) Child's
2) Child’s
3) Child’s
4) Child’s
5) Child’s
6) Child’s
7) Child’s
8) Child’s
Years /Months
Male
Day Month Year
I 11 Female Q  2 
1 kg  lb ___ oz.
kg
1 inches
cm inches
St lb
cm ft in
oz
Section B
1) Does your child have asthma?
Yes Q '  No Q
If No, please Go to Question 4
2) How long has your child been asthmatic?
years / months 
Months / Years F n
Don’t know / Can’t remember □
3) Who diagnosed your child’s asthmatic condition?
GP [2 ]   ^ Hospital doctor or Consultant ^
Others |
4) Has a family member (mother, father, brother, sister) suffered from any or some of 
the following?
w Family membersYes No Dont’l
asthma O : □
eczema □ □ □
urticaria (nettle rash) □ □ □
hay fever □ □ □
other allergies (please specify)
5) Was your child breast fed (or given breast milk)?
Yes 12] I No 1221 2 Don’t know | 13
months / years
If Yes, for how long
Don’t know □
6) When were the following foods first introduced into your child’s diet?
If Other than the specified age (in months) please give detail of age (in years) when the food was 
first introduced in the last bigger box.
Age when following foods was first introduced (months)
Never At birth 1 2 3 4  5 6 7  8 9 10 11 Others
(---------------------------------months--------------------------) (years)
breast milk □ □ □□□□□□□□□□□ □
infant formula □ □ □□□□□□□□□□□ □
follow iq) formula □ □ □□□□□□□□□□□ □
normal cow’s mUk □ □ □□□□□□□□□□□ □
goat’s milk □ □ □□□□□□□□□□□ □
soya milk □ □ □□□□□□□□□□□ □
infant cereals □ □ □□□□□□□□□□□ □
breakfast cereals □ □ □□□□□□□□□□□ □
bread □ □ □□□□□□□□□□□ □
rice □ □ □□□□□□□□□□□ □
beef □ □ □□□□□□□□□□□ □
chicken □ □ □□□□□□□□□□□ □
cheese □ □ □□□□□□□□□□□ □
yoghurt □ □ □□□□□□□□□□□ □
eggs □ □ □□□□□□□□□□□ □
vegetables □ □ □□□□□□□□□□□ □
fruits □ □ □□□□□□□□□□□ □
legumes / beans □ □ □□□□□□□□□□□ □
peanuts □ □ □□□□□□□□□□□ □
7)
8)
Does your child react adversely / have an allergy to the following?
If Yes, for how long has your child reacted been allergic to the following?
Yes (Years / Months) ^  Don’t knowo m m  Oz 0 3grass pollen
other pollen (please specify)
furry animals (eg. cat, dog) 
house dust
mites
moulds
foggy weather
strong fumes
car exhaust fumes
tobacco smoke 
Others (please specify)
Ooo
ooo
o
ooo
oo
o
ooo
o
ooo
o
ooo
o
ooo
Does the following food item(s) give your child an adverse / allergic reaction? ff 
Yes, for how long has your child reacted adversely or been allergic to the food 
item(s)?
Yes (Years / months) No Don’t know
milk and milk product □ i  m m □  z □  3
wheat products eg. bread □ m m □ □
egg □ m m □ □
peanut □  1 1 i n  1 □ □
legumes/beans □  m m □ □
fish □ m m □ □
seafood (eg prawns) □ m m □ □
spinach
□  1 1 i n  1
□ m m
□  L I i n  1
□ □Others (please specify)
I f  your child is asthmatic, please Go to Question 9 
I f  your child is not asthmatic, please Go to Question 15
9) Currently, is your child avoiding any food as a part for his/her treatment for 
asthma?
Yes (22) 1 No [ ^ 2  Not Applicable I I
If No / Not Applicable, please Go to Question 13
If Yes, please describe the food and for long has the food been avoided?
Food item(s) Duration food avoided Reasons for avoidance
years / months
10) Who advised your child to avoid the food item(s) described in Question 8?
doctor Yes □ * No □
nurse Yes □ No □
family Yes □ No □
neighbours Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
11) Has your child’s asthma improved as a result of dietary intervention with foods?
Yes [221 1 No [22] 2 
If Yes, please give details_________________________________
12) In the past has your child avoided food(s) as part of his/her treatment for asthma?
Yes 122] 1 No 122] 2  Not Applicable | |
If No / Not Applicable, please Go to Question 15
If Yes, please describe the food(s), and for how long was the food avoided?
Food item(s) Duration food avoided Reasons for avoidance
years / months
13) Who advised your child to avoid the food item(s)? 
doctor 
nurse 
family 
friends
information from book / magazine 
Others (please specify)
Yes No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
If your answer is No to Question 9 and Yes to Question 12 Please Go to Question 14
14) Please give reasons why your child no longer avoids the food(s)?
15) Does your child react adversely / have an allergy to the following drink(s)?
If Yes for how long has your child reacted adversely to the drink item(s)?
Food item(s) Yes (Years / months) No Don’t know
orange juice/drink i | | | | | | 2
fresh milk 
other milk drink
(please specify)
□□
cordials (please specify) □
blackcurrant drink 
lemon squash 
Others (please specify)
□□□
□
□□ □□ □
□ □
□ □□ □
I f  your child is asthmatic, please Go to Question 16 
I f  your child is not asthmatic, please Go to Question 24
16) Currentlv is your child avoiding any drinks as part of his/her treatment for 
asthma?
Yes [%] 1 No [221 2 Not Applicable I I 
If No / Not Applicable, please Go to Question 19
If Yes, please describe the drinks and for how long has the drinks been avoided?
Drink(s) Duration drink avoided Reasons for avoidance
years / months
17) Who advised your child to avoid the drink(s)?
doctor Yes O ' No □
nurse Yes □ No □
family Yes □ No □
friends Yes
□
No
□
information from book / magazine Yes □ No □
Others (please specify) Yes
□
No
□
18) Has your child’s asthma improve as a result of dietary intervention with drinks?
Yes 221 1 No 1221 2
If Yes, please give details.
19 In the past has your child avoided drinks as part of his/her treatment for 
asthma? Yes [%] i No 2  Not Applicable I I 
If  No / Not Applicable, please Go to Question 23
If  Yes, please describe the drinks and for how long has the drinks been avoided?
Drink(s) Duration drink avoided Reasons for avoidance
years / months
Who advised your child to avoid the drink(s)?
doctor Yes No □
nurse Yes □ No □
family Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
21) Has your child’s asthma improve as a result of dietary intervention with drinks?
Yes 221 1 No 221 2
If Yes, please give details.
If your answer is No to Question 16 and Yes to Question 19 Please Go to Question 22
22) Please give reasons why your child no longer avoid the drink(s)?
10
23) Would you be prepared for your child to avoid item(s) of food(s) eg. eggs, milk or 
milk products, wheat, seafoods, peanuts, should that be considered appropriate as a 
treatment for asthma?
Yes I2H1 
No I | 2
Not sure / don’t know [ 13
Would like more information | [ 4
24) Currently, how often does your child consume the following food items?
If Others, please specify frequency of consumption.
Never Daily 3-5 times 
per week
0 1 2
1-2 times 
per week
3
3-5 times 
per month
3
1-2 times 
per month
4
Others
5
egg □ □ □ □ □ □ □  _
fresh fruits □ □ □ □ □ □ □  —
fresh citrus fruits □ □ □ □ □ □ □  -
fresh fruit juice □ □ □ □ □ □ EH —
milk □ □ □ □ □ □ □ -
yoghurt □ □ □ □ □ □ □ _
cheese □ □ □ □ □ □ □  -
soya milk □ □ □ □ □ □ □ -
goat’s milk □ □ □ □ □ □ □ _
chocolates □ □ □ □ □ □ □ -
peanuts □ □ □ □ □ □ □ -
vitamin supplement □ □ □ □ □ □ □ _
(please specify brand)
mineral supplement □ □ □ □ □ □ □ -
(please specify brand)
11
I f  your child is asthmatic, please Go to Question 25 
I f  your child is not asthmatic, please Go to Question 29
25) How many times has your child had a serious asthma attack in the last 12 months?
none once twice three four five six more than six not applicable
□  o Q i  Q s  D 4 Q  Q  □
26) How many times has your child been admitted into the hospital for asthma attack 
in the last 12 months?
none once twice three four five six more than six not applicable
□  o □ .  O z  0 3  0 4  0  □ ,  □
27) What is your child’s current medication? (Please indicate NAME of medication
used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
28) What was your child’s previous medication? (Please indicate NAME of medication
used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
12
29) Does anyone in the family smoke?
Yes EH 1
No □
Please specify smoker
30) Mother’s education
O levels GCSE CSE 
A levels HNDBTEC 
University / Higher educ
Others (please specify) _
Yes O ' No
Yes
□
No
□
Yes
□
No
□
31) Mother’s occupation Employed EH ^  Housewife I I
Occupation of mother (please specify)________________
32) Father’s education
O levels GCSE CSE 
A levels HND BTEC 
University / Higher education
Others (please specify)______
Yes No 0 2
Yes □ No □
Yes □ No □
33) Father’s occupation Employed EH ^  Unemployed EH ^
Occupation of father (please specify)___________________________
34) Will you be interested to know the results of the study?
Yes 221 1 No I |2
If Yes, please write your address below so that we can forward the results of the study to 
you.
hfr/Mrs ______________________________
Address:
Post code:
Telephone No:
13
35) Would you be willing for your child to participate in further studies into asthma
and food allergy?
Yes
No
Don’t know 
Would like more information
□□□□
Please return questionnaire in the self-addressed stamped envelope provided. 
Thank you very much for responding to all the questions.
The answers you have given will help us to determine if there is any relationship between
asthma and food allergy.
Noor Aini Mohd Yusoff (Research Fellow)
Dr Jane B. Morgan (Senior Lecturer in Nutrition) 
Dr Shelagh M. Hampton (Senior Research Fellow) 
School of Biological Sciences, University of Surrey, 
Guildford, Surrey GU2 5XH 
Telephone (01483) 300800 Extension 9713
and
Department of Paediatries 
Children’s Unit
The Royal Surrey County Hospital 
Egerton Road, Guildford 
Surrey GU2 5XX 
Telephone (01483) 571122
Department of Paediatrics 
Children’s Unit 
Frimley Park Hospital 
Portsmouth Road, Frimley 
Surrey GU16 5UJ 
Telephone (01276) 692777
Appendix 4
Follow-up questionnaire for Children Observational Study
Subject Code Number
ASTHMA AND FOOD ALLERGY IN CHILDREN
Dear Mr. & Mrs.______________________
CONFIDENTIAL
Thank you for participating in the collaborative study carried out by The 
University of Surrey, The Frimley Park Hospital and The Royal Surrey County 
Hospital on “Asthma and Food Allergy in Children”. The blood sample analysis
from _________________ has been delayed as we are continuing to recruit the
control subjects, i.e. children who do not suffer from asthma. We will let you 
know the results as soon as it is finished. However, in the mean time I would very 
much appreciate if you could complete the following information about
As with all other information we have collected o n ________, this information
will be identifiable by a code number only for the purposes of data analysis and 
interpretation.
1. How severe is your child’s asthma? (Please tick one of the boxes below)
mild □
moderate □
severe □
2. Does your child suffer from any or some of the following?
Yes No 
□  □  □ □
urticaria EH EH
other allergies (please specify) EH I I
eczema 
hay fever
diabetes mellitus EH EH
cystic fibrosis EH I I
otiier medical conditions (please specify) 2H EH
T3
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4. What type of cooking stove do you use?
gas
electricity
□
□
5. Do you live close to a busy main road or have you ever lived close to a busy 
main road?
Yes 221 No 221 
If Yes, please state the time (year) of staying close to a busy main road.
from (year)
from (year)
from (year)
to
to
to
Please return by in the self-addressed stamped envelope provided.
If you are unable to answer any of the questions, please return this form in any 
case.
Thank you for your support and cooperation.
Noor Aini Mohd Yusoff 
(Principal Research Investigator) 
Ph: (01483) 259713
Appendix 5 
Information on Dietary Intervention Study
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Appendix 6 
Pre-dietary intervention assessment form
CONFIDENTIAL
Diet and Asthma
PRE-DIETARY INTERVENTION 
ASSESSMENT
University 
o f  Surrey
Reference number
Hosp. Rn:
Name:
Age:
DOB.
years
day month year
University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
1. Sex
2. Weight (current)
3. Height (current)
Male 1 2 ] Fem ale | |
kg
I cm
Clinical Assessment:
1. P resence of cough yes | 2 ]
2. P resence of nocturnal cough yes [ 2 ]
3. P resence of w heeze yes CZI
no
no
no
□
□
□
4. Number of acute asthm a attack in the previous 8 weeks.
once twice three four five six more than six
□  □ □ □ □ □  □
5. Current medication (type, dosage and frequency of use):
Type of medications D osage Frequency of use Name of medications
Bronchodilators
Inhaled
corticosteroids
Oral corticosteroids
6. Severity of asthm a.
miid Q  m oderate Q  severe
7. Respiratory ra te :__________________________
8. PEFR:   l/min.
Appendix 7 
Questionnaire for Dietary Intervention Study
CONFIDENTIAL
Diet and Asthma
Questionnaire
University 
o f  Surrey
Reference number
Date: I  /199
University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
Please answ er ail Q uestions and  tick your answ er in the appropriate box.
1. D oes y o u r child  have an y  o f th e  fo llow ing? If Y es how  long have y o u r child  
had  th e  s ta te d  co n d itio n ?
Y es No If Yes, fo r how  long
years / months
asthm a □ □
eczem a □ □
urticaria (nettle-rash) □ □
hay fever
other allergies (p lea se  specify)
□ □
3. D oes y o u r child  reac t ad v e rse ly  /  have an  allergy  to  th e  fo llow ing?
If Y es, please specify the signs and sym ptoms of the adverse reactions.
S ig n s/S y m p to m s o f ad v e rse  reactionY es No
grass polien □ □
tree pollen □ □
furry animals 
(e.g.cat, dog) □ □
house dust □ □
mites □ □
moulds □ □
foggy w eather □ □
strong fumes □ □
car exhaust fumes □ □
tobacco sm oke
□ □
perfumes □ □
O thers (p lease  specify)
4. D oes th e  follow ing fo o d  item (s) give y o u r child  an  ad v e rse  /  a llerg ic  
re ac tio n ?
If Y es , p lease specify the signs and sym ptoms of the reactions after consuming 
the foods.
Y es
milk and milk products
□
w heat products 
e.g. bread
eggs O
nuts □
(p lease  sp ec ify  ty p e  o f nu ts)
 □
legum es/beans |— |
□
□
fish
prawns
orange juice/drink 
cordials
fizzy drinks (p lease  specify) 
O thers (p lease  specify)
No
□
□
□
□
□  
□
□  □
□
□
S ig n /S y m p to m s o f ad v e rse  reaction
5. C urren tly  is  y o u r ch ild  avo id ing  an y  fo o d s  o r  d rin k s in y o u r d ie t?
If Y es, please describe the food or drink and how long has the food or drink been 
avoided? P lease give reasons why your child avoided taking the food or drink?
Type o f fo o d s/d rin k s  D uration food /d rink  av o id ed  R easo n s  fo r av o id an ce
y ea rs  /m o n th s
6. W ould you  c o n s id e r  allow ing y o u r child  to  co n su m e  a  milk su b s titu te  
g iven to  y o u r child  free  o f ch a rg e ?
Yes 1 2 ] No I I
7. How m any  tim es  h a s  y o u r child  v isited  y o u r GP o r  d o c to rs  in th e  h o sp ita l 
in th e  la s t 12 m o n th s  ?
none once twice three four five six more than six
□  □ □ □ □ □ □  □
8. P lease  sp ec ify  th e  n u m b er o f tim es  y o u r child  v isited  y o u r G P o r  d o c to rs  
in th e  h o sp ita l in th e  la s t 12 m o n th s  b e c a u se  o f h is /h e r a s th m a  co n d itio n ?
none once twice three four five six more than six
□  □ □ □ □ □ □  □
9. How m any  tim e s  h a s  y o u r child  had  a s th m a  a ttack  in th e  la s t 12 m o n th s?
none once twice three four five six more than six
□  □ □ □ □ □ □  □
10. How m any  tim e s  h a s  y o u r child  b een  adm itted  in to  th e  h o sp ita l fo r  a s th m a  
a ttack  in th e  la s t 12 m o n th s?
none once twice three four five six more than six
□  □ □ □ □ □ □  □
11. How m any  tim es  h a s  y o u r child  b een  a b s e n t  from  sc h o o l d u e  to  a s th m a  
a ttack  s in c e  th e  sc h o o l re o p en s  in S ep tem b e r 1996?
none once twice three four five six more than six
□  □ □ □ □ □ □  □
12. D oes an y o n e  in y o u r hom e sm o k e?
Yes [ 2 ]  No I I
Appendix 8 
Non-compliance and PEFR forms
Dear Parents,
I f ______________ consumed eggs, milk and their products accidently, please
recall these events and note them in the form provided. Please record date, time 
and type of foods consumed. The amount of the food consumed is not important.
Date Time Type of foods
1/
r^Vcf kk U
Daily P eak  Flow C hart 
S u b jec t R eference Num ber:
Month
Date
Day Mon TuÎS Wed Thurs Fri Sat Sun Mon Tues Wed Thurs Fri Sat Sun
Time am pm am pm am pm am pm am pm am pm am pm am pm am pm am pm am pm am pm am pm am pm
700
680
660
640
620
ovv
580
560
540
520
JW
480
460
440
420
/inn—4W
380
360
340
320
7nn—jyjyj
280
260
240
220
200—
180
160
140
120
100—
80
60
40
20
Month
Date
Day
Time
700
680
660
640
620
600
580
560
540
520
500
480
460
440
420
400
380
360
340
320
300
280
260
240
220
200
180
160
140
120
100
80
60
40
20
Remarks / Medications
Appendix 9
Booklet on food products free from milk and eggs
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Appendix 10 
(see pocket of thesis)
7-day food record (diary)
Appendix 11 
Post-dietary intervention assessment form
CONFIDENTIAL
Diet and Asthma
POST-DIETARY INTERVENTION 
ASSESSMENT
University 
o f  Surrey
Reference number
Hosp.Rn:
Name:
Age:
D.G.B.
_ years
d a y  m o n th  y e a r
Date: I  1 199
University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
Weight (current) 
Height (current)
kg
cm
C lin ica l A s s e s s m e n t :
1. P resence of cough yes Q n o Q
2. P resence of nocturnal cough yes Q no r~ i
3. P resence of w heeze yes O n o O
4. Number of acute asthm a attack in the previous 8 w eeks.
once twice three four five six more than six
□  □ □ □ □ □  □
5. Current medication (type, dosage and frequency of use):
Type of medications Dosage Frequency of 
use
Name of medications
Bronchodilators
Inhaled
corticosteroids
Oral corticosteroids
6. Severity of asthm a.
mild Q  m oderate Q  severe  Q
7. C h e s t_____________________________
8. Respiratory ra te :__________________________
9. PEFR: IVmin.
10. Progress in the last 8 w eeks including: 
diurnal co u g h ______________________
nocturnal cough
sleep
w heeze
PEFR
others
11. Name of G.P. 
Address:
12. Hospital Consultant:
Appendix 12 
Questionnaire for Adult Observational Study
University 
o f  Surrey
University of Surrey
Asthma / Eczema and Food Allergy in Adult
QUESTIONNAIRE
Reference number
Date: / /199 University of Surrey 
Guildford 
Surrey GU2 5XH 
England
Telephone: (01483) 300800
Fax: (01483) 300803
Telex: 859331
Please answer all Questions and tick your answer in the appropriate box. Your responses will 
help us determine i f  there is any relationship between asthma or eczema and food allergy.
Section A
Years / Months
1) Respondent’s age
2)
3)
4)
5)
Respondent’s gender Male [__J 1 Female | | 2
Respondent’s weight (current) 1 1 1 kg St lb
Respondent’s height (current) cm ft in
Respondent’s educational level 
0  levels GCSE CSE Yes Q 1 No
A levels HND BTEC Yes □ No □
University /Higher education Yes □ No □
oz
If Student at the University (please indicate (tick) present status)
Undergraduate Postgraduate Diploma Master PhD□ □ □ □
Others (please specify)__________________________
6) Respondent’s occupation Employed i Unemployed Q  2
Occupation (please specify)_________________________
7) Do you smoke?
Yes [2 ]  1 
No Q ]
Section B
1) Do you have asthma?
Yes 12] I No [2 ]  2 
If No, please Go to Question 4
2) How long have you been asthmatic?
years / months
Months / Years
Don’t know/ Can’t remember □
3) Who diagnosed your asthmatic condition?
GP 22]  ^ Hospital doctor or Consultant 2 ] j  2 
Others |22| 3 (please give detail) _______________
4) Do you have eczema?
Yes d] 1 No EZ] 2
If No, please Go to Question 7
5) How long have you had eczema?
years / months
Months / Years
Don’t know / Can’t remember □
6) Who diagnosed your eczema condition?
GP [22  ^ Hospital doctor or Consultant [22] 2 
Others | | 3 (please give detail)  ______________
7) Has a family member (mother, father, brother, sister) suffered from any or some of 
the following?
Yes No Don’t know
asthma □ . □ 3 .
eczema □ □ □
urticaria (nettle-rash) □ □ □ ■
hay fever □ □ □ .
other allergies (please specify)□□
8) Do you react adversely / have an allergy to the following?
If Yes, for how long have you reacted / been allergic to the following?
yes (Years / Months) No Don't know
grass pollen
other pollens (please specify)
furry animals (eg. cat, dog) 
house dust
mites
moulds
foggy weather
strong fumes
car exhaust fumes
tobacco smoke 
Others (please specify)
□□□□□□
□
□□□
□
□
□□□□
□
□□□
□
□□□
□
□□□
10) Does the following food item(s) give you an adverse / allergic reaction?
If Yes, for how long have you reacted adversely or been allergic to the food item(s)?
Yes (Years / months) No Don’t know
milk and milk product m m □ 3 □ 3
wheat products eg. bread □ m m □ □
egg □ mi Cl 1 □ □
peanut □ m m □ □
legumes/beans □ m m □ □
fish □ m m □ □
seafood (eg prawns) □ m m □ □
spinach
Others (please specify) □ m m □ □□ DTI mi□ CJ 1 1
I f  you are asthmatic, please Go to Question 9 
I f  you are not asthmatic, please Go to Question 15
9) Currently, are you avoiding any food as a part of your treatment for asthma?
Yes I I 1 No I 1 2 Not Applicable | | 88
If No / Not Applicable, please Go to Question 12
If Yes, please describe the food and for long has the food been avoided?
Food item(s) Duration food avoided 
years / months
Reasons for avoidance
10) Who advised you to avoid the food item(s) described in Question 9?
doctor Yes No □
nurse Yes □ No □
family Yes □ No □
neighbours Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
11) Have your asthma improved as a result of dietary intervention with foods?
Yes 122 1 No [22 2
If Yes, please give details
12) In the past have you avoided food(s) as part of your treatment for asthma?
Yes [22 I No I I 2  Not Applicable [22 88
If  No / Not Applicable, please Go to Question 15
If Yes, please describe the food(s), and for how long was the food avoided?
Food item(s) Duration food avoided Reasons for avoidance
years / months
f f l
13) Who advised you to avoid the food item(s)? 
doctor 
nurse 
family 
friends
information from book / magazine 
Others (please specify)
Yes O ' No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
If your answer is ^  to Question 9 and Yes to Question 1 2  
Please Go to Question 14.
14) Please give reasons why you no longer avoid the food(s)?
I f  you have eczema, please Go to Question 15 
I f  you do not have eczema, please Go to Question 21
15) Currently, are you avoiding any food as a part of your treatment for eczema? 
Yes I I  1 No I  1 2 Not Applicable | |
If No / Not Applicable, please Go to Question 18
If Yes, please describe the food and for long has the food been avoided?
Food item(s) Duration food avoidedReasons for avoidance
years / months
16) Who advised you to avoid the food item(s) described in Question 15?
doctor Yes No □
nurse Yes □ No □
family Yes □ No □
neighbours Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
17) Have your eczema improved as a result of dietary intervention with foods?
Yes 2 2  1 No 22] 2
If Yes, please give details
18) In the past have you avoided food(s) as part of your treatment for eczema?
Yes I I 1 No I 12  Not Applicable | [ 88
If No / Not Applicable, please Go to Question 21
If Yes, please describe the food(s), and for how long was the food avoided?
Food item(s) Duration food avoided Reasons for avoidance
years / months
m
19) Who advised you to avoid the food item(s)? 
doctor 
nurse 
family 
friends
information from book / magazine 
Others (please specify)
Yes O ' No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
Yes □ No □
If your answer is ^  to Question 15 and Yes to Question 18 
Please Go to Question 20
20) Please give reasons why you no longer avoid the food(s)?
10
21) Do you react adversely / have an allergy to the following drink(s)? 
If Yes, for how long have you reacted adversely to the drink item(s)?
Food item(s)
orange juice/drink 
fresh milk 
other milk drinks 
(please specify)_
cordials (please specify)
blackcurrant drink 
lemon squash 
Others (please specify)
□
□□
□
□
Yes (Years / months) 
□ .□□
No□ Don’t know 2 O  3□ □□ □
□ □
□ □□ □
I f  your are asthmatic, please Go to Question 22 
I f  you are ngtasthmatic, please Go to Question 29
22) Currently are you avoiding any drinks as part of your treatment for asthma?
Yes I I 1 No I 12  Not Applicable | | 88
If No / Not Applicable, please Go to Question 25
If Yes, please describe the drinks and for how long has the drinks been avoided?
Drink(s) Duration drink avoided
years / months
Reasons for avoidance
11
23) Who advised you to avoid the drink(s)?
26)
doctor Yes □ > No □
nurse Yes □ No □
family Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
24) Have your asthma improved as a result of dietary intervention with drinks?
Yes 122] 1 No 22] 2
If Yes, please give details.
25) In the past have you avoided drinks as part of your treatment for asthma? 
Yes EZI 1 No 2 Not Applicable EZI 88
If No / Not Applicable, please Go to Question 29
If  Yes, please describe the drinks and for how long has the drinks been avoided?
Drink(s) Duration drink avoided Reasons for avoidance
years / months
Who advised you to avoid the drink(s)?
doctor Yes No □
nurse Yes □ No □
family Yes □ No □
friends Yes □ No □
information from book / magazine Yes □ No □
Others (please specify) Yes □ No □
12
27) Have your asthma improved as a result o f dietary intervention with drinks?
Yes [2 ]  1 No [2 ]  2
If Yes, please give details.
If your answer is No to Question 22 and Yes to Question 25 
Please Go to Question 28
28) Please give reasons why you no longer avoid the drink(s)?
29) Would you be prepared to avoid item(s) of food(s) eg. eggs, milk or milk products, 
wheat, seafoods, peanuts, should that be considered appropriate as a treatment for 
asthma or eczema?
Yes
No
Not sure / don’t know 
Would like more information
□□□□
13
30) Currently, how often do you consume the following food items? 
If Other, please specify frequency of consumption.
0
None
1
Daily
2
3-5 times 
per week
3
1-2 times 
per week
3
3-5 times 
per month
4 5 
1-2 times Other 
per month
eggs □ □ □ □ □ □ m
fresh fruits □ □ □ □ □ □ □ -
fresh citrus fruits □ □ □ □ □ □ □ _
fresh fruit juice
□ □ □ □ □ □ □ -
milk □ □ □ □ □ □ □ -
yoghurt
□ □ □ □ □ □ □ -
cheese □ □ □ □ □ □ □ -
soya milk □ □ □ □ □ □ □ _
goat’s milk □ □ □ □ □ □ □ _
chocolates
□ □ □ □ □ □ □ -
peanuts □ □ □ □ □ □ □ _
fish □ □ □ □ □ □ □ _
prawns □ □ □ □ □ □ □ -
vitamin supplement □ □ □ □ □ □ □ _
(please specify brand)
mineral supplement | |
□ □ □ □ □ □ -
(please specify brand)
14
I f  you are asthmatic, please Go to Question 31 
I f  you are not asthmatic, please Go to Question 35
31) How many times have you had a serious asthma attack in the last 12 months?
none once twice three four five six more than six not applicable
O ' O' O' O' O' O' O' O' o
32) How many times have you been admitted into the hospital for asthma attack in the 
last 12 months?
none once twice three four five six more than six not applicable
O ' O' O' O' O' O' O' O' o
33) What is yonr current medication for asthma? (Please indicate NAME of medication 
used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
34) What was your previous medication for asthma? (Please indicate NAME of 
medication used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
15
I f  you have eczema, please Go to Question 35 
I f  you do not have eczema, please Go to Question 37
35) What is your current medication for eczema? (Please indicate NAME of 
medication used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
36) What was your previous medication for eczema? (Please indicate NAME of 
medication used, DOSAGE and LENGTH OF TIME)
Name of Medication Dose Frequency Length of time
37) Will yon be interested to know the results of the study?
Yes EZI 1 No EZI 2
If Yes, please write your address below so that we can forward the results of the study to 
you.
Mr / Mrs / Ms 
Address:
Post code: 
Telephone No:
1 6
38) Would you be willing to participate in further studies into asthma or eczema and 
food allergy?
Yes 2 ]  1
N o 1 2 ]  2
Don’t know | 13
Would like more information j j 4
Thank you very much for responding to all the questions.
The answers you have given will help us to determine if there is any relationship 
between asthma / eczema and food allergy.
Noor Aini Mohd Yusoff (Principal Research Investigator) 
Dr Jane B. Morgan (Senior Lecturer in Nutrition)
Dr Shelagh M. Hampton (Senior Research Fellow)
School of Biological Sciences, University of Surrey,
Guildford, Surrey GU2 5XH
Telephone (01483) 300800 Extension 9713
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IgG (pg/ml) and total IgE (kU/L) concentrations in 
asthmatic children recruited into the diet-group and 
non-diet group pre-dietary and post-dietary intervention 
(a diet devoid of egg and milk for 8 weeks)
Figure 4.5 Pre-dietary intervention and post-dietary intervention 128
total IgE (kU/L) and anti-ovalbumin IgG concentrations 
(pg/ml) in asthmatic children recruited into the diet-group 
Figure 4.6 Pre-dietary intervention and post-dietary intervention 128
total IgE (kU/L) and anti-ovalbumin IgG 
concentrations (pg/ml) in asthmatic children recruited 
into the non-diet group 
Figure 4.7 Pre-dietary intervention and post-dietary intervention 129
anti-ovalbumin IgE (grade) and anti-ovalbumin 
IgG (pg/ml) concentrations in asthmatic children 
recruited into the diet-group
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Figure 4.8 Pre-dietary intervention and post-dietary intervention 129
anti-ovalbumin IgE (grade) and anti-ovalbumin IgG 
(pg/ml) concentrations in asthmatic children recruited 
into the non-diet group 
Figure 4.9 Mean peak expiratory flow rate (PEFR) in asthmatic 132
children recruited into the diet-group (DG) and non-diet 
group (NDG) before and after dietary intervention 
(a diet devoid of egg and milk for 8 weeks)
Figure 4.10 Pre-dietary and post-dietary intervention PEFR (L/min) 133 
and anti-ovalbumin IgG (pg/ml) in asthmatic children 
recruited into the diet-group 
Figure 4.11 Pre-dietary and post-dietary intervention PEFR (L/min) 133
and anti-ovalbumin IgE (grade) in asthmatic children 
recruited into the diet-group 
F igure 4.12 Pre-dietary and post-dietary intervention PEFR (L/min) 134
and anti-ovalbumin IgG (pg/ml) in asthmatic children 
recruited into the non-diet group 
F igure 4.13 Pre-dietary and post-dietary intervention PEFR (L/min) 134
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recruited into the diet-group 
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Figure 4.15 Pre-dietary and post-dietary intervention PEFR (L/min) 135
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children recruited into the non-diet group 
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Figure 4.17 Pre-dietary and post-dietary intervention peak 143
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recruited into the diet- and non-diet groups 
Figure 4.18 Pre-dietary and post-dietary intervention peak expiratory 143
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(grade) in asthmatic children with egg allergy recruited 
into the diet- and non-diet groups 
Figure 4.19 Pre-dietary and post-dietary intervention 144
anti-p-lactoglobulin IgG (pg/ml) and PEFR (L/min) 
in asthmatic children with milk allergy recruited into 
the diet- and non-diet groups 
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